Media Center

 

Portfolio News Archives

« Back to Current News

Sesen Bio
December 3, 2018 - Sesen Bio Appoints Drug Development Expert, Dennis Kim, M.D., MPH, as Chief Medical Officer
» Press Release | Company News

GBT
December 3, 2018 - GBT Announces Positive 24-week Results from Phase 3 HOPE Study Demonstrating Clinically and Statistically Significant Improvements in Hemoglobin and Clinical Measures of Hemolysis and a Favorable Safety Profile
» Press Release | Company News

GBT
December 3, 2018 - GBT Announces U.S. FDA Agrees with its Proposal Relating to Accelerated Approval Pathway for Voxelotor for the Treatment of Sickle Cell Disease and GBT Plans to Submit New Drug Application (NDA)
» Press Release | Company News

Agios Pharmaceuticals
December 3, 2018 - Agios Presents Updated Data from the Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1 Mutant Positive Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Ineligible for Standard Treatment and Myelodysplastic Syndrome (MDS)
» Press Release | Company News

Agios Pharmaceuticals
December 3, 2018 - Agios Announces Updated Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Standard Induction and Consolidation Chemotherapy in Newly Diagnosed AML Patients With an IDH Mutation
» Press Release | Company News

bluebird bio
December 3, 2018 - bluebird bio Presents New Data for LentiGlobin Gene Therapy in Transfusion Dependent β-Thalassemia at 60th Annual Meeting of the American Society of Hematology
» Press Release | Company News

bluebird bio
December 3, 2018 - bluebird bio Presents New Data for LentiGlobin Gene Therapy in Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology
» Press Release | Company News

Magenta Therapeutics
December 2, 2018 - Magenta Therapeutics Presents New Data from Phase 2 Study of MGTA-456 Cell Therapy in Patients with Inherited Metabolic Disorders
» Press Release | Company News

Magenta Therapeutics
December 2, 2018 - Magenta Therapeutics Presents Preclinical Data on Targeted Non-Genotoxic Conditioning Programs Demonstrating Potent Stem Cell Depletion and Anti-Leukemia Survival Benefit
» Press Release | Company News

GBT
December 2, 2018 - GBT to Host Conference Call at 8:30 a.m. Eastern Time Tomorrow to Provide a Regulatory Update for Voxelotor
» Press Release | Company News

Editas Medicine
December 2, 2018 - Editas Medicine Announces Pre-Clinical Data Supporting Novel Approach for Treatment of Sickle Cell Disease and Beta-Thalassemia
» Press Release | Company News

Blueprint Medicines
December 2, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
» Press Release | Company News

bluebird bio
December 2, 2018 - bluebird bio and Celgene Corporation Present Initial Data from Ongoing Phase 1 Clinical Study of Next-Generation Anti-BCMA CAR T Cell Therapy bb21217 in Patients with Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
» Press Release | Company News

Magenta Therapeutics
December 1, 2018 - Magenta Therapeutics Presents New Preclinical Data on MGTA-145 Stem Cell Mobilization Product Candidate
» Press Release | Company News

Magenta Therapeutics
December 1, 2018 - Magenta Therapeutics Presents New Preclinical Data on MGTA-145 Stem Cell Mobilization Product Candidate
» Press Release | Company News

bluebird bio
December 1, 2018 - bluebird bio Presents Updated Data from Clinical Studies of LentiGlobin Gene Therapy in Transfusion-Dependent β-Thalassemia and Sickle Cell Disease at 60th Annual Meeting of the American Society of Hematology
» Press Release | Company News

bluebird bio
November 30, 2018 - bluebird bio to Host Live Webcast of Investor and Analyst Event at the 60th Annual Meeting of the American Society of Hematology
» Press Release | Company News

Editas Medicine
November 30, 2018 - Editas Medicine Announces FDA Acceptance of IND Application for EDIT-101
» Press Release | Company News

Voyager Therapeutics
November 29, 2018 - Voyager Therapeutics Enters into Strategic Manufacturing Collaborations with Brammer Bio and Fujifilm Diosynth Biotechnologies
» Press Release | Company News

Constellation Pharmaceuticals
November 29, 2018 - Constellation Pharmaceuticals to Present at BMO Healthcare Conference
» Press Release | Company News

Constellation Pharmaceuticals
November 29, 2018 - Constellation Pharmaceuticals Appoints Patrick Trojer, Ph.D., as Chief Scientific Officer
» Press Release | Company News

bluebird bio
November 27, 2018 - Celgene Corporation and bluebird bio Complete Enrollment of Pivotal KarMMa Study of anti-BCMA Car T Cell Therapy bb2121 in Patients with Relapsed and Refractory Multiple Myeloma
» Press Release | Company News

Zafgen
November 26, 2018 - Zafgen Provides Update on Investigational New Drug Application for ZGN-1061
» Press Release | Company News

Magenta Therapeutics
November 26, 2018 - Magenta Therapeutics to Host Webcast of Investor and Analyst Event During ASH
» Press Release | Company News

Kala Pharmaceuticals
November 23, 2018 - Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Zafgen
November 21, 2018 - Zafgen to Present at the 30th Annual Piper Jaffray Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
November 21, 2018 - Sage Therapeutics to Present at Piper Jaffray 30th Annual Healthcare Conference
» Press Release | Company News

Pliant Therapeutics
November 20, 2018 - Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Primary Sclerosing Cholangitis
» Press Release | Company News

SAGE Therapeutics
November 20, 2018 - Sage Therapeutics Receives Notification of PDUFA Extension for ZULRESSO™ (brexanolone) Injection
» Press Release | Company News

Magenta Therapeutics
November 19, 2018 - Magenta Therapeutics Appoints Jason Ryan as Chief Operating and Financial Officer
» Press Release | Company News

Voyager Therapeutics
November 19, 2018 - Voyager Therapeutics to Present at the Evercore ISI Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
November 16, 2018 - Agios Presents Updated Data from Phase 1 Dose-Escalation Study of AG-881 in Patients with IDH Mutant Positive Advanced Glioma
» Press Release | Company News

Neon Therapeutics
November 16, 2018 - Neon Therapeutics Named a Top Place to Work in Massachusetts by The Boston Globe
» Press Release | Company News

bluebird bio
November 15, 2018 - bluebird bio to Present at the Evercore ISI HealthCONx Conference
» Press Release | Company News

Blueprint Medicines
November 15, 2018 - Blueprint Medicines Announces Updated NAVIGATOR Trial Results in Patients with Advanced Gastrointestinal Stromal Tumors Supporting Development of Avapritinib Across All Lines of Therapy
» Press Release | Company News

Constellation Pharmaceuticals
November 15, 2018 - Constellation Pharmaceuticals Highlights EZH2 Inhibition Program in Prostate Cancer at Biomedical Conference
» Press Release | Company News

Rhythm Pharmaceuticals
November 15, 2018 - Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Alström Syndrome at ObesityWeek 2018
» Press Release | Company News

Ablexis
November 13, 2018 - Ablexis Announces Progress in Its Intellectual Property on AlivaMab Mouse and Immunoglobulin Locus Engineering
» Press Release | Company News

Jounce Therapeutics
November 13, 2018 - Jounce Therapeutics Reports Third Quarter 2018 Financial Results
» Press Release | Company News

REVOLUTION Medicines
November 13, 2018 - REVOLUTION Medicines Announces Presentations at Scientific Meetings in Third and Fourth Quarters of 2018
» Press Release | Company News

Myokardia
November 12, 2018 - MyoKardia Presents Preclinical Evidence of Mavacamten’s Novel Effect on Diastolic Compliance at the 2018 American Heart Association Scientific Sessions
» Press Release | Company News

Neon Therapeutics
November 12, 2018 - Neon Therapeutics Reports Third Quarter 2018 Financial Results and Recent Business Highlights
» Press Release | Company News

CytomX Therapeutics
November 9, 2018 - CytomX Therapeutics Presents CX-072 Clinical Translational Data at 2018 SITC Annual Meeting
» Press Release | Company News

Neon Therapeutics
November 9, 2018 - Neon Therapeutics Presents Updated Data at the Society for Immunotherapy of Cancer’s 33rd Annual Meeting
» Press Release | Company News

Pliant Therapeutics
November 9, 2018 - Pliant Therapeutics Presents Preclinical Data in NASH and PSC at The Liver Meeting 2018
» Press Release | Company News

Rhythm Pharmaceuticals
November 9, 2018 - Rhythm Pharmaceuticals Reports Third Quarter 2018 Financial Results
» Press Release | Company News

Taris Biomedical
November 9, 2018 - TARIS Announces Late-Breaking Poster on the Natural History of Muscle-Invasive Bladder Cancer Patients Not Receiving Potentially Curative Therapy
» Press Release | Company News

Kala Pharmaceuticals
November 8, 2018 - Kala Pharmaceuticals Reports Third Quarter 2018 Financial Results
» Press Release | Company News

Magenta Therapeutics
November 8, 2018 - Magenta Therapeutics Reports Recent Operational Progress and Third Quarter 2018 Financial Results
» Press Release | Company News

Sesen Bio
November 8, 2018 - Sesen Bio Reports Third Quarter 2018 Financial Results and Planned VISTA Trial Readouts
» Press Release | Company News

Constellation Pharmaceuticals
November 8, 2018 - Constellation Pharmaceuticals Announces Third-Quarter and Nine-Month 2018 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
November 7, 2018 - Allena Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Business Update
» Press Release | Company News

CytomX Therapeutics
November 7, 2018 - CytomX to Present at the Jefferies 2018 London Healthcare Conference
» Press Release | Company News

Editas Medicine
November 7, 2018 - Editas Medicine Announces Third Quarter 2018 Results and Update
» Press Release | Company News

Kala Pharmaceuticals
November 7, 2018 - Kala Pharmaceuticals to Present at the Jefferies 2018 London Healthcare Conference
» Press Release | Company News

Myokardia
November 7, 2018 - MyoKardia Reports Third Quarter 2018 Financial Results
» Press Release | Company News

Myokardia
November 7, 2018 - MyoKardia to Present at the Credit Suisse 27th Annual Healthcare Conference
» Press Release | Company News

Neon Therapeutics
November 7, 2018 - Neon Therapeutics Appoints Industry Veteran Robert Bazemore to its Board of Directors
» Press Release | Company News

Nurix, Inc.
November 7, 2018 - Nurix Therapeutics to Present at the Stifel Healthcare Conference
» Press Release | Company News

Rhythm Pharmaceuticals
November 7, 2018 - Rhythm Pharmaceuticals to Present at Stifel 2018 Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
November 7, 2018 - Sage Therapeutics to Present at Stifel 2018 Healthcare Conference
» Press Release | Company News

Voyager Therapeutics
November 7, 2018 - Voyager Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Highlights
» Press Release | Company News

Voyager Therapeutics
November 7, 2018 - Voyager Therapeutics Announces Positive Longer-Term Data for VY-AADC for Parkinson’s Disease
» Press Release | Company News

Zafgen
November 7, 2018 - Zafgen Reports Third Quarter 2018 Operating and Financial Results
» Press Release | Company News

Allena Pharmaceuticals
November 6, 2018 - Allena Pharmaceuticals to Present at Upcoming Investor Conferences in November
» Press Release | Company News

CytomX Therapeutics
November 6, 2018 - CytomX Therapeutics Announces CX-072 Clinical Presentations at 2018 SITC Annual Meeting
» Press Release | Company News

CytomX Therapeutics
November 6, 2018 - CytomX Therapeutics Announces Third Quarter 2018 Financial Results
» Press Release | Company News

GBT
November 6, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

GBT
November 6, 2018 - GBT Reports Recent Business Progress and Provides Third Quarter 2018 Financial Results
» Press Release | Company News

Jounce Therapeutics
November 6, 2018 - Jounce Therapeutics to Announce Third Quarter 2018 Financial Results and Host Conference Call on Tuesday, November 13, 2018
» Press Release | Company News

SAGE Therapeutics
November 6, 2018 - Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress
» Press Release | Company News

Zafgen
November 6, 2018 - Zafgen to Present at the Stifel 2018 Healthcare Conference
» Press Release | Company News

Ablexis
November 5, 2018 - Ablexis Announces Antibody Discovered Using AlivaMab Mouse Platform Enters Clinical Development
» Press Release | Company News

Myokardia
November 5, 2018 - MyoKardia to Present Clinical Evidence of Mavacamten’s Effect on Diastolic Function at 2018 American Heart Association Scientific Sessions
» Press Release | Company News

Myokardia
November 5, 2018 - MyoKardia Announces Twelve Abstracts Accepted for Presentation During the 2018 American Heart Association Scientific Sessions
» Press Release | Company News

SAGE Therapeutics
November 5, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Ninepoint Medical
November 5, 2018 - NinePoint Medical Announces FDA Clearance of an Artificial Intelligence Software Upgrade for the NvisionVLE® Imaging System
» Press Release | Company News

SAGE Therapeutics
November 2, 2018 - Sage Therapeutics Stock Trading Halted Today; FDA Advisory Committee Meeting to Discuss ZULRESSO™ (brexanolone) Injection for the Treatment of Postpartum Depression
» Press Release | Company News

Constellation Pharmaceuticals
November 2, 2018 - Constellation Pharmaceuticals to Present at Upcoming Investor Conferences
» Press Release | Company News

SAGE Therapeutics
November 2, 2018 - Sage Therapeutics Announces FDA Advisory Committee Votes 17-1 in Support of Benefit-Risk Profile of ZULRESSO™ (brexanolone) Injection for Treatment of Postpartum Depression
» Press Release | Company News

Agios Pharmaceuticals
November 1, 2018 - Agios to Present Updated Clinical Data at the 2018 ASH Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
November 1, 2018 - Agios Reports Third Quarter 2018 Financial Results
» Press Release | Company News

bluebird bio
November 1, 2018 - bluebird bio Reports Third Quarter 2018 Financial Results and Highlights Operational Progress
» Press Release | Company News

bluebird bio
November 1, 2018 - bluebird bio to Present New Data from Early- and Late-Stage Pipeline of Investigational Gene and Cell Therapies at the American Society of Hematology Annual Meeting
» Press Release | Company News

Constellation Pharmaceuticals
November 1, 2018 - Constellation Pharmaceuticals Receives FDA Fast Track Designation for CPI-0610 in Treatment of Myelofibrosis
» Press Release | Company News

GBT
November 1, 2018 - GBT Announces Upcoming Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition
» Press Release | Company News

Magenta Therapeutics
November 1, 2018 - Magenta Therapeutics Announces Acceptance of Nine Abstracts Covering Clinical and Preclinical Data at ASH, Representing Progress across the Portfolio of Conditioning, Stem Cell Mobilization and Expansion Programs
» Press Release | Company News

Neon Therapeutics
November 1, 2018 - Neon Therapeutics to Host Investor Event at Society for Immunotherapy of Cancer 33rd Annual Meeting
» Press Release | Company News

Zafgen
November 1, 2018 - Zafgen To Host Conference Call To Discuss Third Quarter 2018 Financial Results
» Press Release | Company News

Editas Medicine
October 31, 2018 - Editas Medicine to Host Conference Call Discussing Third Quarter 2018 Corporate Update and Results
» Press Release | Company News

Tango Therapeutics
October 31, 2018 - Gilead Sciences And Tango Therapeutics Announce Strategic Collaboration To Develop Next-Generation Targeted Immuno-Oncology Therapies
» Press Release | Company News

Voyager Therapeutics
October 31, 2018 - Voyager Therapeutics to Host Third Quarter 2018 Financial Results and Corporate Highlights Conference Call
» Press Release | Company News

Blueprint Medicines
October 30, 2018 - Blueprint Medicines Reports Third Quarter 2018 Financial Results
» Press Release | Company News

CytomX Therapeutics
October 30, 2018 - CytomX Therapeutics to Announce Third Quarter 2018 Financial Results
» Press Release | Company News

Myokardia
October 30, 2018 - MyoKardia Shares Data from Ongoing Clinical Programs and Details Three New Research Programs at 2018 R&D Day
» Press Release | Company News

Blueprint Medicines
October 29, 2018 - Blueprint Medicines Strengthens Leadership with the Appointments of Christina Rossi as Chief Commercial Officer and Paul Beresford as General Manager, International
» Press Release | Company News

Goldfinch Bio
October 29, 2018 - Goldfinch Bio Announces GFB-887 As Clinical Development Candidate And Presents Data Demonstrating Selective Inhibition Of TRPC5 For The Treatment Of Genetically-Driven Kidney Disease
» Press Release | Company News

Allena Pharmaceuticals
October 25, 2018 - Allena Pharmaceuticals to Present Data Characterizing Significant Unmet Need in Enteric Hyperoxaluria at ASN Kidney Week 2018
» Press Release | Company News

Kala Pharmaceuticals
October 25, 2018 - Kala Pharmaceuticals Appoints Steven Zhang As Vice President Of Medical Affairs
» Press Release | Company News

Myokardia
October 25, 2018 - MyoKardia Announces Initiative to Create Hypertrophic Cardiomyopathy Patient Community in Collaboration with 23andMe
» Press Release | Company News

Myokardia
October 24, 2018 - MyoKardia Doses First Patient in MAVA Long-Term Extension Study of Mavacamten for Hypertrophic Cardiomyopathy
» Press Release | Company News

Blueprint Medicines
October 23, 2018 - Blueprint Medicines to Report Third Quarter 2018 Financial Results on Tuesday, October 30, 2018
» Press Release | Company News

SAGE Therapeutics
October 23, 2018 - Sage Therapeutics to Report Third Quarter 2018 Financial Results on Tuesday, November 6, 2018
» Press Release | Company News

Ablexis
October 23, 2018 - Ablexis Announces Licensing Agreement with Voyager Therapeutics
» Press Release | Company News

Allena Pharmaceuticals
October 22, 2018 - Allena Pharmaceuticals Presents Preclinical Data Demonstrating Normalized Urine Uric Acid Excretion and Plasma Urate Reduction Following Treatment with ALLN-346
» Press Release | Company News

CytomX Therapeutics
October 22, 2018 - CytomX Therapeutics Presents Clinical Data from Probody™ Platform and CX-072 at 2018 ESMO Annual Meeting
» Press Release | Company News

Myokardia
October 22, 2018 - MyoKardia to Host R&D Day on October 30, 2018
» Press Release | Company News

Neon Therapeutics
October 22, 2018 - Neon Therapeutics Presents Data from Ongoing Phase 1b NT-001 Clinical Trial at European Society for Medical Oncology 2018 Congress
» Press Release | Company News

Kala Pharmaceuticals
October 19, 2018 - Kala Pharmaceuticals Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
» Press Release | Company News

Agios Pharmaceuticals
October 18, 2018 - Agios to Webcast Conference Call of Third Quarter 2018 Financial Results on November 1, 2018
» Press Release | Company News

Allena Pharmaceuticals
October 18, 2018 - Allena Pharmaceuticals Highlights Ongoing Efforts to Address Rare and Severe Metabolic Disorders Affecting the Kidney with Presentations at Upcoming Medical Meetings
» Press Release | Company News

Kala Pharmaceuticals
October 18, 2018 - Kala Pharmaceuticals to Present at the 2018 American Academy of Ophthalmology (AAO) Annual Meeting and at the Ophthalmology Innovation Summit at AAO
» Press Release | Company News

Foundation Medicine
October 17, 2018 - Foundation Medicine Announces Strategic Collaboration with Major Pharmaceutical Company
» Press Release | Company News

Nurix, Inc.
October 17, 2018 - Nurix Therapeutics to Present at the Targeted Protein Degradation Summit 2018
» Press Release | Company News

REVOLUTION Medicines
October 16, 2018 - REVOLUTION Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets
» Press Release | Company News

Kala Pharmaceuticals
October 16, 2018 - Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration for KPI-121 0.25% for Dry Eye Disease
» Press Release | Company News

REVOLUTION Medicines
October 16, 2018 - REVOLUTION Medicines Acquires Warp Drive Bio to Expand Drug Discovery Portfolio Focused on Frontier Oncology Targets
» Press Release | Company News

Voyager Therapeutics
October 16, 2018 - Voyager Therapeutics Announces Preclinical Data for Huntington’s Disease and Amyotrophic Lateral Sclerosis Programs at the Congress of the European Society of Gene and Cell Therapy
» Press Release | Company News

Rhythm Pharmaceuticals
October 15, 2018 - Rhythm Pharmaceuticals Appoints Murray W. Stewart, M.D., as Chief Medical Officer
» Press Release | Company News

Kala Pharmaceuticals
October 11, 2018 - Kala Pharmaceuticals Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
» Press Release | Company News

Constellation Pharmaceuticals
October 10, 2018 - Constellation Pharmaceuticals Enhances and Expands Phase 2 MANIFEST Study of CPI-0610 in Myelofibrosis
» Press Release | Company News

Nurix, Inc.
October 10, 2018 - Nurix Therapeutics to Present at the 2018 BIO Investor Forum
» Press Release | Company News

Rheos Medicines
October 10, 2018 - Rheos Medicines Expands Leadership Team with Appointments of Gad Soffer as Chief Operating Officer and J. Duncan Higgons to Board of Directors
» Press Release | Company News

Tango Therapeutics
October 10, 2018 - Tango Therapeutics Appoints Malte Peters, MD, to Board of Directors
» Press Release | Company News

Relay Therapeutics
October 9, 2018 - Relay Therapeutics Names Linda A. Hill, Ph.D., to Its Board of Directors
» Press Release | Company News

REVOLUTION Medicines
October 9, 2018 - REVOLUTION Medicines Announces First Patient Dosed with RMC-4630 in Phase 1 Clinical Study in Patients with Advanced Solid Tumors
» Press Release | Company News

Ablexis
October 9, 2018 - Ablexis Announces Licensing Agreement with Memorial Sloan Kettering Cancer Center
» Press Release | Company News

CytomX Therapeutics
October 8, 2018 - CytomX Therapeutics Announces Presentations at 2018 ESMO Annual Meeting
» Press Release | Company News

Blueprint Medicines
October 6, 2018 - Blueprint Medicines Announces Updated Data from Phase 1 ARROW Clinical Trial Showing Broad, Durable Activity of BLU-667 in Advanced RET-Altered Medullary and Papillary Thyroid Cancers
» Press Release | Company News

bluebird bio
October 5, 2018 - bluebird bio Announces European Medicines Agency’s Acceptance of Marketing Authorization Application for LentiGlobin™ Gene Therapy for the Treatment of Transfusion-Dependent β-Thalassemia
» Press Release | Company News

Goldfinch Bio
October 5, 2018 - Goldfinch Bio to Present Data on Trpc5 Inhibitor for Proteinuric Kidney Disease and Its Kidney Genome Atlas for Identification of Novel Targets
» Press Release | Company News

GBT
October 4, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

GBT
October 4, 2018 - GBT Announces Upcoming Presentations at National Sickle Cell Disease Association of America (SCDAA) Convention
» Press Release | Company News

Zafgen
October 4, 2018 - Zafgen to Present Data from Multiple Nonclinical, Ind-Enabling Studies of Zgn-1258 at the 2018 Foundation for Prader-Willi Research Family Conference
» Press Release | Company News

Kala Pharmaceuticals
October 3, 2018 - Kala Pharmaceuticals Announces Pricing of Public Offering of 7,500,000 Shares of Common Stock
» Press Release | Company News

Neon Therapeutics
October 3, 2018 - Neon Therapeutics to Present Data from Ongoing Phase 1b NT-001 Clinical Trial at the European Society for Medical Oncology 2018 Congress
» Press Release | Company News

SAGE Therapeutics
October 3, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Kala Pharmaceuticals
October 2, 2018 - Kala Pharmaceuticals Announces Financing from Athyrium Capital Management Totaling $110 Million
» Press Release | Company News

Kala Pharmaceuticals
October 2, 2018 - Kala Pharmaceuticals Announces Proposed Public Offering of Common Stock
» Press Release | Company News

bluebird bio
October 1, 2018 - bluebird bio to Present at the LEERINK Partners Roundtable Series: Rare Disease & Immuno-Oncology
» Press Release | Company News

Blueprint Medicines
October 1, 2018 - Blueprint Medicines Presents Foundational Preclinical Data Supporting the Development of BLU-782, a Highly Selective ALK2 Inhibitor, for the Treatment of Patients with Fibrodysplasia Ossificans Progressiva
» Press Release | Company News

Editas Medicine
October 1, 2018 - Editas Medicine Grows Scientific Leadership with Two New Appointments
» Press Release | Company News

Jounce Therapeutics
October 1, 2018 - Jounce Therapeutics Founder Dr. James P. Allison Jointly Awarded 2018 Nobel Prize in Physiology or Medicine for the Discovery of Cancer Therapy by Inhibition of Negative Immune Regulation
» Press Release | Company News

Neon Therapeutics
October 1, 2018 - Neon Therapeutics to Present at the Society for Immunotherapy of Cancer 33rd Annual Meeting
» Press Release | Company News

Neon Therapeutics
October 1, 2018 - Neon Therapeutics Congratulates Founder James P. Allison, Ph.D., for 2018 Nobel Prize in Physiology or Medicine
» Press Release | Company News

Rhythm Pharmaceuticals
September 28, 2018 - Rhythm Pharmaceuticals Announces Launch of TEMPO Registry for Rare Genetic Disorders of Obesity
» Press Release | Company News

Rhythm Pharmaceuticals
September 28, 2018 - Rhythm Pharmaceuticals Announces Presentation of Updated Clinical Data from Phase 2 Basket Studies Evaluating Setmelanotide in Bardet-Biedl Syndrome and Alström Syndrome at 57th Annual ESPE Meeting
» Press Release | Company News

Decibel Therapeutics
September 27, 2018 - Decibel Therapeutics and Oricula Therapeutics Announce Exclusive License for ORC-13661 in Phase 1 Development for Hearing and Balance Protection
» Press Release | Company News

Blueprint Medicines
September 26, 2018 - Blueprint Medicines Announces Proof-of-Concept Data Showing Combination of BLU-667 and Osimertinib Overcame Treatment Resistance in Two Patients with EGFR-Mutant, Non-Small Cell Lung Cancer and an Acquired RET Fusion
» Press Release | Company News

GBT
September 26, 2018 - GBT Announces Participation at the 2018 Cantor Global Healthcare Conference
» Press Release | Company News

Jounce Therapeutics
September 26, 2018 - Jounce Therapeutics to Present at the 2018 Cantor Global Healthcare Conference
» Press Release | Company News

Allena Pharmaceuticals
September 25, 2018 - Allena Pharmaceuticals to Present at Upcoming Investor Conferences in October
» Press Release | Company News

CytomX Therapeutics
September 25, 2018 - CytomX to Present at Upcoming Healthcare Conferences
» Press Release | Company News

Neon Therapeutics
September 25, 2018 - Neon Therapeutics to Present at Upcoming Investor Conferences in October
» Press Release | Company News

Rhythm Pharmaceuticals
September 25, 2018 - Rhythm Pharmaceuticals to Present at Ladenburg Thalmann 2018 Healthcare Conference
» Press Release | Company News

Blueprint Medicines
September 24, 2018 - Blueprint Medicines Showcases Broad Portfolio of Highly Selective Investigational Kinase Medicines with Presentations at Upcoming Medical Meetings
» Press Release | Company News

Foundation Medicine
September 24, 2018 - Foundation Medicine Introduces FoundationOne®Liquid, the Latest Advance in the Company’s Liquid Biopsy Test for Solid Tumors in Patients with Advanced Cancer
» Press Release | Company News

Magenta Therapeutics
September 24, 2018 - Magenta Therapeutics Added to Russell 2000 and 3000 Indexes
» Press Release | Company News

Myokardia
September 24, 2018 - MyoKardia to Present at the 2018 Cantor Global Healthcare Conference
» Press Release | Company News

Kala Pharmaceuticals
September 21, 2018 - Kala Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Myokardia
September 20, 2018 - MyoKardia Launches Inaugural MyoSeeds™ Research Grants Program to Advance Independent Research in Heart Disease
» Press Release | Company News

Sesen Bio
September 20, 2018 - Sesen Bio to Present Three-month VISTA Trial Data at Global Congress on Bladder Cancer 2018
» Press Release | Company News

Constellation Pharmaceuticals
September 12, 2018 - Constellation Pharmaceuticals Congratulates Dr. David Allis and Dr. Michael Grunstein, Winners of the 2018 Lasker Award
» Press Release | Company News

Casma Therapeutics
September 11, 2018 - Casma Therapeutics Announces Partnership with Fondazione Telethon, Founder of the Telethon Institute of Genetics and Medicine (TIGEM)
» Press Release | Company News

Editas Medicine
September 10, 2018 - Editas Medicine Announces U.S. Court of Appeals for the Federal Circuit Affirms Favorable U.S. Patent and Trademark Office Decision in CRISPR Interference
» Press Release | Company News

Rhythm Pharmaceuticals
September 7, 2018 - Rhythm Pharmaceuticals to Present at Morgan Stanley 16th Annual Global Healthcare Conference
» Press Release | Company News

GBT
September 7, 2018 - GBT Announces Participation at the 2018 Morgan Stanley Global Healthcare Conference
» Press Release | Company News

GBT
September 6, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

GBT
September 6, 2018 - GBT Brings Together Sickle Cell Disease Influencers at 7th Annual Sickle Cell Disease (SCD) Therapeutics Conference
» Press Release | Company News

Neon Therapeutics
September 6, 2018 - Neon Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference
» Press Release | Company News

Rheos Medicines
September 6, 2018 - Rheos Medicines Appoints Sanjay Keswani as Chief Executive Officer to Lead Company’s Pioneering Drug Development in Immunometabolism
» Press Release | Company News

SAGE Therapeutics
September 6, 2018 - Sage Therapeutics Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Pliant Therapeutics
September 6, 2018 - Pliant Therapeutics Announces Research Collaboration with Cleveland Clinic to Develop New Disease Targets for Gastrointestinal Fibrosis
» Press Release | Company News

SAGE Therapeutics
September 6, 2018 - Sage Therapeutics to Present at Morgan Stanley 16th Annual Global Healthcare Conference
» Press Release | Company News

bluebird bio
September 5, 2018 - bluebird bio Presents Updated Data from Phase 2/3 Starbeam Study of Investigational Lenti-D™ Gene Therapy for CALD and Initial Data from Observational Study ALD-103 of Allogeneic Hematopoietic Stem Cell Transplant in CALD at 2018 SSIEM
» Press Release | Company News

Blueprint Medicines
September 5, 2018 - Blueprint Medicines to Present at 16th Annual Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Fulcrum Therapeutics
September 5, 2018 - Fulcrum Therapeutics Announces $80 Million Series B Financing
» Press Release | Company News

Agios Pharmaceuticals
September 4, 2018 - Agios Announces Chief Executive Officer Succession Plan
» Press Release | Company News

Constellation Pharmaceuticals
September 4, 2018 - Constellation Pharmaceuticals Announces Appointments to Board of Directors
» Press Release | Company News

SAGE Therapeutics
August 31, 2018 - Sage Therapeutics Announces The Lancet Publishes Integrated Data from Pivotal Trials for Brexanolone Injection in Postpartum Depression
» Press Release | Company News

bluebird bio
August 29, 2018 - bluebird bio to Present at Investor Conferences in September
» Press Release | Company News

Jounce Therapeutics
August 29, 2018 - Jounce Therapeutics to Present at Upcoming Investor Conferences in September
» Press Release | Company News

Kala Pharmaceuticals
August 29, 2018 - Kala Pharmaceuticals to Present at Upcoming Investor Conferences
» Press Release | Company News

Myokardia
August 29, 2018 - MyoKardia to Present at Two Upcoming Investor Conferences in September
» Press Release | Company News

Agios Pharmaceuticals
August 28, 2018 - Agios to Present at the Citi 13th Annual Biotech Conference Wednesday, September 5, 2018
» Press Release | Company News

Taris Biomedical
August 28, 2018 - TARIS Announces Positive Topline Data for TAR-302 in Patients with Idiopathic Overactive Bladder
» Press Release | Company News

Voyager Therapeutics
August 28, 2018 - Voyager Therapeutics to Present at Investor Conferences in September
» Press Release | Company News

Editas Medicine
August 27, 2018 - Editas Medicine Announces Transition of Chief Medical Officer
» Press Release | Company News

bluebird bio
August 23, 2018 - bluebird bio and Gritstone Oncology Announce Strategic Collaboration to Develop Novel Cancer Cell Therapies
» Press Release | Company News

GBT
August 23, 2018 - GBT Expands Sickle Cell Disease Pipeline with Worldwide Licensing Agreement for Inclacumab for the Treatment of Vaso-occlusive Crisis
» Press Release | Company News

Kala Pharmaceuticals
August 23, 2018 - Kala Pharmaceuticals Announces FDA Approval of INVELTYS™ for the Treatment of Post-Operative Inflammation and Pain Following Ocular Surgery
» Press Release | Company News

Myokardia
August 23, 2018 - New Insights on Disease Burden for Hypertrophic Cardiomyopathy Patients Published in Circulation
» Press Release | Company News

Neon Therapeutics
August 21, 2018 - Neon Therapeutics Appoints Jolie M. Siegel as General Counsel
» Press Release | Company News

GBT
August 21, 2018 - GBT Appoints Heidi L. Wagner as Senior Vice President, Government Affairs and Policy
» Press Release | Company News

Editas Medicine
August 16, 2018 - Editas Medicine Announces the Completion of the Recombinant DNA Advisory Committee (RAC) Registration Process
» Press Release | Company News

Constellation Pharmaceuticals
August 14, 2018 - Constellation Pharmaceuticals Announces Second-Quarter and Six-Month 2018 Financial Results
» Press Release | Company News

Fulcrum Therapeutics
August 14, 2018 - Fulcrum Therapeutics Promotes Diego Cadavid, M.D., to Senior Vice President, Clinical Development
» Press Release | Company News

Sesen Bio
August 14, 2018 - Sesen Bio Reports Second Quarter 2018 Financial Results and Pipeline Updates
» Press Release | Company News

Jounce Therapeutics
August 9, 2018 - Jounce Therapeutics Reports Second Quarter 2018 Financial Results
» Press Release | Company News

Kala Pharmaceuticals
August 9, 2018 - Kala Pharmaceuticals Reports Second Quarter 2018 Financial Results
» Press Release | Company News

Magenta Therapeutics
August 9, 2018 - Magenta Therapeutics Reports Recent Operational Progress and Second Quarter 2018 Financial Results
» Press Release | Company News

Sesen Bio
August 9, 2018 - Sesen Bio Announces Vicinium Granted Fast Track Designation by FDA for Treatment of Non-Muscle Invasive Bladder Cancer
» Press Release | Company News

Ambys Medicines
August 8, 2018 - Ambys Medicines and Takeda Announce Partnership to Pioneer First-in-Class Therapies for the Treatment of Serious Liver Diseases
» Press Release | Company News

Ambys Medicines
August 8, 2018 - Ambys Medicines Launches with $140 Million to Pioneer Regenerative Medicine Therapies for Serious Liver Diseases
» Press Release | Company News

CytomX Therapeutics
August 8, 2018 - CytomX Therapeutics Announces Second Quarter 2018 Financial Results
» Press Release | Company News

Kala Pharmaceuticals
August 8, 2018 - Kala Pharmaceuticals to Present at the Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Magenta Therapeutics
August 8, 2018 - Magenta Therapeutics to Present at Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Myokardia
August 8, 2018 - MyoKardia Reports Second Quarter 2018 Financial Results
» Press Release | Company News

Rhythm Pharmaceuticals
August 8, 2018 - Rhythm Pharmaceuticals Reports Second Quarter 2018 Financial Results
» Press Release | Company News

Zafgen
August 8, 2018 - Zafgen to Present at the Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Allena Pharmaceuticals
August 7, 2018 - Allena Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Allena Pharmaceuticals
August 7, 2018 - Allena Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update
» Press Release | Company News

CytomX Therapeutics
August 7, 2018 - CytomX to Present at the 2018 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

GBT
August 7, 2018 - GBT Announces Participation at the 2018 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Myokardia
August 7, 2018 - MyoKardia to Present at the 2018 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
August 7, 2018 - Sage Therapeutics Announces Second Quarter 2018 Financial Results and Highlights Pipeline and Business Progress
» Press Release | Company News

Sesen Bio
August 7, 2018 - Sesen Bio Announces CEO and Board Transitions as Company Prepares for 12-Month Vista Trial Data and Regulatory Submission in 2019
» Press Release | Company News

Voyager Therapeutics
August 7, 2018 - Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights
» Press Release | Company News

Zafgen
August 7, 2018 - Zafgen Reports Second Quarter 2018 Operating and Financial Results
» Press Release | Company News

bluebird bio
August 6, 2018 - bluebird bio and Regeneron Announce Collaboration to Discover, Develop and Commercialize New Cell Therapies for Cancer
» Press Release | Company News

Casma Therapeutics
August 6, 2018 - Casma Therapeutics Expands Executive Team with Appointment of Two Senior Vice Presidents
» Press Release | Company News

Editas Medicine
August 6, 2018 - Allergan and Editas Medicine Announce Exercise of Options to Jointly Develop CRISPR Genome Editing Experimental Medicine EDIT-101
» Press Release | Company News

Editas Medicine
August 6, 2018 - Editas Medicine Announces Second Quarter 2018 Results and Update
» Press Release | Company News

Foundation Medicine
August 6, 2018 - Foundation Medicine Publishes New Data in Nature Medicine Supporting Blood Tumor Mutational Burden (bTMB) as a Novel Predictor of Response to Cancer Immunotherapy
» Press Release | Company News

Neon Therapeutics
August 6, 2018 - Neon Therapeutics Reports Second Quarter 2018 Financial Results and Recent Business Highlights
» Press Release | Company News

Pliant Therapeutics
August 6, 2018 - Pliant Therapeutics Receives FDA Orphan Drug Designation for Lead Program PLN-74809 in Idiopathic Pulmonary Fibrosis
» Press Release | Company News

bluebird bio
August 3, 2018 - bluebird bio to Present at the 2018 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
August 3, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

bluebird bio
August 3, 2018 - bluebird bio to Present Updated Data for Lenti-D™ Gene Therapy for Cerebral Adrenoleukodystrophy at SSIEM 2018 Symposium
» Press Release | Company News

GBT
August 3, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

Agios Pharmaceuticals
August 2, 2018 - Agios Reports Second Quarter 2018 Financial Results
» Press Release | Company News

Alcresta Therapeutics
August 2, 2018 - Data from the ASSURE Study of Long-Term Use of RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE Published in Journal of Pediatric Gastroenterology and Nutrition
» Press Release | Company News

bluebird bio
August 2, 2018 - bluebird bio Reports Second Quarter 2018 Financial Results and Highlights Operational Progress
» Press Release | Company News

Decibel Therapeutics
August 2, 2018 - Decibel Therapeutics Research on The Role of Molecular Diversity in Neurons Critical for Hearing Published in Cell
» Press Release | Company News

GBT
August 2, 2018 - GBT Reports Recent Business Progress and Provides Second Quarter 2018 Financial Results
» Press Release | Company News

Jounce Therapeutics
August 2, 2018 - Jounce Therapeutics to Announce Second Quarter 2018 Financial Results and Host Conference Call on Thursday, August 9, 2018
» Press Release | Company News

Sesen Bio
August 2, 2018 - Sesen Bio to Present at the Canaccord Genuity 38th Annual Growth Conference
» Press Release | Company News

Voyager Therapeutics
August 2, 2018 - Voyager Therapeutics to Present at Investor Conferences in August
» Press Release | Company News

Zafgen
August 2, 2018 - Zafgen Announces Departure of President and Chief Scientific Officer Dr. Thomas Hughes
» Press Release | Company News

Blueprint Medicines
August 1, 2018 - Blueprint Medicines to Present at Upcoming Investor Conferences in August
» Press Release | Company News

Blueprint Medicines
August 1, 2018 - Blueprint Medicines Reports Second Quarter 2018 Financial Results
» Press Release | Company News

Myokardia
August 1, 2018 - MyoKardia to Report Second Quarter 2018 Financial Results on Wednesday, August 8, 2018
» Press Release | Company News

SAGE Therapeutics
August 1, 2018 - Sage Therapeutics to Present at Canaccord 38th Annual Growth Conference
» Press Release | Company News

Zafgen
August 1, 2018 - Zafgen to Present at the Canaccord Genuity 38th Annual Growth Conference
» Press Release | Company News

Foundation Medicine
July 31, 2018 - Roche Purchases Shares in Tender Offer for FMI
» Press Release | Company News

Kala Pharmaceuticals
July 31, 2018 - Kala Pharmaceuticals Announces Dosing of First Patient in Phase 3 STRIDE 3 Trial of KPI-121 0.25% in Patients with Dry Eye Disease
» Press Release | Company News

Voyager Therapeutics
July 31, 2018 - Voyager Therapeutics Announces Second Quarter 2018 Financial Results and Corporate Highlights Conference Call
» Press Release | Company News

Zafgen
July 31, 2018 - Zafgen to Host Conference Call to Discuss Second Quarter 2018 Financial Results
» Press Release | Company News

CytomX Therapeutics
July 30, 2018 - CytomX Therapeutics to Announce Second Quarter 2018 Financial Results
» Press Release | Company News

Editas Medicine
July 30, 2018 - Editas Medicine to Host Conference Call Discussing Second Quarter 2018 Corporate Update and Results
» Press Release | Company News

bluebird bio
July 27, 2018 - bluebird bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
» Press Release | Company News

Blueprint Medicines
July 25, 2018 - Blueprint Medicines to Report Second Quarter 2018 Financial Results on Wednesday, August 1, 2018
» Press Release | Company News

SAGE Therapeutics
July 24, 2018 - Sage Therapeutics to Report Second Quarter 2018 Financial Results on Tuesday, August 7, 2018
» Press Release | Company News

bluebird bio
July 24, 2018 - bluebird bio’s LentiGlobin™ Gene Therapy Granted Accelerated Assessment by European Medicines Agency for the Treatment of Transfusion-Dependent β-Thalassemia
» Press Release | Company News

Agios Pharmaceuticals
July 23, 2018 - Agios to Webcast Conference Call of Second Quarter 2018 Financial Results on August 2, 2018
» Press Release | Company News

Allena Pharmaceuticals
July 23, 2018 - Allena Pharmaceuticals Announces First Patients Treated in Phase 2 Basket Study of ALLN-177 in Patients with Primary Hyperoxaluria or Enteric Hyperoxaluria and Advanced Chronic Kidney Disease
» Press Release | Company News

bluebird bio
July 23, 2018 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Rhythm Pharmaceuticals
July 23, 2018 - Rhythm Pharmaceuticals Receives European Medicines Agency PRIME Designation for Setmelanotide in Rare Genetic Disorders of Obesity
» Press Release | Company News

Agios Pharmaceuticals
July 20, 2018 - FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH1 Mutation
» Press Release | Company News

Constellation Pharmaceuticals
July 18, 2018 - Constellation Pharmaceuticals Announces Pricing of Initial Public Offering
» Press Release | Company News

Foundation Medicine
July 18, 2018 - Foundation Medicine and Guardant Health Agree to Settle Patent Infringement Lawsuit
» Press Release | Company News

REVOLUTION Medicines
July 18, 2018 - Sanofi and REVOLUTION Medicines Launch Global Partnership to Develop Potential First-in-Class Targeted Treatments for Multiple Cancers
» Press Release | Company News

CytomX Therapeutics
July 17, 2018 - CytomX Therapeutics Announces Closing of Public Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
July 17, 2018 - Voyager Therapeutics Receives FDA Guidance on Development Path for VY-AADC for Parkinson’s Disease and Provides Clinical Update
» Press Release | Company News

Pliant Therapeutics
July 16, 2018 - Pliant Therapeutics Raises $62 Million in Series B Financing to Advance Therapies for Fibrotic Diseases
» Press Release | Company News

CytomX Therapeutics
July 12, 2018 - CytomX Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

CytomX Therapeutics
July 10, 2018 - CytomX Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Relay Therapeutics
July 10, 2018 - Relay Therapeutics Names Steven Kafka To Its Board of Directors
» Press Release | Company News

Zafgen
July 9, 2018 - Zafgen and the Foundation for Prader-Willi Research Announce PATH for PWS Natural History Study
» Press Release | Company News

SAGE Therapeutics
July 5, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

GBT
July 3, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

Foundation Medicine
July 2, 2018 - Roche commences tender offer for all shares of Foundation Medicine, Inc. for US$ 137.00 per share in cash
» Press Release | Company News

Zafgen
July 2, 2018 - Zafgen Announces Closing of Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Common Shares
» Press Release | Company News

Ninepoint Medical
July 1, 2018 - NinePoint Medical Appoints Eman Namati, Ph.D., to Chief Executive Officer
» Press Release | Company News

Neon Therapeutics
June 29, 2018 - Neon Therapeutics Announces Closing of Initial Public Offering
» Press Release | Company News

Cedilla Therapeutics
June 28, 2018 - Cedilla Therapeutics Expands Leadership Team with New Appointments to Direct Biology, Drug Discovery and Proteomics
» Press Release | Company News

GBT
June 27, 2018 - GBT Announces Positive Top-line Data from Part A of the Phase 3 HOPE Study of Voxelotor in Sickle Cell Disease
» Press Release | Company News

Fulcrum Therapeutics
June 27, 2018 - Fulcrum Therapeutics Strengthens Board of Directors with Appointment of Kate Haviland
» Press Release | Company News

Zafgen
June 27, 2018 - Zafgen Announces Proposed Offering of Common Stock
» Press Release | Company News

Neon Therapeutics
June 26, 2018 - Neon Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

Agios Pharmaceuticals
June 26, 2018 - Agios and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Ivosidenib in Greater China
» Press Release | Company News

Myokardia
June 26, 2018 - MyoKardia Doses First Patient in Pivotal Phase 3 EXPLORER-HCM Trial of Mavacamten in Symptomatic Obstructive Hypertrophic Cardiomyopathy
» Press Release | Company News

Warp Drive Bio
June 26, 2018 - Warp Drive Bio Awarded Composition-of-Matter Patent Covering New Class of Medicines
» Press Release | Company News

Zafgen
June 25, 2018 - Reminder: Zafgen to Host ZGN-1061 Phase 2 Data Conference Call
» Press Release | Company News

Zafgen
June 25, 2018 - Zafgen Set to Join Russell 3000® Index
» Press Release | Company News

Zafgen
June 23, 2018 - Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 In Patients With Difficult-to-Control Type 2 Diabetes
» Press Release | Company News

Ablexis
June 21, 2018 - Ablexis Targets Market Expansion Opportunities for AlivaMab Mouse Following Acquisition by Deerfield Management and the Founding of AlivaMab Discovery Services
» Press Release | Company News

Blueprint Medicines
June 21, 2018 - Blueprint Medicines Initiates VOYAGER Phase 3 Clinical Trial of Avapritinib in Patients with Advanced Gastrointestinal Stromal Tumors
» Press Release | Company News

Voyager Therapeutics
June 21, 2018 - Voyager Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted for VY-AADC for the Treatment of Parkinson’s Disease
» Press Release | Company News

Blueprint Medicines
June 21, 2018 - Blueprint Medicines Initiates VOYAGER Phase 3 Clinical Trial of Avapritinib in Patients with Advanced Gastrointestinal Stromal Tumors
» Press Release | Company News

Magenta Therapeutics
June 20, 2018 - Magenta Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

Rhythm Pharmaceuticals
June 20, 2018 - Rhythm Pharmaceuticals, Inc. Announces Pricing of Public Offering
» Press Release | Company News

Allena Pharmaceuticals
June 19, 2018 - Allena Pharmaceuticals Completes Animal Proof-of-Concept Study for ALLN-346, Lead Product Candidate for Hyperuricemia in the Setting of Advanced Chronic Kidney Disease
» Press Release | Company News

Allena Pharmaceuticals
June 19, 2018 - Allena Pharmaceuticals Completes Animal Proof-of-Concept Study for ALLN-346, Lead Product Candidate for Hyperuricemia in the Setting of Advanced Chronic Kidney Disease
» Press Release | Company News

Decibel Therapeutics
June 19, 2018 - Decibel Therapeutics Closes $55 Million Series C Financing
» Press Release | Company News

Foundation Medicine
June 19, 2018 - Roche and Foundation Medicine reach definitive merger agreement to accelerate broad availability of comprehensive genomic profiling in oncology
» Press Release | Company News

Kala Pharmaceuticals
June 19, 2018 - Kala Pharmaceuticals Announces Update to KPI-121 0.25% Development Plan
» Press Release | Company News

Agios Pharmaceuticals
June 18, 2018 - Agios Announces Initiation of Global Phase 3 Trial (ACTIVATE) of AG-348 in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused
» Press Release | Company News

Alcresta Therapeutics
June 18, 2018 - Alcresta Therapeutics Announces RELiZORB® (iMMOBILIZED LIPASE) CARTRIDGE has been Issued a Unique Q-Code (Q9994) by CMS
» Press Release | Company News

Rhythm Pharmaceuticals
June 18, 2018 - Rhythm Pharmaceuticals Announces New Topline Clinical Data from Ongoing Phase 2 Basket Studies Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
» Press Release | Company News

Rhythm Pharmaceuticals
June 18, 2018 - Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
» Press Release | Company News

bluebird bio
June 15, 2018 - bluebird bio Presents New Data from Northstar (HGB-204) and Northstar-2 (HGB-207) Studies of LentiGlobin™ Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia at Annual Congress of the European Hematology Association
» Press Release | Company News

bluebird bio
June 15, 2018 - bluebird bio Announces New Interim Data from Phase 1 (HGB-206) Study of LentiGlobin™ Gene Therapy in Patients with Severe Sickle Cell Disease at Annual Congress of the European Hematology Association
» Press Release | Company News

Blueprint Medicines
June 15, 2018 - Blueprint Medicines Announces Updated Data from Ongoing Phase 1 EXPLORER Clinical Trial of Avapritinib in Patients with Advanced Systemic Mastocytosis Showing Profound and Durable Clinical Activity
» Press Release | Company News

GBT
June 15, 2018 - GBT Announces New Phase 2a Voxelotor Data in Adolescents with Sickle Cell Disease (SCD) at 23rd European Hematology Association (EHA) Congress
» Press Release | Company News

CytomX Therapeutics
June 14, 2018 - CytomX Announces Appointment of Lloyd A. Rowland Jr. as General Counsel
» Press Release | Company News

Rhythm Pharmaceuticals
June 14, 2018 - Rhythm Pharmaceuticals Completes Pivotal Enrollment in Two Ongoing Phase 3 Clinical Trials Evaluating Setmelanotide in Rare Genetic Disorders of Obesity
» Press Release | Company News

SAGE Therapeutics
June 13, 2018 - Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea
» Press Release | Company News

Editas Medicine
June 13, 2018 - Editas Medicine to Participate in The JMP Securities Life Sciences Conference
» Press Release | Company News

SAGE Therapeutics
June 12, 2018 - Sage Announces Pivotal Phase 3 Trial Status for SAGE-217 in Major Depressive Disorder and Postpartum Depression based on FDA Breakthrough Therapy Meeting
» Press Release | Company News

Allena Pharmaceuticals
June 11, 2018 - Allena Pharmaceuticals Appoints Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors
» Press Release | Company News

GBT
June 8, 2018 - GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease (SCD) Program at Foundation for Sickle Cell Disease Research’s 12th Annual Symposium
» Press Release | Company News

SAGE Therapeutics
June 8, 2018 - Sage Therapeutics to Present at Goldman Sachs 39th Annual Global Healthcare Conference
» Press Release | Company News

Zafgen
June 8, 2018 - Zafgen, Inc. Appoints Industry Veteran and Healthcare Policy Expert Dr. Wendy Everett to its Board of Directors
» Press Release | Company News

bluebird bio
June 5, 2018 - bluebird bio Announces Investor Events in June
» Press Release | Company News

GBT
June 5, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

Foundation Medicine
June 5, 2018 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Agios Pharmaceuticals
June 4, 2018 - New Data from Phase 1 Study of Ivosidenib or Enasidenib in Combination with Azacitidine Demonstrate Robust Responses and a Well Tolerated Safety Profile in Newly Diagnosed IDHm AML Patients
» Press Release | Company News

Blueprint Medicines
June 4, 2018 - Blueprint Medicines and CStone Pharmaceuticals Announce Exclusive Collaboration and License Agreement to Develop and Commercialize Avapritinib, BLU-554 and BLU-667 in Greater China
» Press Release | Company News

CytomX Therapeutics
June 4, 2018 - CytomX Therapeutics Presents Preliminary Clinical Proof-of-Concept Data from Probody™ Platform and CX-072 at 2018 ASCO Annual Meeting
» Press Release | Company News

SAGE Therapeutics
June 4, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Sesen Bio
June 4, 2018 - Sesen Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
June 2, 2018 - Updated Data from Ivosidenib Phase 1 Dose-Escalation and Expansion Trial in IDH1m Relapsed or Refractory AML Continue to Show Durable Responses as a Single Agent
» Press Release | Company News

Jounce Therapeutics
June 2, 2018 - Jounce Therapeutics Presents Preliminary Efficacy Data from Ongoing Phase 1/2 ICONIC Trial of JTX-2011 in Patients with Advanced Cancers
» Press Release | Company News

CytomX Therapeutics
June 1, 2018 - CytomX Announces Conference Call and Webcast to Review PROCLAIM-072 Clinical Data Presentations at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting
» Press Release | Company News

Rhythm Pharmaceuticals
June 1, 2018 - Rhythm Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
» Press Release | Company News

Blueprint Medicines
May 31, 2018 - Blueprint Medicines to Present at Upcoming Investor Conferences in June
» Press Release | Company News

CytomX Therapeutics
May 31, 2018 - CytomX to Present at the Jefferies 2018 Healthcare Conference
» Press Release | Company News

Goldfinch Bio
May 31, 2018 - Goldfinch Bio Presents Data on TRPC5 Inhibition as a Target for Proteinuric Kidney Disease and Announces GFB-887 as Lead Drug Program to treat FSGS
» Press Release | Company News

Allena Pharmaceuticals
May 30, 2018 - Allena Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
May 30, 2018 - Sage Therapeutics Announces FDA Acceptance of NDA Filing and Grant of Priority Review for Brexanolone IV in the Treatment of Postpartum Depression
» Press Release | Company News

Sesen Bio
May 30, 2018 - Sesen Bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Sesen Bio
May 30, 2018 - Sesen Bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Zafgen
May 30, 2018 - Zafgen, Inc. Expands Executive Leadership Team with Appointment of Brian McVeigh as Chief Business Officer
» Press Release | Company News

Casma Therapeutics
May 30, 2018 - Casma Therapeutics Co-Founder Reports Health Benefits of Increased Autophagy in Mammals in Nature Publication
» Press Release | Company News

Foundation Medicine
May 29, 2018 - Foundation Medicine and Collaborators to Present New Data at ASCO 2018 Supporting Comprehensive Genomic Profiling (CGP) to Inform Personalized Approaches in Cancer Care
» Press Release | Company News

Sesen Bio
May 29, 2018 - Sesen Bio to Present at the Jefferies 2018 Global Healthcare Conference
» Press Release | Company News

Voyager Therapeutics
May 29, 2018 - Voyager Therapeutics Announces Management Change
» Press Release | Company News

Foundation Medicine
May 24, 2018 - Foundation Medicine Establishes Immuno-Oncology Companion Diagnostics Collaboration with Merck
» Press Release | Company News

SAGE Therapeutics
May 23, 2018 - Sage Therapeutics to Present at Bernstein’s 34th Annual Strategic Decisions Conference
» Press Release | Company News

bluebird bio
May 23, 2018 - FDA Grants Breakthrough Therapy Designation to Lenti-D™ for the Treatment of Cerebral Adrenoleukodystrophy
» Press Release | Company News

Pliant Therapeutics
May 22, 2018 - Pliant Therapeutics Presents Idiopathic Pulmonary Fibrosis Biomarker Discovery Research at American Thoracic Society 2018 International Conference
» Press Release | Company News

PanOptica
May 22, 2018 - PanOptica Doses First Patient with New Formulation of PAN-90806, a Novel, Topical Anti-VEGF Eye Drop, in Phase 1/2 Clinical Trial
» Press Release | Company News

CytomX Therapeutics
May 22, 2018 - CytomX Therapeutics Announces FDA Clearance of Investigational New Drug Application for CX-2029, a CD71-Directed Probody Therapeutic
» Press Release | Company News

Myokardia
May 22, 2018 - MyoKardia Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Sesen Bio
May 21, 2018 - Phase 3 Registration Trial for Non-Muscle Invasive Bladder Cancer Achieves 42% Complete Response Rate at Three Months in Carcinoma in Situ Patients
» Press Release | Company News

Fulcrum Therapeutics
May 21, 2018 - Fulcrum Therapeutics and the FSHD Clinical Trial Research Network Announce Clinical Trial Readiness Study
» Press Release | Company News

Myokardia
May 21, 2018 - MyoKardia Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Myokardia
May 21, 2018 - MyoKardia Announces Design of Phase 3 EXPLORER-HCM Study Evaluating Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy
» Press Release | Company News

Voyager Therapeutics
May 17, 2018 - Voyager Therapeutics Announces New Data at the American Society of Gene and Cell Therapy 2018 Annual Meeting
» Press Release | Company News

GBT
May 17, 2018 - GBT Announces Upcoming Data Presentations Supporting Voxelotor Sickle Cell Disease Program at 23rd European Hematology Association (EHA) Congress
» Press Release | Company News

Blueprint Medicines
May 17, 2018 - Blueprint Medicines Announces Data Presentations at Upcoming ASCO and EHA Meetings Supporting Plans for Rapid Development of Avapritinib in Patients with Gastrointestinal Stromal Tumors and Systemic Mastocytosis
» Press Release | Company News

bluebird bio
May 17, 2018 - bluebird bio to Present New Data from LentiGlobinTM Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease Clinical Studies at Annual Congress of the European Hematology Association
» Press Release | Company News

Jounce Therapeutics
May 16, 2018 - Jounce Therapeutics to Present Data from Ongoing ICONIC Trial of JTX-2011 at the 2018 American Society of Clinical Oncology Annual Meeting
» Press Release | Company News

CytomX Therapeutics
May 16, 2018 - CytomX Therapeutics Announces Presentations at 2018 ASCO Annual Meeting
» Press Release | Company News

bluebird bio
May 16, 2018 - bluebird bio to Present Updated Clinical Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
May 16, 2018 - Agios to Present New Clinical Data from its IDH Programs at ASCO
» Press Release | Company News

Sesen Bio
May 16, 2018 - Eleven Biotherapeutics Announces Corporate Name Change to Sesen Bio
» Press Release | Company News

Sesen Bio
May 15, 2018 - Eleven Biotherapeutics Reports First Quarter Financial Results and Pipeline Updates
» Press Release | Company News

Celsius Therapeutics
May 15, 2018 - Celsius Therapeutics Launches with $65 Million in Series A Financing to Develop Precision Therapeutics For People with Autoimmune Diseases and Cancer
» Press Release | Company News

Rhythm Pharmaceuticals
May 14, 2018 - Rhythm Pharmaceuticals Reports First Quarter 2018 Financial Results
» Press Release | Company News

Kala Pharmaceuticals
May 10, 2018 - Kala Pharmaceuticals Reports First Quarter 2018 Financial Results
» Press Release | Company News

Myokardia
May 10, 2018 - MyoKardia to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
» Press Release | Company News

Myokardia
May 10, 2018 - MyoKardia Doses First Patient in PIONEER Open-Label Extension Study of Mavacamten for Symptomatic, Obstructive Hypertrophic Cardiomyopathy
» Press Release | Company News

Voyager Therapeutics
May 10, 2018 - Voyager Therapeutics Announces First Quarter 2018 Financial Results and Corporate Highlights
» Press Release | Company News

CytomX Therapeutics
May 9, 2018 - CytomX Therapeutics Announces First Quarter 2018 Financial Results
» Press Release | Company News

Jounce Therapeutics
May 9, 2018 - Jounce Therapeutics Reports First Quarter 2018 Financial Results
» Press Release | Company News

Kala Pharmaceuticals
May 9, 2018 - Kala Pharmaceuticals Strengthens Commercial Organization in Preparation for First Product Launch
» Press Release | Company News

Rhythm Pharmaceuticals
May 9, 2018 - Rhythm Pharmaceuticals Announces Nature Medicine Publication of Longer-Term Data from Phase 2 Study of Setmelanotide for Treatment of LEPR Deficiency Obesity
» Press Release | Company News

Rhythm Pharmaceuticals
May 9, 2018 - Rhythm Pharmaceuticals to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
» Press Release | Company News

Tango Therapeutics
May 9, 2018 - Tango Therapeutics Bolsters Expertise in Oncology Translational Research and Clinical Pharmacology with Leadership Expansion
» Press Release | Company News

bluebird bio
May 8, 2018 - bluebird bio to Present at Investor Conferences in May
» Press Release | Company News

Allena Pharmaceuticals
May 8, 2018 - Allena Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
» Press Release | Company News

Editas Medicine
May 8, 2018 - Editas Medicine to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
» Press Release | Company News

Kala Pharmaceuticals
May 8, 2018 - Kala Pharmaceuticals to Present at Upcoming Investor Conferences
» Press Release | Company News

Myokardia
May 8, 2018 - MyoKardia Reports First Quarter 2018 Financial Results
» Press Release | Company News

Neon Therapeutics
May 8, 2018 - Neon Therapeutics Announces First Patient Treated in Clinical Trial Evaluating Personal Cancer Vaccine NEO-PV-01 in Combination with KEYTRUDA® (pembrolizumab) and Chemotherapy
» Press Release | Company News

Nurix, Inc.
May 8, 2018 - Nurix Appoints Nancy Pryer, Ph.D., Chief Development Officer
» Press Release | Company News

Pliant Therapeutics
May 8, 2018 - Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
» Press Release | Company News

SAGE Therapeutics
May 8, 2018 - Sage Therapeutics to Present at Bank of America Merrill Lynch 2018 Health Care Conference
» Press Release | Company News

Zafgen
May 8, 2018 - Zafgen Reports First Quarter 2018 Operating and Financial Results
» Press Release | Company News

CytomX Therapeutics
May 7, 2018 - CytomX to Present at the Bank of America Merrill Lynch 2018 Health Care Conference
» Press Release | Company News

GBT
May 7, 2018 - GBT Reports Recent Business Progress and First Quarter 2018 Financial Results
» Press Release | Company News

GBT
May 4, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

Agios Pharmaceuticals
May 4, 2018 - Agios Provides Business Update on Discovery Research Strategy and Pipeline, Progress on Clinical Programs, Commercial Launch Preparations and Reports First Quarter 2018 Financial Results at Investor Day
» Press Release | Company News

Editas Medicine
May 3, 2018 - Editas Medicine Announces First Quarter 2018 Results and Update
» Press Release | Company News

Casma Therapeutics
May 3, 2018 - Third Rock Ventures Launches Casma Therapeutics with $58.5 Million Investment to Harness the Cellular Process of Autophagy to Develop Breakthrough Therapies
» Press Release | Company News

SAGE Therapeutics
May 3, 2018 - Sage Therapeutics Announces First Quarter 2018 Financial Results and Provides Update on Pipeline and Progress toward Launch Readiness
» Press Release | Company News

SAGE Therapeutics
May 3, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Myokardia
May 3, 2018 - MyoKardia to Report First Quarter 2018 Financial Results on Tuesday, May 8, 2018
» Press Release | Company News

bluebird bio
May 2, 2018 - bluebird bio Reports First Quarter 2018 Financial Results and Highlights Operational Progress
» Press Release | Company News

Blueprint Medicines
May 2, 2018 - Blueprint Medicines Reports First Quarter 2018 Financial Results
» Press Release | Company News

Zafgen
May 2, 2018 - Zafgen to Present at Deutsche Bank 43rd Annual Health Care Conference
» Press Release | Company News

Jounce Therapeutics
May 2, 2018 - Jounce Therapeutics to Announce First Quarter 2018 Financial Results and Host Conference Call on Wednesday, May 9, 2018
» Press Release | Company News

Foundation Medicine
May 2, 2018 - Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights
» Press Release | Company News

Jounce Therapeutics
May 1, 2018 - Jounce Therapeutics to Present at Deutsche Bank 43rd Annual Health Care Conference
» Press Release | Company News

Ninepoint Medical
May 1, 2018 - NinePoint Medical, Inc. Enters Into A Strategic Partnership and Worldwide Distribution with Merit Medical Systems, Inc.
» Press Release | Company News

Zafgen
May 1, 2018 - Zafgen to Host Conference Call to Discuss First Quarter 2018 Financial Results
» Press Release | Company News

CytomX Therapeutics
May 1, 2018 - CytomX Therapeutics to Announce First Quarter 2018 Financial Results
» Press Release | Company News

insitro
May 1, 2018 - insitro: Rethinking drug discovery using machine learning
» Press Release | Company News

Voyager Therapeutics
April 30, 2018 - Voyager Therapeutics Announces Upcoming Data Presentations at the American Society of Gene and Cell Therapy 2018 Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
April 27, 2018 - Agios Announces Revised Starting Time of 8:00am ET for Investor Day and First Quarter 2018 Financial Results Webcast on Friday, May 4, 2018
» Press Release | Company News

Editas Medicine
April 26, 2018 - Editas Medicine to Host Conference Call Discussing First Quarter 2018 Corporate Update and Results
» Press Release | Company News

Foundation Medicine
April 26, 2018 - Foundation Medicine’s New Liquid Biopsy Assay Granted Breakthrough Device Designation by U.S. Food and Drug Administration
» Press Release | Company News

Foundation Medicine
April 26, 2018 - Foundation Medicine, Roche and DIAN Diagnostics Collaborate to Advance Personalized Cancer Care in China
» Press Release | Company News

Blueprint Medicines
April 25, 2018 - Blueprint Medicines to Report First Quarter 2018 Financial Results on Wednesday, May 2, 2018
» Press Release | Company News

Cedilla Therapeutics
April 24, 2018 - Third Rock Ventures Launches Cedilla Therapeutics with $56 Million Investment to Target Protein Stability Using Small Molecule Therapeutics
» Press Release | Company News

REVOLUTION Medicines
April 24, 2018 - REVOLUTION Medicines Raises $56 Million Series B Financing
» Press Release | Company News

SAGE Therapeutics
April 24, 2018 - Sage Therapeutics to Report First Quarter 2018 Financial Results on Thursday, May 3, 2018
» Press Release | Company News

SAGE Therapeutics
April 23, 2018 - Sage Therapeutics Submits New Drug Application to U.S. FDA for Intravenous Brexanolone in the Treatment of Postpartum Depression
» Press Release | Company News

bluebird bio
April 18, 2018 - bluebird bio Announces New England Journal of Medicine Publication of Interim Data from Two Phase 1/2 Clinical Studies of LentiGlobinTM Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
» Press Release | Company News

Foundation Medicine
April 17, 2018 - Foundation Medicine Announces Timing for First Quarter 2018 Financial Results and Conference Call
» Press Release | Company News

SAGE Therapeutics
April 17, 2018 - Sage Therapeutics to Present Brexanolone Postpartum Depression Data and SAGE-217 Major Depressive Disorder Data at Upcoming Spring Medical Meetings
» Press Release | Company News

bluebird bio
April 16, 2018 - bluebird bio to Present at Alliance for Regenerative Medicine’s 6th Annual Cell & Gene Therapy Investor Day
» Press Release | Company News

Taris Biomedical
April 16, 2018 - TARIS® Presents Data Demonstrating Significant Local and Systemic Immune Modulation Following Continuous Low-Dose Bladder Delivery of Gemcitabine
» Press Release | Company News

Blueprint Medicines
April 15, 2018 - Blueprint Medicines Announces Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667 from Phase 1 ARROW Clinical Trial in Patients with RET-Altered Solid Tumors
» Press Release | Company News

Blueprint Medicines
April 15, 2018 - Blueprint Medicines Publication in Cancer Discovery Highlights Preclinical and Clinical Proof-of-Concept Data for Highly Selective RET Inhibitor BLU-667
» Press Release | Company News

Sesen Bio
April 12, 2018 - New Preclinical Data Highlighting Eleven Biotherapeutics’ DeBouganin Program to be Presented at 2018 AACR Annual Meeting
» Press Release | Company News

Jounce Therapeutics
April 12, 2018 - Jounce Therapeutics to Present Nonclinical Translational Data at the 2018 American Association for Cancer Research (AACR) Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
April 11, 2018 - Agios to Webcast Investor Day and First Quarter 2018 Financial Results on Friday, May 4, 2018
» Press Release | Company News

Foundation Medicine
April 11, 2018 - Foundation Medicine and its Collaborators Present New Findings Supporting Tissue- and Blood-based Comprehensive Genomic Profiling (CGP) to Inform Targeted and Cancer Immunotherapy Treatment Strategies
» Press Release | Company News

Constellation Pharmaceuticals
April 9, 2018 - Constellation Pharmaceuticals Announces $100 Million Financing
» Press Release | Company News

Kala Pharmaceuticals
April 9, 2018 - Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Kala Pharmaceuticals
April 9, 2018 - Kala Pharmaceuticals to Present at the 2018 American Society of Cataract and Refractive Surgery Annual Meeting (ASCRS) and at the Ophthalmology Innovation Summit at ASCRS
» Press Release | Company News

Magenta Therapeutics
April 9, 2018 - Magenta Therapeutics Secures $52 Million in Series C Financing
» Press Release | Company News

Taris Biomedical
April 9, 2018 - TARIS® Announces Late-Breaking Poster Presentation at American Association of Cancer Research Annual Meeting
» Press Release | Company News

Magenta Therapeutics
April 5, 2018 - Magenta Therapeutics Announces First Patient Transplanted with MGTA-456 in Phase 2 Study in Inherited Metabolic Disorders
» Press Release | Company News

Sesen Bio
April 4, 2018 - Eleven Biotherapeutics Reports Fourth Quarter and Full-Year 2017 Operating Results and Vicinium Development Progress
» Press Release | Company News

Myokardia
April 4, 2018 - MyoKardia Announces Appointment of Taylor C. Harris as Chief Financial Officer
» Press Release | Company News

Relay Therapeutics
April 4, 2018 - Relay Therapeutics Strengthens Leadership Team With Key Additions In R&D, Legal, And Finance
» Press Release | Company News

SAGE Therapeutics
April 4, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Sesen Bio
April 3, 2018 - Preliminary Data from Phase 3 VISTA Trial in Bladder Cancer to Be Presented in a Plenary Session at American Urological Association Annual Meeting
» Press Release | Company News

GBT
April 3, 2018 - GBT Announces Participation at the H.C. Wainwright Global Life Sciences Conference
» Press Release | Company News

GBT
April 3, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

Magenta Therapeutics
April 3, 2018 - Magenta Therapeutics Announces Departure of Chief Operating Officer Bastiano Sanna, Ph.D.
» Press Release | Company News

Taris Biomedical
April 3, 2018 - U.S. FDA Grants Fast Track Designation to TARIS® for TAR-200 (GemRIS™) in Muscle Invasive Bladder Cancer
» Press Release | Company News

Myokardia
April 2, 2018 - MyoKardia Begins Dosing in Phase 2 MAVERICK-HCM Clinical Trial of Mavacamten in Symptomatic Non-obstructive Hypertrophic Cardiomyopathy Patients
» Press Release | Company News

Rhythm Pharmaceuticals
April 2, 2018 - Rhythm Pharmaceuticals Announces Licensing Agreement with Takeda for the Development and Commercialization of Preclinical Treatment for Prader-Willi Syndrome
» Press Release | Company News

Foundation Medicine
March 30, 2018 - Foundation Medicine Announces Commercial Availability of FoundationOne CDx™, the First FDA-Approved Comprehensive Genomic Profiling Assay for All Solid Tumors Incorporating Multiple Companion Diagnostics
» Press Release | Company News

bluebird bio
March 28, 2018 - bluebird bio and Celgene Corporation Enter into Agreement to Co-Develop and Co-Promote Anti-BCMA CAR T Cell Therapy bb2121 in the United States
» Press Release | Company News

Editas Medicine
March 28, 2018 - Editas Medicine Names James C. Mullen as Chairman of the Board of Directors
» Press Release | Company News

Allena Pharmaceuticals
March 27, 2018 - Allena Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
» Press Release | Company News

Kala Pharmaceuticals
March 26, 2018 - Kala Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
» Press Release | Company News

Rheos Medicines
March 22, 2018 - Third Rock Ventures Launches Rheos Medicines with $60 Million in Series A Funding to Harness Immunometabolism to Develop Precision Medicines for Immune-mediated Diseases
» Press Release | Company News

Sesen Bio
March 21, 2018 - Eleven Biotherapeutics Announces Pricing of $10.0 Million Offering Priced At-the-Market
» Press Release | Company News

Agios Pharmaceuticals
March 19, 2018 - Agios Announces First Patient Dosed with MAT2A Inhibitor AG-270 in Phase 1 Study in Patients with Advanced Solid Tumors or Lymphoma with an MTAP Deletion
» Press Release | Company News

Goldfinch Bio
March 19, 2018 - Goldfinch Bio to Present at BioCentury’s Future Leaders in Biotech Industry Conference
» Press Release | Company News

Kala Pharmaceuticals
March 19, 2018 - Kala Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call
» Press Release | Company News

Rhythm Pharmaceuticals
March 19, 2018 - Rhythm Pharmaceuticals Announces Presentation of Genetic Epidemiology of LEPR, POMC, And PCSK1 Variants at ENDO 2018
» Press Release | Company News

Foundation Medicine
March 18, 2018 - Foundation Medicine Announces Final National Coverage Determination (NCD) from the Centers for Medicare & Medicaid Services (CMS), Including Coverage for FoundationOne CDx™ Across All Solid Tumors
» Press Release | Company News

Foundation Medicine
March 16, 2018 - Foundation Medicine Advances Patient Access to Precision Medicine; Pursues Regulatory Approval for FoundationOne CDx™ in Japan
» Press Release | Company News

Fulcrum Therapeutics
March 15, 2018 - Fulcrum Therapeutics to Present at BioCentury’s Future Leaders in the Biotech Industry Conference
» Press Release | Company News

GBT
March 15, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

Blueprint Medicines
March 14, 2018 - Blueprint Medicines to Present Proof-of-Concept Data from Ongoing Phase 1 Clinical Trial of BLU-667 in Patients with RET-Altered Solid Tumors in a Clinical Trials Plenary Session at AACR Annual Meeting 2018
» Press Release | Company News

Kala Pharmaceuticals
March 14, 2018 - Kala Pharmaceuticals to Present at the Oppenheimer 28th Annual Healthcare Conference
» Press Release | Company News

Taris Biomedical
March 14, 2018 - TARIS® Initiates Dosing of TAR-200 (GemRIS™) in Muscle-Invasive Bladder Cancer Patients Unfit for Curative Intent Therapy
» Press Release | Company News

Taris Biomedical
March 14, 2018 - TARIS® Announces Research Collaboration Focused on Natural History of Muscle Invasive Bladder Cancer Patients Not Receiving Curative Intent Therapy
» Press Release | Company News

Voyager Therapeutics
March 14, 2018 - Voyager Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
» Press Release | Company News

Foundation Medicine
March 13, 2018 - Foundation Medicine and Guardant Health Agree to Resolve False Advertising Lawsuit
» Press Release | Company News

Goldfinch Bio
March 13, 2018 - Goldfinch Bio Bolsters Leadership Team by Appointing Dr. Peter Mundel as Chief Scientific Officer and Electing Dr. Frank Maddux to Board of Directors
» Press Release | Company News

Warp Drive Bio
March 13, 2018 - Warp Drive Bio to Present at Cowen and Company 38th Annual Health Care Conference
» Press Release | Company News

Sesen Bio
March 12, 2018 - Enrollment Completed in Phase 3 Registration Trial for Non-Muscle Invasive Bladder Cancer
» Press Release | Company News

GBT
March 12, 2018 - Global Blood Therapeutics Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
» Press Release | Company News

Rhythm Pharmaceuticals
March 12, 2018 - Rhythm Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results
» Press Release | Company News

Taris Biomedical
March 12, 2018 - TARIS® to Present at Cowen Health Care Conference
» Press Release | Company News

Voyager Therapeutics
March 9, 2018 - Voyager Therapeutics Announces Longer-Term Data from Ongoing Phase 1b Trial of VY-AADC for Advanced Parkinson’s Disease
» Press Release | Company News

Foundation Medicine
March 8, 2018 - Foundation Medicine to Present at Cowen and Company's 38th Annual Healthcare Conference
» Press Release | Company News

GBT
March 8, 2018 - Global Blood Therapeutics Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock
» Press Release | Company News

GBT
March 8, 2018 - Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Jounce Therapeutics
March 8, 2018 - Jounce Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results
» Press Release | Company News

Magenta Therapeutics
March 8, 2018 - Magenta Therapeutics Strengthens Leadership Team with Promotions, New Hires
» Press Release | Company News

Myokardia
March 8, 2018 - MyoKardia Reports Fourth Quarter and Full Year 2017 Financial Results
» Press Release | Company News

Myokardia
March 8, 2018 - MyoKardia Announces Positive Results from Low-Dose Cohort of Phase 2 PIONEER-HCM Study of Mavacamten in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients
» Press Release | Company News

Tango Therapeutics
March 8, 2018 - Tango Therapeutics Expands Board of Directors with the Addition of Leading Oncology Experts with Deep Experience in Targeted and Personalized Therapies
» Press Release | Company News

Allena Pharmaceuticals
March 7, 2018 - Allena Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference
» Press Release | Company News

bluebird bio
March 7, 2018 - bluebird bio to Present at Investor Conferences in March
» Press Release | Company News

CytomX Therapeutics
March 7, 2018 - CytomX Therapeutics Announces Full-Year 2017 Financial Results and Provides Operational Update
» Press Release | Company News

Foundation Medicine
March 7, 2018 - Foundation Medicine Announces 2017 Fourth Quarter and Year-End Results, Recent Highlights and 2018 Outlook
» Press Release | Company News

Relay Therapeutics
March 7, 2018 - Relay Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference
» Press Release | Company News

Rhythm Pharmaceuticals
March 7, 2018 - Rhythm Pharmaceuticals to Present at Upcoming Investor Conferences in March
» Press Release | Company News

Zafgen
March 7, 2018 - Zafgen to Present at Cowen 38th Annual Health Care Conference
» Press Release | Company News

Allena Pharmaceuticals
March 6, 2018 - Allena Pharmaceuticals Initiates First Phase 3 Trial for ALLN-177 in Patients with Enteric Hyperoxaluria
» Press Release | Company News

Blueprint Medicines
March 6, 2018 - Blueprint Medicines to Present at Cowen and Company 38th Annual Health Care Conference
» Press Release | Company News

Constellation Pharmaceuticals
March 6, 2018 - Constellation Pharmaceuticals to Present at the 38th Annual Cowen and Company Health Care Conference
» Press Release | Company News

Editas Medicine
March 6, 2018 - Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
» Press Release | Company News

GBT
March 6, 2018 - GBT Appoints Industry Leader David L. Johnson as Chief Commercial Officer
» Press Release | Company News

Goldfinch Bio
March 6, 2018 - Goldfinch Bio to Present at Cowen and Company Healthcare Conference
» Press Release | Company News

Myokardia
March 6, 2018 - MyoKardia to Present at the Cowen and Company 38th Annual Health Care Conference
» Press Release | Company News

Zafgen
March 6, 2018 - Zafgen Reports Fourth Quarter and Full Year 2017 Financial Results; Announces Positive Interim Data from Ongoing ZGN-1061 Phase 2 Proof-of-Concept Trial in Patients with Type 2 Diabetes
» Press Release | Company News

Agios Pharmaceuticals
March 5, 2018 - Agios to Present at the Cowen 38th Annual Healthcare Conference Monday, March 12, 2018
» Press Release | Company News

Sesen Bio
March 5, 2018 - Eleven Biotherapeutics to Present at the Cowen and Company 38th Annual Health Care Conference
» Press Release | Company News

GBT
March 5, 2018 - GBT Announces Participation at Upcoming Investor Conferences in March
» Press Release | Company News

GBT
March 5, 2018 - GBT Announces New Employment Inducement Grants
» Press Release | Company News

Jounce Therapeutics
March 5, 2018 - Jounce Therapeutics to Present at Cowen and Company 38th Annual Health Care Conference
» Press Release | Company News

Kala Pharmaceuticals
March 5, 2018 - Kala Pharmaceuticals Appoints Gregory Perry to Board of Directors and as Audit Committee Chair
» Press Release | Company News

Magenta Therapeutics
March 5, 2018 - Magenta Therapeutics and Heidelberg Pharma Sign Exclusive Multi-Target Research Agreement for the Development of Antibody Drug Conjugates
» Press Release | Company News

SAGE Therapeutics
March 5, 2018 - Sage Therapeutics to Present at Cowen & Co. 38th Annual Health Care Conference
» Press Release | Company News

SAGE Therapeutics
March 5, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

CytomX Therapeutics
March 1, 2018 - CytomX to Present at Upcoming Investor Conferences
» Press Release | Company News

Jounce Therapeutics
March 1, 2018 - Jounce Therapeutics to Announce Fourth Quarter and Full Year 2017 Financial Results and Host Conference Call on Thursday, March 8, 2018
» Press Release | Company News

Myokardia
March 1, 2018 - MyoKardia to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, March 8, 2018
» Press Release | Company News

Zafgen
March 1, 2018 - Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2017 Financial Results
» Press Release | Company News

Editas Medicine
February 28, 2018 - Editas Medicine Supports Rare Disease Day® and Joins Global Movement to Raise Important Awareness for Rare Diseases
» Press Release | Company News

Fulcrum Therapeutics
February 28, 2018 - Fulcrum Therapeutics to Present at the 11th Annual Future of Genomic Medicine Conference
» Press Release | Company News

Editas Medicine
February 27, 2018 - Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2017 Corporate Update and Results
» Press Release | Company News

GBT
February 27, 2018 - GBT Reports Recent Business Progress and Fourth Quarter and Year-End 2017 Financial Results
» Press Release | Company News

Voyager Therapeutics
February 27, 2018 - Voyager Therapeutics to Host Fourth Quarter and Full Year 2017 Financial Results and Corporate Highlights Conference Call
» Press Release | Company News

Magenta Therapeutics
February 26, 2018 - Magenta Therapeutics Presents Clinical and Preclinical Data at ASBMT Conference, Including New Preclinical Results on Microglial Engraftment with MGTA-456 Expanded Cord Blood Stem Cell Product
» Press Release | Company News

Voyager Therapeutics
February 26, 2018 - Voyager Therapeutics to Present at Cowen Health Care Conference
» Press Release | Company News

CytomX Therapeutics
February 22, 2018 - CytomX Therapeutics to Announce Full-Year 2017 Financial Results and Host Operational Update Webcast Conference Call
» Press Release | Company News

SAGE Therapeutics
February 22, 2018 - Sage Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Provides Pipeline Update
» Press Release | Company News

bluebird bio
February 21, 2018 - bluebird bio Reports Fourth Quarter and Full Year 2017 Financial Results and Highlights Operational Progress
» Press Release | Company News

Blueprint Medicines
February 21, 2018 - Blueprint Medicines Reports Fourth Quarter and Full Year 2017 Financial Results
» Press Release | Company News

Magenta Therapeutics
February 21, 2018 - Magenta Therapeutics Hires John Davis, MD, MPH, as Chief Medical Officer
» Press Release | Company News

Voyager Therapeutics
February 20, 2018 - Voyager Therapeutics and AbbVie Announce Global Strategic Collaboration to Develop Potential New Treatments for Alzheimer’s Disease and Other Tau-Related Neurodegenerative Diseases
» Press Release | Company News

Editas Medicine
February 16, 2018 - Editas Medicine Names Jessica Hopfield, Ph.D., to Board of Directors
» Press Release | Company News

Agios Pharmaceuticals
February 15, 2018 - FDA Accepts New Drug Application and Grants Priority Review for Ivosidenib in Relapsed or Refractory AML with an IDH1 Mutation
» Press Release | Company News

Agios Pharmaceuticals
February 14, 2018 - Agios Reports Fourth Quarter and Full Year 2017 Financial Results
» Press Release | Company News

bluebird bio
February 14, 2018 - bluebird bio Appoints Alison Finger as Chief Commercial Officer
» Press Release | Company News

Blueprint Medicines
February 14, 2018 - Blueprint Medicines to Report Fourth Quarter and Full Year 2017 Financial Results on Wednesday, February 21, 2018
» Press Release | Company News

Myokardia
February 14, 2018 - MyoKardia to Present at the RBC Capital Markets’ 2018 Healthcare Conference
» Press Release | Company News

Myokardia
February 14, 2018 - MyoKardia Begins Patient Dosing in Phase 1b Clinical Study of MYK-491 in Dilated Cardiomyopathy Patients
» Press Release | Company News

Foundation Medicine
February 13, 2018 - Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2017 Financial Results and Conference Call
» Press Release | Company News

SAGE Therapeutics
February 13, 2018 - Sage Therapeutics to Report Fourth Quarter and Full Year 2017 Financial Results on Thursday, February 22, 2018
» Press Release | Company News

SAGE Therapeutics
February 12, 2018 - Sage Therapeutics to Present at Leerink Partners 7th Annual Global Healthcare Conference
» Press Release | Company News

Constellation Pharmaceuticals
February 9, 2018 - Constellation Pharmaceuticals Announces Upcoming Presentations of Lead EZH2 and BET Clinical Programs
» Press Release | Company News

Editas Medicine
February 8, 2018 - Editas Medicine to Participate in Upcoming Investor Conferences
» Press Release | Company News

Sesen Bio
February 8, 2018 - Eleven Biotherapeutics to Present at 2018 BIO CEO & Investor Conference
» Press Release | Company News

SAGE Therapeutics
February 8, 2018 - Sage Therapeutics Prices Public Offering of Common Stock
» Press Release | Company News

Zafgen
February 8, 2018 - Zafgen to Present at the Leerink Partners 7th Annual Global Healthcare Conference
» Press Release | Company News

GBT
February 7, 2018 - GBT Announces Participation at the Leerink Partners 7th Annual Global Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
February 7, 2018 - Sage Therapeutics Receives FDA Breakthrough Therapy Designation for SAGE-217 for the Treatment of Major Depressive Disorder
» Press Release | Company News

SAGE Therapeutics
February 7, 2018 - Sage Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
February 7, 2018 - Voyager Therapeutics to Present at Leerink Partners Annual Global Healthcare Conference
» Press Release | Company News

bluebird bio
February 2, 2018 - bluebird bio to Present at LEERINK Partners Global Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
January 31, 2018 - Agios to Webcast Conference Call of Fourth Quarter and Full Year 2017 Financial Results on February 14, 2018
» Press Release | Company News

SAGE Therapeutics
January 31, 2018 - Sage Therapeutics Announces Positive Results from Placebo-Controlled Trial in a Model of Insomnia Demonstrating Activity on Sleep Parameters and Supporting Development of SAGE-217 as Potential Treatment for Sleep Disorders
» Press Release | Company News

Voyager Therapeutics
January 31, 2018 - Voyager Therapeutics Announces CEO Succession Plan for 2018
» Press Release | Company News

Foundation Medicine
January 30, 2018 - Foundation Medicine and European Organisation for Research and Treatment of Cancer (EORTC) Announce Collaboration to Advance Precision Medicine Using Comprehensive Genomic Profiling to Facilitate Clinical Trial Enrollment
» Press Release | Company News

Sesen Bio
January 24, 2018 - Eleven Biotherapeutics Appoints Richard Fitzgerald as Chief Financial Officer
» Press Release | Company News

Agios Pharmaceuticals
January 23, 2018 - Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Voyager Therapeutics
January 23, 2018 - Voyager Therapeutics Announces FDA Clearance of Investigational New Drug Application for VY-AADC for Advanced Parkinson’s Disease
» Press Release | Company News

Myokardia
January 19, 2018 - MyoKardia Announces Appointment of Cynthia Ladd as General Counsel
» Press Release | Company News

Agios Pharmaceuticals
January 18, 2018 - Agios Announces Pricing of $475 Million Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
January 17, 2018 - Agios Announces Proposed Offering of Common Stock
» Press Release | Company News

Constellation Pharmaceuticals
January 16, 2018 - Constellation Pharmaceuticals Announces Initiation of Phase 1b/2 Study of CPI-1205
» Press Release | Company News

Foundation Medicine
January 16, 2018 - Foundation Medicine and Pfizer Announce Broad Partnership to Develop Companion Diagnostics for Pfizer's Oncology Portfolio
» Press Release | Company News

GBT
January 9, 2018 - GBT Receives FDA Breakthrough Therapy Designation for Voxelotor for Treatment of Sickle Cell Disease (SCD)
» Press Release | Company News

Editas Medicine
January 8, 2018 - Editas Medicine Reports on Recent Progress and Announces “EM22” Five-year Goals at J.P. Morgan Healthcare Conference
» Press Release | Company News

Foundation Medicine
January 8, 2018 - Foundation Medicine Reports Preliminary 2017 Results
» Press Release | Company News

SAGE Therapeutics
January 8, 2018 - Sage Therapeutics to Provide Pipeline Update at J.P. Morgan Healthcare Conference and Outline Key 2018 Initiatives to Support Planned Evolution to a Fully-Integrated Commercial Biopharmaceutical Company
» Press Release | Company News

Kala Pharmaceuticals
January 5, 2018 - Kala Pharmaceuticals Announces Topline Results for Two Phase 3 Trials (STRIDE 1 and STRIDE 2) of KPI-121 0.25% in Dry Eye Disease
» Press Release | Company News

Kala Pharmaceuticals
January 5, 2018 - Kala Pharmaceuticals Announces New Drug Application for INVELTYSTM (KPI-121 1%) Has Been Accepted for Review by the U.S. Food and Drug Administration
» Press Release | Company News

Magenta Therapeutics
January 5, 2018 - Magenta Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference on Tuesday, January 9th, 2018
» Press Release | Company News

Zafgen
January 5, 2018 - Zafgen Reports Strong Clinical Progress and Updates Outlook for 2018
» Press Release | Company News

Constellation Pharmaceuticals
January 4, 2018 - Constellation Pharmaceuticals to Present at 36th Annual JP Morgan Healthcare Conference
» Press Release | Company News

Rhythm Pharmaceuticals
January 4, 2018 - Rhythm Pharmaceuticals Announces Progress in Clinical Development of Setmelanotide for Treatment of Rare Genetic Disorders of Obesity
» Press Release | Company News

Editas Medicine
January 3, 2018 - Editas Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Foundation Medicine
January 3, 2018 - Foundation Medicine to Present at the 36th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

GBT
January 3, 2018 - GBT to Present at the 36th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Jounce Therapeutics
January 3, 2018 - Jounce Therapeutics to Present at the 36th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Myokardia
January 3, 2018 - MyoKardia to Present at 36th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
January 3, 2018 - Sage Therapeutics to Present at J.P. Morgan Healthcare Conference on Tuesday, January 9, 2018
» Press Release | Company News

Sesen Bio
January 2, 2018 - Eleven Biotherapeutics to Present at Biotech Showcase 2018
» Press Release | Company News

SAGE Therapeutics
January 2, 2018 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Agios Pharmaceuticals
December 26, 2017 - Agios Submits New Drug Application to the FDA for Ivosidenib for the Treatment of Patients with Relapsed/Refractory AML and an IDH1 Mutation
» Press Release | Company News

GBT
December 22, 2017 - GBT Appoints Wendy L. Yarno to Board of Directors
» Press Release | Company News

bluebird bio
December 21, 2017 - bluebird bio to Present at Investor Conferences in January
» Press Release | Company News

Taris Biomedical
December 21, 2017 - TARIS Biomedical® Announces $25M Series B Financing
» Press Release | Company News

Taris Biomedical
December 20, 2017 - TARIS and Bristol-Myers Squibb Announce Clinical Trial Collaboration
» Press Release | Company News

CytomX Therapeutics
December 18, 2017 - CytomX Therapeutics Added to NASDAQ Biotechnology Index
» Press Release | Company News

GBT
December 15, 2017 - Global Blood Therapeutics Prices a $100.0 Million Common Stock Public Offering
» Press Release | Company News

Allena Pharmaceuticals
December 14, 2017 - Allena Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
» Press Release | Company News

GBT
December 14, 2017 - Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Jounce Therapeutics
December 14, 2017 - Jounce Therapeutics Added to NASDAQ Biotechnology Index
» Press Release | Company News

Relay Therapeutics
December 14, 2017 - Relay Therapeutics Secures $63 Million in Series B Financing
» Press Release | Company News

Sesen Bio
December 13, 2017 - Eleven Biotherapeutics Announces Chief Scientific Officer To Chair A Session At The Antibody Engineering And Therapeutics Meeting
» Press Release | Company News

bluebird bio
December 12, 2017 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Blueprint Medicines
December 12, 2017 - Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
» Press Release | Company News

Constellation Pharmaceuticals
December 12, 2017 - Constellation Pharmaceuticals Announces First Patient Dosed in Phase 1b/2 PROSTAR Combination Study of CPI-1205 in Advanced Form of Prostate Cancer
» Press Release | Company News

Neon Therapeutics
December 12, 2017 - Neon Therapeutics Expands Board of Directors with Leading Experts in Cancer Drug Discovery and Corporate Finance
» Press Release | Company News

Agios Pharmaceuticals
December 11, 2017 - New Data from Ivosidenib Phase 1 Dose-Escalation and Expansion Trial Demonstrate Durable Responses in Patients with IDH1m Relapsed or Refractory AML
» Press Release | Company News

Agios Pharmaceuticals
December 11, 2017 - Data from Phase 1 Studies of Ivosidenib or Enasidenib in Combination with Full Doses of Standard of Care Chemotherapy Demonstrate Tolerability and Preliminary Clinical Activity in Newly Diagnosed AML Patients With an IDH Mutation
» Press Release | Company News

bluebird bio
December 11, 2017 - bluebird bio Presents Updated Data from HGB-205 Study of LentiGlobinTM Gene Therapy in Patients with Severe Sickle Cell Disease and Transfusion-Dependent β-Thalassemia at American Society of Hematology Annual Meeting
» Press Release | Company News

bluebird bio
December 11, 2017 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Blueprint Medicines
December 11, 2017 - Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
» Press Release | Company News

Editas Medicine
December 11, 2017 - Editas Medicine Reports Data Supporting Multiple Approaches to Create Treatments for Sickle Cell Disease and Beta-Thalassemia
» Press Release | Company News

GBT
December 11, 2017 - GBT Announces Presentation of Six Studies at ASH Supporting Voxelotor Sickle Cell Disease (SCD) Program
» Press Release | Company News

Magenta Therapeutics
December 11, 2017 - Magenta Therapeutics Presents Preclinical Data from Stem Cell Mobilization and Expansion Programs
» Press Release | Company News

Magenta Therapeutics
December 11, 2017 - Magenta Therapeutics’ Expanded Stem Cell Product, MGTA-456, Engrafts in 100% of Patients, Leading to Robust Neutrophil and Immune Recovery in Two Phase 2 Clinical Studies
» Press Release | Company News

Agios Pharmaceuticals
December 10, 2017 - Agios Presents Updated Data from DRIVE PK Study Demonstrating AG-348 is Well-Tolerated and Results in Clinically Relevant, Rapid and Sustained Hemoglobin Increases in Patients with Pyruvate Kinase Deficiency
» Press Release | Company News

bluebird bio
December 10, 2017 - Celgene Corporation and bluebird bio Announce Updated Results from Ongoing Multicenter Phase 1 Study of bb2121 Anti- BCMA CAR T Cell Therapy in Patients with Late Stage Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
» Press Release | Company News

bluebird bio
December 10, 2017 - bluebird bio Presents New Data from Clinical Studies of LentiGlobinTM Gene Therapy in Transfusion-Dependent β-Thalassemia at American Society of Hematology Annual Meeting
» Press Release | Company News

bluebird bio
December 10, 2017 - bluebird bio Announces Updated Clinical Results from Ongoing Phase 1 Multicenter Study of LentiGlobin™ Gene Therapy in Severe Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

Blueprint Medicines
December 10, 2017 - Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of Avapritinib (BLU-285) in Patients with Advanced Systemic Mastocytosis Showing Evidence of Strong Clinical Activity
» Press Release | Company News

GBT
December 9, 2017 - GBT Announces New Phase 2a Data at ASH for Voxelotor in Adolescents with Sickle Cell Disease (SCD)
» Press Release | Company News

Magenta Therapeutics
December 9, 2017 - Magenta Therapeutics’ Lead Targeted Antibody Drug Conjugate Shows Promising Preclinical Results for Non-Genotoxic Conditioning for Bone Marrow Transplant
» Press Release | Company News

bluebird bio
December 7, 2017 - bluebird bio and TC BioPharm Announce Strategic Collaboration to Research and Develop Gamma Delta CAR T Cell Product Candidates for Cancer Immunotherapy
» Press Release | Company News

Jounce Therapeutics
December 7, 2017 - Jounce Therapeutics to Present at BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference
» Press Release | Company News

Magenta Therapeutics
December 7, 2017 - New Data Published in Journal Cell Show Robust Mobilization of Highly Engraftable Stem Cells in Mouse Models with Combination of GROβ and Plerixafor
» Press Release | Company News

Neon Therapeutics
December 7, 2017 - Neon Therapeutics Announces Clinical Trial Collaboration with Merck
» Press Release | Company News

SAGE Therapeutics
December 7, 2017 - Sage Therapeutics to Present at BMO Prescriptions for Success Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
December 7, 2017 - Sage Therapeutics Reports Positive Top-line Results from Phase 2 Placebo-Controlled Trial of SAGE-217 in Major Depressive Disorder
» Press Release | Company News

Editas Medicine
December 6, 2017 - Editas Medicine, Inc., Announces Pricing of $50 Million Offering of Common Stock
» Press Release | Company News

Foundation Medicine
December 6, 2017 - Foundation Medicine and Collaborators to Present New Data at the American Society of Hematology (ASH) Annual Meeting that Supports Use of FoundationOne®Heme to Advance Personalized Medicine in Blood Cancers
» Press Release | Company News

Tango Therapeutics
December 6, 2017 - Tango Therapeutics Announces the Addition of Shakti Narayan, Ph.D., J.D. as Chief Business Officer
» Press Release | Company News

Agios Pharmaceuticals
December 5, 2017 - Agios Appoints Jacqualyn Fouse, Ph.D., to the Board of Directors
» Press Release | Company News

Editas Medicine
December 5, 2017 - Editas Medicine, Inc., Announces Offering of Common Stock
» Press Release | Company News

Goldfinch Bio
December 5, 2017 - Goldfinch Bio Appoints Anthony Johnson, M.D., President and Chief Executive Officer, and Michael Broxson, Chief Business and Operating Officer
» Press Release | Company News

Neon Therapeutics
December 5, 2017 - Neon Therapeutics Completes $106 Million Crossover Series B Financing
» Press Release | Company News

SAGE Therapeutics
December 4, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Sesen Bio
November 30, 2017 - Eleven Biotherapeutics to Present at the LD Micro Main Event 2017
» Press Release | Company News

Foundation Medicine
November 30, 2017 - FDA Approves Foundation Medicine's FoundationOne CDx™, the First and Only Comprehensive Genomic Profiling Test for All Solid Tumors Incorporating Multiple Companion Diagnostics
» Press Release | Company News

GBT
November 30, 2017 - Global Blood Therapeutics Announces New Employment Inducement Grants
» Press Release | Company News

bluebird bio
November 29, 2017 - bluebird bio Acquires Manufacturing Facility in North Carolina and Executes Multiple Global Supply Agreements to Enhance Ability to Deliver Gene Therapies to Patients
» Press Release | Company News

Decibel Therapeutics
November 29, 2017 - Regeneron and Decibel Therapeutics Announce Strategic Collaboration to Discover and Develop Therapeutics for Hearing Loss and Tinnitus
» Press Release | Company News

CytomX Therapeutics
November 28, 2017 - CytomX Therapeutics Announces FDA Acceptance of Investigational New Drug Application for CTLA-4 Probody Therapeutic
» Press Release | Company News

Constellation Pharmaceuticals
November 21, 2017 - Constellation Pharmaceuticals to Present at Piper Jaffray Healthcare Conference
» Press Release | Company News

Sesen Bio
November 20, 2017 - Eleven Biotherapeutics Reports Third Quarter 2017 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
November 17, 2017 - Agios Presents Updated Phase 1 Data from Dose Expansion Cohort of Ivosidenib (AG-120) in Patients with IDH1 Mutant Positive Glioma
» Press Release | Company News

bluebird bio
November 16, 2017 - Celgene Corporation and bluebird bio Announce bb2121 Anti-BCMA CAR-T Cell Therapy Has Been Granted Breakthrough Therapy Designation from FDA and Prime Eligibility from EMA for Relapsed and Refractory Multiple Myeloma
» Press Release | Company News

bluebird bio
November 16, 2017 - bluebird bio Announces First Patient Treated in Northstar-3 (HGB-212), Phase 3 Study of LentiGlobin™ in Patients with Transfusion-Dependent β-Thalassemia (TDT) and β0/β0 Genotype
» Press Release | Company News

Voyager Therapeutics
November 16, 2017 - Voyager Therapeutics Highlights Lead Program VY-AADC for Advanced Parkinson’s Disease, AAV Novel Capsid and Delivery Optimization Efforts, and Pipeline Programs at its R&D Day
» Press Release | Company News

Myokardia
November 15, 2017 - Preclinical Studies with MyoKardia’s Mavacamten Demonstrate Evidence of Reduced Contractility and Improved Left Ventricular Compliance
» Press Release | Company News

Relay Therapeutics
November 15, 2017 - Relay Therapeutics Names Sarah O’Brien as Vice President of Human Resources
» Press Release | Company News

Rhythm Pharmaceuticals
November 14, 2017 - Rhythm Pharmaceuticals Reports Third Quarter 2017 Financial Results
» Press Release | Company News

SAGE Therapeutics
November 14, 2017 - Sage Therapeutics Prices Public Offering of Common Stock
» Press Release | Company News

GBT
November 13, 2017 - Global Blood Therapeutics Announces Completion of Safety Review by Independent Data and Safety Monitoring Board (DSMB) for Phase 3 HOPE Study in Sickle Cell Disease
» Press Release | Company News

Jounce Therapeutics
November 13, 2017 - Jounce Therapeutics Reports Third Quarter 2017 Financial Results
» Press Release | Company News

Kala Pharmaceuticals
November 13, 2017 - Kala Pharmaceuticals Appoints Todd Bazemore as Chief Operating Officer
» Press Release | Company News

Myokardia
November 13, 2017 - MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor
» Press Release | Company News

SAGE Therapeutics
November 13, 2017 - Sage Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
November 13, 2017 - Voyager Therapeutics to Present at Investor Conferences in November
» Press Release | Company News

Voyager Therapeutics
November 12, 2017 - Voyager Therapeutics to Host R&D Day on November 16, 2017
» Press Release | Company News

Blueprint Medicines
November 10, 2017 - Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors Showing Strengthened Clinical Activity across Spectrum of KIT and PDGFRα Genotypes
» Press Release | Company News

Sesen Bio
November 9, 2017 - Eleven Biotherapeutics To Present at Stifel 2017 Healthcare Conference
» Press Release | Company News

Sesen Bio
November 9, 2017 - Eleven Biotherapeutics To Report Third Quarter 2017 Financial Results on November 14, 2017
» Press Release | Company News

Jounce Therapeutics
November 9, 2017 - Jounce Therapeutics to Present at the Stifel 2017 Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
November 9, 2017 - Sage Therapeutics Announces Brexanolone Achieves Primary Endpoints in Both Phase 3 Clinical Trials in Postpartum Depression
» Press Release | Company News

Blueprint Medicines
November 8, 2017 - Blueprint Medicines to Present at Jefferies Global Healthcare Conference
» Press Release | Company News

Jounce Therapeutics
November 8, 2017 - Jounce Therapeutics to Announce Third Quarter 2017 Financial Results and Host Conference Call on Monday, November 13, 2017
» Press Release | Company News

SAGE Therapeutics
November 8, 2017 - Sage Therapeutics Appoints Asha Nayak, M.D., Ph.D., to Board of Directors
» Press Release | Company News

CytomX Therapeutics
November 7, 2017 - CytomX Announces Third Quarter 2017 Financial Results and Operational Progress
» Press Release | Company News

Editas Medicine
November 7, 2017 - Editas Medicine Announces Third Quarter 2017 Results and Update
» Press Release | Company News

GBT
November 7, 2017 - Global Blood Therapeutics Announces Participation at the Stifel 2017 Healthcare Conference
» Press Release | Company News

Jounce Therapeutics
November 7, 2017 - Jounce Therapeutics to Present Preclinical Data at the Society for Immunotherapy of Cancer (SITC) 32nd Annual Meeting
» Press Release | Company News

Kala Pharmaceuticals
November 7, 2017 - Kala Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
» Press Release | Company News

Voyager Therapeutics
November 7, 2017 - Voyager Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Zafgen
November 7, 2017 - Zafgen Reports Third Quarter 2017 Financial Results
» Press Release | Company News

Alcresta Therapeutics
November 6, 2017 - Alcresta Therapeutics, Inc. Presented Results at the North American Cystic Fibrosis Conference from the ASSURE Study: An Evaluation of the Long-Term Use of RELiZORB®
» Press Release | Company News

Voyager Therapeutics
November 6, 2017 - Voyager Therapeutics Announces Proposed Offering of Common Stock
» Press Release | Company News

Editas Medicine
November 3, 2017 - Editas Medicine to Host Conference Call Discussing Third Quarter 2017 Corporate Update and Results
» Press Release | Company News

SAGE Therapeutics
November 3, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Sesen Bio
November 3, 2017 - Eleven Biotherapeutics Announces Closing of $8.0 Million Underwritten Public Offering
» Press Release | Company News

GBT
November 2, 2017 - Global Blood Therapeutics Reports Recent Business Progress and Provides Third Quarter 2017 Financial Results
» Press Release | Company News

Myokardia
November 2, 2017 - MyoKardia Reports Third Quarter 2017 Financial Results and Operational Progress
» Press Release | Company News

SAGE Therapeutics
November 2, 2017 - Sage Therapeutics Announces Third Quarter 2017 Financial Results and Provides Pipeline Update
» Press Release | Company News

Voyager Therapeutics
November 2, 2017 - Voyager Therapeutics Reports Third Quarter 2017 Financial Results and Corporate Highlights
» Press Release | Company News

Allena Pharmaceuticals
November 1, 2017 - Allena Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
» Press Release | Company News

Agios Pharmaceuticals
November 1, 2017 - Agios Reports Third Quarter 2017 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
November 1, 2017 - Agios to Present New Data from PKR and IDH Programs at the 2017 ASH Annual Meeting
» Press Release | Company News

bluebird bio
November 1, 2017 - bluebird bio Reports Third Quarter 2017 Financial Results and Recent Operational Progress
» Press Release | Company News

bluebird bio
November 1, 2017 - bluebird bio to Present New Data from Clinical Studies of LentiGlobinTM Gene Therapy in Transfusion-Dependent ß-Thalassemia and Severe Sickle Cell Disease and bb2121 in Relapsed/Refractory Multiple Myeloma at ASH Annual Meeting
» Press Release | Company News

Blueprint Medicines
November 1, 2017 - Blueprint Medicines to Present Updated Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis in Plenary Scientific Session at 59th ASH Annual Meeting and Exposition
» Press Release | Company News

Blueprint Medicines
November 1, 2017 - Blueprint Medicines Announces Publication of BLU-285 Translational Data
» Press Release | Company News

CytomX Therapeutics
November 1, 2017 - CytomX to Present at the Jefferies 2017 London Healthcare Conference
» Press Release | Company News

Sesen Bio
November 1, 2017 - Eleven Biotherapeutics Prices of $8.0 Million Underwritten Public Offering
» Press Release | Company News

Foundation Medicine
November 1, 2017 - Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights
» Press Release | Company News

GBT
November 1, 2017 - Global Blood Therapeutics Announces Upcoming Data Presentations Supporting Sickle Cell Disease Program at 59th American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

Magenta Therapeutics
November 1, 2017 - Magenta Therapeutics to Present Clinical Results and Preclinical Research at American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

Myokardia
November 1, 2017 - MyoKardia Announces Presentations at 2017 American Heart Association Scientific Sessions
» Press Release | Company News

Agios Pharmaceuticals
October 31, 2017 - Agios to Present at the 26th Annual Credit Suisse Healthcare Conference Tuesday, November 7, 2017
» Press Release | Company News

bluebird bio
October 31, 2017 - bluebird bio Announces ASH Abstract Conference Call on November 1st and Upcoming Investor Events in November
» Press Release | Company News

Blueprint Medicines
October 31, 2017 - Blueprint Medicines Reports Third Quarter 2017 Financial Results
» Press Release | Company News

Myokardia
October 31, 2017 - MyoKardia to Present at Two Upcoming Investor Conferences in November
» Press Release | Company News

Neon Therapeutics
October 31, 2017 - Vedantra Pharmaceuticals Extends Research Collaboration with Neon Therapeutics to Develop Novel Cancer Immunotherapies
» Press Release | Company News

Rhythm Pharmaceuticals
October 31, 2017 - Rhythm Announces Preliminary Data from Phase 2 Study of Setmelanotide for Treatment of Bardet-Biedl Syndrome
» Press Release | Company News

Voyager Therapeutics
October 30, 2017 - Voyager Therapeutics to Host Third Quarter 2017 Financial Results and Corporate Highlights Conference Call
» Press Release | Company News

Voyager Therapeutics
October 30, 2017 - Voyager Therapeutics Announces Update to Parkinson’s Disease Program
» Press Release | Company News

GBT
October 28, 2017 - Global Blood Therapeutics Announces Presentation of Case Study Demonstrating Positive Effect of Voxelotor (GBT440) in a Sickle Cell Disease Patient with Severe and Symptomatic Anemia
» Press Release | Company News

CytomX Therapeutics
October 26, 2017 - CytomX Therapeutics to Announce Third Quarter 2017 Financial Results
» Press Release | Company News

Magenta Therapeutics
October 26, 2017 - Magenta Therapeutics Strengthens Leadership Team
» Press Release | Company News

Myokardia
October 26, 2017 - MyoKardia to Announce Third Quarter 2017 Financial Results on Thursday, November 2, 2017
» Press Release | Company News

Agios Pharmaceuticals
October 25, 2017 - Agios to Webcast Conference Call of Third Quarter 2017 Financial Results on November 1, 2017
» Press Release | Company News

Kala Pharmaceuticals
October 25, 2017 - Kala Pharmaceuticals Submits New Drug Application to U.S. Food and Drug Administration For INVELTYS™ (KPI-121 1%)
» Press Release | Company News

Blueprint Medicines
October 24, 2017 - Blueprint Medicines to Report Third Quarter 2017 Financial Results on Tuesday, October 31, 2017
» Press Release | Company News

Constellation Pharmaceuticals
October 24, 2017 - Constellation Pharmaceuticals Completes Management Team with Key Leadership Appointments
» Press Release | Company News

CytomX Therapeutics
October 24, 2017 - CytomX Therapeutics Appoints Charles S. Fuchs, M.D., MPH to Board of Directors
» Press Release | Company News

GBT
October 24, 2017 - Global Blood Therapeutics Announces Approval of First-in-Class “Voxelotor” as Nonproprietary Name for GBT440
» Press Release | Company News

Magenta Therapeutics
October 24, 2017 - Magenta Therapeutics Appoints Alison Lawton, Jeff Albers and Blake Byers to its Board of Directors
» Press Release | Company News

SAGE Therapeutics
October 24, 2017 - Sage Therapeutics to Report Third Quarter 2017 Financial Results on Thursday, November 2, 2017
» Press Release | Company News

GBT
October 23, 2017 - Global Blood Therapeutics Announces Discontinuation of Idiopathic Pulmonary Fibrosis (IPF) Program
» Press Release | Company News

Jounce Therapeutics
October 23, 2017 - Jounce Therapeutics Appoints Luis A. Diaz, Jr., M.D., to its Board of Directors
» Press Release | Company News

Ninepoint Medical
October 23, 2017 - New Clinical Data Presented at the World Congress of Gastroenterology @ ACG 2017 Shows Increased Dysplasia Detection Using Volumetric Laser Endomicroscopy with Laser Marking
» Press Release | Company News

Editas Medicine
October 19, 2017 - Editas Medicine Demonstrates Dose-Dependent, In Vivo Editing with EDIT-101 in CEP290 Transgenic Mice
» Press Release | Company News

Goldfinch Bio
October 17, 2017 - Goldfinch Bio Announces Collaborations with Icahn School of Medicine at Mount Sinai and Vanderbilt University Medical Center to Augment World’s Largest Genomic Registry of Patients with Kidney Disease
» Press Release | Company News

Voyager Therapeutics
October 17, 2017 - Voyager Therapeutics Announces New Data Presentations at the Congress of the European Society of Gene and Cell Therapy
» Press Release | Company News

CytomX Therapeutics
October 16, 2017 - CytomX Announces Upcoming Poster Presentations at AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics International Conference
» Press Release | Company News

Foundation Medicine
October 16, 2017 - Foundation Medicine to Present Validation for FoundationOne CDx™, a Comprehensive Genomic Profiling Assay for Advancing Precision Cancer Care
» Press Release | Company News

Warp Drive Bio
October 16, 2017 - Warp Drive Bio Forms Strategic Collaboration to Advance Novel Classes of Antibiotics to Combat Multi-Drug-Resistant Bacterial Infections
» Press Release | Company News

Sesen Bio
October 13, 2017 - Eleven Biotherapeutics Appoints Richard Fitzgerald as Interim Chief Financial Officer
» Press Release | Company News

Ninepoint Medical
October 13, 2017 - New Clinical Data using the NvisionVLE® Imaging System to be presented at the World Congress of Gastroenterology @ ACG 2017 and UEGW 2017
» Press Release | Company News

Foundation Medicine
October 12, 2017 - Foundation Medicine Announces Timing for Third Quarter 2017 Financial Results and Conference Call
» Press Release | Company News

Fulcrum Therapeutics
October 11, 2017 - Fulcrum Therapeutics to Present at the 18th Annual Fragile X and Related Neurodevelopmental Disorders Workshop
» Press Release | Company News

GBT
October 11, 2017 - Global Blood Therapeutics Announces Presentation of New Data Showing Positive Effect of GBT440 on Sickle Cell Disease Patient with Variant Genotype
» Press Release | Company News

Blueprint Medicines
October 10, 2017 - Blueprint Medicines Announces Appointment of Christopher Murray, Ph.D. as Senior Vice President, Technical Operations
» Press Release | Company News

Foundation Medicine
October 10, 2017 - Foundation Medicine Appoints Tom Civik as Chief Commercial Officer
» Press Release | Company News

Rhythm Pharmaceuticals
October 10, 2017 - Rhythm Pharmaceuticals, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
» Press Release | Company News

PanOptica
October 6, 2017 - PanOptica Secures $11 Million to Advance Clinical Development of PAN-90806 - a Novel, Topical Anti-VEGF Eye Drop
» Press Release | Company News

Voyager Therapeutics
October 6, 2017 - Voyager Therapeutics Announces Multiple Data Presentations at the Congress of the European Society of Gene and Cell Therapy
» Press Release | Company News

bluebird bio
October 6, 2017 - bluebird bio to Present at Chardan Gene Therapy Conference
» Press Release | Company News

REVOLUTION Medicines
October 5, 2017 - REVOLUTION Medicines Appoints Vincent Miller, M.D. to Board of Directors
» Press Release | Company News

Rhythm Pharmaceuticals
October 4, 2017 - Rhythm Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
» Press Release | Company News

bluebird bio
October 4, 2017 - bluebird bio Announces Publication of Interim Data from Starbeam Study of Lenti-DTM Drug Product in Patients with Cerebral Adrenoleukodystrophy (CALD) in The New England Journal of Medicine
» Press Release | Company News

Neon Therapeutics
October 4, 2017 - Neon Therapeutics Enters License Agreement with the Netherlands Cancer Institute for Neoantigen-based T Cell Therapeutics
» Press Release | Company News

CytomX Therapeutics
October 3, 2017 - Amgen And CytomX Therapeutics Announce Strategic Collaboration In Immuno-Oncology
» Press Release | Company News

Editas Medicine
October 3, 2017 - Editas Medicine to Participate in Investor Conferences in October
» Press Release | Company News

GBT
October 3, 2017 - Global Blood Therapeutics Announces Upcoming Presentations of GBT440 Data at Two Sickle Cell Disease Meetings in October
» Press Release | Company News

Goldfinch Bio
October 3, 2017 - Goldfinch Bio And Neptune Announce Collaboration To Discover New Treatments For Patients With Kidney Disease
» Press Release | Company News

Voyager Therapeutics
October 3, 2017 - Voyager Therapeutics to Present at Investor Conferences in October
» Press Release | Company News

Foundation Medicine
October 2, 2017 - Foundation Medicine Receives Approval from the State of New York for its FoundationACT Liquid Biopsy Assay
» Press Release | Company News

Kala Pharmaceuticals
October 2, 2017 - Kala Pharmaceuticals Appoints Andrew I. Koven To Board Of Directors
» Press Release | Company News

bluebird bio
September 28, 2017 - bluebird bio Announces First Patient Treated with Second Anti-BCMA CAR T bb21217 in CRB-402 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma
» Press Release | Company News

Myokardia
September 27, 2017 - MyoKardia Provides Update on MYK-491 Clinical Progress
» Press Release | Company News

Editas Medicine
September 26, 2017 - Editas Medicine Receives EMA’s Orphan Medicinal Product Designation for EDIT-101 for the Treatment of LCA10
» Press Release | Company News

GBT
September 26, 2017 - Global Blood Therapeutics Announces New Employment Inducement Grants
» Press Release | Company News

Goldfinch Bio
September 26, 2017 - Goldfinch Bio Expands Leadership Team With World-Class Preclinical and Clinical Expertise to Augment Company’s Unprecedented Investigation Into The Molecular Drivers of Kidney Disease
» Press Release | Company News

Magenta Therapeutics
September 26, 2017 - Fierce Biotech Names Magenta Therapeutics as one of its “Fierce 15” Biotech Companies of 2017
» Press Release | Company News

Pliant Therapeutics
September 26, 2017 - Pliant Appoints Katerina Leftheris, Ph.D., as Vice President of Chemistry and John Curnutte, M.D., Ph.D. to the Board of Directors
» Press Release | Company News

Relay Therapeutics
September 26, 2017 - FierceBiotech Names Relay Therapeutics as one of its "Fierce 15" Biotech Companies of 2017
» Press Release | Company News

Tango Therapeutics
September 26, 2017 - Tango Therapeutics Named a “Fierce 15” Company by FierceBiotech
» Press Release | Company News

Fulcrum Therapeutics
September 25, 2017 - Fulcrum Therapeutics to Present at the 10th Annual BioPharm America International Partnering Conference
» Press Release | Company News

Tango Therapeutics
September 25, 2017 - Tango Therapeutics Appoints Barbara Weber, MD, as Chief Executive Officer
» Press Release | Company News

Sesen Bio
September 22, 2017 - Eleven Biotherapeutics Announces Completion of Vicinium Manufacturing for Ongoing Clinical Trials in Non-Muscle Invasive Bladder Cancer
» Press Release | Company News

SAGE Therapeutics
September 22, 2017 - Sage Therapeutics to Participate in Leerink Investor Conference
» Press Release | Company News

Alcresta Therapeutics
September 20, 2017 - Alcresta Therapeutics Receives New Innovative Technology Contract from Vizient, Inc. For RELiZORB® (iMMOBILIZED LIPASE) Cartridge
» Press Release | Company News

bluebird bio
September 20, 2017 - bluebird bio Appoints Mary Lynne Hedley, Ph.D. to Board of Directors
» Press Release | Company News

Zafgen
September 19, 2017 - Zafgen to Present at the 2017 Ladenburg Thalmann Healthcare Conference
» Press Release | Company News

Myokardia
September 18, 2017 - MyoKardia Presents Additional Positive Data from Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) at the Heart Failure Society of America’s 21st Annual Scientific Meeting
» Press Release | Company News

Voyager Therapeutics
September 18, 2017 - Voyager Therapeutics Appoints Matthew P. Ottmer as Chief Operating Officer
» Press Release | Company News

Ablexis
September 14, 2017 - Ablexis Announces Licensing of the AlivaMab Mouse to Five Prime Therapeutics
» Press Release | Company News

REVOLUTION Medicines
September 14, 2017 - REVOLUTION Medicines Reports Discovery that May Expand Range of Clinically Actionable Cancer Mutations
» Press Release | Company News

bluebird bio
September 13, 2017 - bluebird bio Announces First Patient Treated in Expansion Cohort of CRB-401, Phase 1 Study of Anti-BCMA CAR T Therapy bb2121
» Press Release | Company News

CytomX Therapeutics
September 13, 2017 - CytomX to Present at the Cantor Fitzgerald Healthcare Conference
» Press Release | Company News

Editas Medicine
September 12, 2017 - Editas Medicine Initiates Clinical Natural History Study to Evaluate Patients with Leber Congenital Amaurosis Type 10 (LCA10)
» Press Release | Company News

SAGE Therapeutics
September 12, 2017 - Sage Therapeutics Reports Top-Line Results from Phase 3 STATUS Trial of Brexanolone in Super-Refractory Status Epilepticus
» Press Release | Company News

Zafgen
September 12, 2017 - Zafgen Presents New Preclinical Data on ZGN-1061 at the 53rd Annual Meeting of The European Association For The Study of Diabetes
» Press Release | Company News

Zafgen
September 12, 2017 - Zafgen Initiates Phase 2 Clinical Trial for ZGN-1061 In Patients with Type 2 Diabetes
» Press Release | Company News

Blueprint Medicines
September 10, 2017 - Blueprint Medicines Announces New Data from Ongoing Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma
» Press Release | Company News

Foundation Medicine
September 8, 2017 - Foundation Medicine to Present Validation Data for Its Assay Measuring Tumor Mutational Burden in Blood (bTMB), a New, Non-Invasive Predictor of Response to Immunotherapy
» Press Release | Company News

CytomX Therapeutics
September 8, 2017 - CytomX Announces Upcoming Trials in Progress Poster Presentations at European Society for Medical Oncology Annual Meeting
» Press Release | Company News

SAGE Therapeutics
September 7, 2017 - Sage Therapeutics to Present at Morgan Stanley Healthcare Conference
» Press Release | Company News

bluebird bio
September 6, 2017 - bluebird bio to Present Interim Clinical Data from Starbeam Study of Lenti-DTM Drug Product in Cerebral Adrenoleukodystrophy (CALD) at Child Neurology Society (CNS) 2017 Annual Meeting
» Press Release | Company News

Blueprint Medicines
September 6, 2017 - Blueprint Medicines to Present at Morgan Stanley 15th Annual Global Healthcare Conference
» Press Release | Company News

GBT
September 6, 2017 - Global Blood Therapeutics To Convene Sickle Cell Disease Influencers at Annual Sickle Cell Disease (SCD) Therapeutics Conference
» Press Release | Company News

SAGE Therapeutics
September 6, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Voyager Therapeutics
September 6, 2017 - Voyager Therapeutics Announces Positive Results from Ongoing Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
» Press Release | Company News

Agios Pharmaceuticals
September 5, 2017 - Agios to Present at the Morgan Stanley 15th Annual Global Healthcare Conference Monday, September 11, 2017
» Press Release | Company News

Editas Medicine
September 5, 2017 - Editas Medicine to Participate in Morgan Stanley 15th Annual Global Healthcare Conference
» Press Release | Company News

Sesen Bio
September 5, 2017 - Eleven Biotherapeutics to Present at the Rodman & Renshaw 19th Annual Global Investment Conference
» Press Release | Company News

Fulcrum Therapeutics
September 5, 2017 - Fulcrum Therapeutics to Present at BioCentury’s 24th Annual NewsMakers in the Biotech Industry Conference
» Press Release | Company News

GBT
September 5, 2017 - Global Blood Therapeutics Receives Rare Pediatric Disease Designation from FDA for GBT440 for Treatment of Sickle Cell Disease (SCD)
» Press Release | Company News

Kala Pharmaceuticals
September 5, 2017 - Kala Pharmaceuticals to Present At The 2017 Wells Fargo Healthcare Conference
» Press Release | Company News

bluebird bio
September 1, 2017 - bluebird bio to Present at Investor Conferences in September
» Press Release | Company News

Foundation Medicine
August 30, 2017 - Foundation Medicine to Present at the 2017 Wells Fargo Healthcare Conference
» Press Release | Company News

GBT
August 30, 2017 - Global Blood Therapeutics Announces Upcoming Participation in Multiple Investor Conferences in September
» Press Release | Company News

Jounce Therapeutics
August 30, 2017 - Jounce Therapeutics to Present at Upcoming Investor Conferences in September
» Press Release | Company News

Myokardia
August 30, 2017 - MyoKardia to Present at Two Upcoming Investor Conferences in September
» Press Release | Company News

Voyager Therapeutics
August 30, 2017 - Voyager Therapeutics to Participate in September Investor Conferences
» Press Release | Company News

Blueprint Medicines
August 21, 2017 - Blueprint Medicines to Present Updated Data from Ongoing Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma at ESMO 2017 Congress and 11th ILCA Annual Conference
» Press Release | Company News

Jounce Therapeutics
August 15, 2017 - Jounce Therapeutics Names Hugh Cole as Chief Business Officer and Head of Corporate Development
» Press Release | Company News

Neon Therapeutics
August 15, 2017 - Ms. Teresa Regan Joins Neon Therapeutics as VP of Human Resources
» Press Release | Company News

Sesen Bio
August 14, 2017 - Eleven Biotherapeutics Reports Second Quarter 2017 Financial Results
» Press Release | Company News

Myokardia
August 14, 2017 - MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

CytomX Therapeutics
August 10, 2017 - CytomX to Present at the 2017 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Myokardia
August 10, 2017 - MyoKardia to Present at 2017 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

bluebird bio
August 9, 2017 - bluebird bio to Present at Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Editas Medicine
August 9, 2017 - Editas Medicine Achieves Milestone Under Juno Therapeutics Collaboration for Technical Progress Towards Overcoming the Tumor Microenvironment
» Press Release | Company News

Editas Medicine
August 9, 2017 - Editas Medicine Announces Second Quarter 2017 Results and Update
» Press Release | Company News

Fulcrum Therapeutics
August 9, 2017 - Fulcrum Therapeutics Named Finalist for the 2017 Xconomy Awards in the Patient Partnership Category
» Press Release | Company News

GBT
August 9, 2017 - Global Blood Therapeutics Announces Participation at the 2017 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Jounce Therapeutics
August 9, 2017 - Jounce Therapeutics Reports Second Quarter 2017 Financial Results
» Press Release | Company News

GBT
August 9, 2017 - Global Blood Therapeutics Announces Participation at the 2017 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
August 8, 2017 - Agios Reports Second Quarter 2017 Financial Results
» Press Release | Company News

Myokardia
August 8, 2017 - MyoKardia Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
August 8, 2017 - Voyager Therapeutics Reports Second Quarter 2017 Financial Results and Corporate Highlights
» Press Release | Company News

Zafgen
August 8, 2017 - Zafgen Reports Second Quarter 2017 Financial Results
» Press Release | Company News

CytomX Therapeutics
August 7, 2017 - CytomX Announces Second Quarter 2017 Financial Results and Mid-Year Update Webcast Conference Call
» Press Release | Company News

Editas Medicine
August 7, 2017 - Editas Medicine to Host Conference Call Discussing Second Quarter 2017 Corporate Update and Results
» Press Release | Company News

Sesen Bio
August 7, 2017 - Eleven Biotherapeutics to Report Second Quarter 2017 Financial Results on Monday, August 14, 2017
» Press Release | Company News

GBT
August 7, 2017 - Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2017 Financial Results
» Press Release | Company News

Myokardia
August 7, 2017 - MyoKardia Reports Positive Topline Results in Phase 2 PIONEER-HCM Study of Mavacamten (Formerly MYK-461) in Symptomatic, Obstructive Hypertrophic Cardiomyopathy
» Press Release | Company News

Myokardia
August 7, 2017 - MyoKardia Reports Second Quarter 2017 Financial Results and Operational Progress
» Press Release | Company News

Myokardia
August 7, 2017 - MyoKardia Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
August 3, 2017 - Agios to Present at the Canaccord Genuity 37th Annual Growth Conference Thursday, August 10, 2017
» Press Release | Company News

Blueprint Medicines
August 3, 2017 - Blueprint Medicines to Present at Upcoming Investor Conferences in August
» Press Release | Company News

Sesen Bio
August 3, 2017 - Eleven Biotherapeutics to Present at Canaccord Genuity 37th Annual Growth Conference
» Press Release | Company News

SAGE Therapeutics
August 3, 2017 - Sage Therapeutics Announces Second Quarter 2017 Financial Results and Provides Pipeline Update
» Press Release | Company News

bluebird bio
August 2, 2017 - bluebird bio Reports Second Quarter 2017 Financial Results and Recent Operational Progress
» Press Release | Company News

Blueprint Medicines
August 2, 2017 - Blueprint Medicines Reports Second Quarter 2017 Financial Results
» Press Release | Company News

Jounce Therapeutics
August 2, 2017 - Jounce Therapeutics to Announce Second Quarter 2017 Financial Results and Host Conference Call on Wednesday, August 9, 2017
» Press Release | Company News

Voyager Therapeutics
August 2, 2017 - Voyager Therapeutics to Host Second Quarter 2017 Financial Results and Corporate Highlights Conference Call
» Press Release | Company News

Zafgen
August 2, 2017 - Zafgen To Present At The Canaccord Genuity 37th Annual Growth Conference
» Press Release | Company News

Agios Pharmaceuticals
August 1, 2017 - FDA Grants Approval of IDHIFA®, the First Oral Targeted Therapy for Adult Patients with Relapsed/Refractory Acute Myeloid Leukemia and an IDH2 Mutation
» Press Release | Company News

Foundation Medicine
August 1, 2017 - Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights
» Press Release | Company News

Rhythm Pharmaceuticals
August 1, 2017 - Rhythm Expands Executive Leadership Team
» Press Release | Company News

Zafgen
August 1, 2017 - Zafgen To Host Conference Call To Discuss Second Quarter 2017 Financial Results
» Press Release | Company News

Alcresta Therapeutics
July 31, 2017 - Alcresta Therapeutics Announces Positive Results, RELiZORB® Increased Fat Absorption in Both Adult and Pediatric Patients with Cystic Fibrosis Receiving Enteral Nutrition
» Press Release | Company News

Myokardia
July 31, 2017 - MyoKardia to Announce Second Quarter 2017 Financial Results and Host Conference Call on Monday, August 7, 2017
» Press Release | Company News

Agios Pharmaceuticals
July 28, 2017 - Agios to Webcast Conference Call of Second Quarter 2017 Financial Results on August 8, 2017
» Press Release | Company News

Allena Pharmaceuticals
July 27, 2017 - European Commission Grants Orphan Drug Designation to Allena Pharmaceuticals' Investigational Therapy for the Treatment of Primary Hyperoxaluria
» Press Release | Company News

Blueprint Medicines
July 27, 2017 - Blueprint Medicines to Evaluate Opportunities to Advance Rare Disease Discovery Program in Fibrodysplasia Ossificans Progressiva Following Discontinuation of Collaboration with Alexion
» Press Release | Company News

CytomX Therapeutics
July 27, 2017 - CytomX Therapeutics to Announce Second Quarter 2017 Financial Results and Provide Mid-Year Update
» Press Release | Company News

Blueprint Medicines
July 26, 2017 - Blueprint Medicines to Report Second Quarter 2017 Financial Results on Wednesday, August 2, 2017
» Press Release | Company News

GBT
July 26, 2017 - Global Blood Therapeutics Announces New Employment Inducement Grants
» Press Release | Company News

Kala Pharmaceuticals
July 25, 2017 - Kala Pharmaceuticals Announces Close of Initial Public Offering and Exercise of Underwriters’ Option
» Press Release | Company News

Neon Therapeutics
July 25, 2017 - Neon Therapeutics and Apexigen Announce Immuno-Oncology Clinical Trial Collaboration
» Press Release | Company News

Relay Therapeutics
July 24, 2017 - Relay Therapeutics Names Deborah Palestrant, Ph.D., Vice President of Corporate Development and Strategy
» Press Release | Company News

Kala Pharmaceuticals
July 20, 2017 - Kala Pharmaceuticals Announces Pricing of Initial Public Offering
» Press Release | Company News

Alcresta Therapeutics
July 20, 2017 - Alcresta Therapeutics Receives 510(K) Clearance For Use of RELiZORB® in Children
» Press Release | Company News

SAGE Therapeutics
July 20, 2017 - Sage Therapeutics to Report Second Quarter 2017 Financial Results on Thursday, August 3, 2017
» Press Release | Company News

Constellation Pharmaceuticals
July 18, 2017 - Constellation Pharmaceuticals Appoints Adrian Senderowicz, M.D., as Senior Vice President and Chief Medical Officer
» Press Release | Company News

Goldfinch Bio
July 18, 2017 - ASHG Honors Daniel MacArthur with Inaugural Early-Career Award
» Press Release | Company News

Voyager Therapeutics
July 17, 2017 - Voyager Therapeutics Announces Publication from the California Institute of Technology of a Second-Generation Gene Therapy Capsid Demonstrating Further Enhanced Gene Transfer to the Brain
» Press Release | Company News

Allena Pharmaceuticals
July 13, 2017 - FDA Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria
» Press Release | Company News

Foundation Medicine
July 12, 2017 - Foundation Medicine Announces Timing for Second Quarter 2017 Financial Results and Conference Call
» Press Release | Company News

GBT
July 10, 2017 - Global Blood Therapeutics Expands Ongoing Phase 2a HOPE-KIDS 1 Study into Younger Pediatric Population
» Press Release | Company News

Neon Therapeutics
July 10, 2017 - CRISPR Therapeutics and Neon Therapeutics Enter Research Collaboration
» Press Release | Company News

SAGE Therapeutics
July 10, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Decibel Therapeutics
July 6, 2017 - Decibel Therapeutics Announces Investment from GV to Expand Capabilities for Biological Target Identification in Hearing Loss and Tinnitus
» Press Release | Company News

Neon Therapeutics
July 5, 2017 - Initial Results from Dana-Farber Cancer Institute Personalized Neoantigen Vaccine Published in Nature
» Press Release | Company News

CytomX Therapeutics
June 29, 2017 - CytomX Achieves Development Milestone in Strategic Oncology Collaboration with AbbVie for CD71-Targeting Probody Drug Conjugate
» Press Release | Company News

CytomX Therapeutics
June 28, 2017 - CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-CX-2009 Trial
» Press Release | Company News

GBT
June 28, 2017 - Global Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)
» Press Release | Company News

bluebird bio
June 27, 2017 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Rhythm Pharmaceuticals
June 27, 2017 - Rhythm and Camurus Announce Positive Initial Data for Extended-Release Delivery of Setmelanotide for the Treatment of Rare Genetic Disorders of Obesity
» Press Release | Company News

bluebird bio
June 26, 2017 - bluebird bio Announces Topline Interim Clinical Data from Starbeam Study of Lenti-D™ Drug Product in Cerebral Adrenoleukodystrophy (CALD)
» Press Release | Company News

bluebird bio
June 26, 2017 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
June 26, 2017 - Voyager Therapeutics Announces Clinical Trial Update with VY-AADC01 for Advanced Parkinson’s Disease
» Press Release | Company News

Agios Pharmaceuticals
June 24, 2017 - Agios Announces Updated Data from Fully Enrolled DRIVE PK Study Demonstrating AG-348’s Potential as the First Disease-modifying Treatment for Patients with Pyruvate Kinase Deficiency
» Press Release | Company News

Agios Pharmaceuticals
June 24, 2017 - New Data from Phase 1/2 Trial of Oral IDHIFA® (enasidenib) Demonstrate Durable Complete Responses in Patients with IDH2 Mutant Relapsed or Refractory AML
» Press Release | Company News

bluebird bio
June 23, 2017 - bluebird bio Announces Early Data from Phase 3 Northstar-2 (HGB-207) Study of LentiGlobinTM Drug Product at European Hematology Association (EHA) Annual Meeting
» Press Release | Company News

bluebird bio
June 23, 2017 - bluebird bio Presents New Data from HGB-205 Study of LentiGlobinTM Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease (SCD) at European Hematology Association (EHA) Annual Meeting
» Press Release | Company News

GBT
June 23, 2017 - Global Blood Therapeutics Announces New Data Supporting Ongoing Clinical Development of GBT440 in Adolescents with Sickle Cell Disease
» Press Release | Company News

Neon Therapeutics
June 16, 2017 - Dr. Yasir Al-Wakeel Joins Neon Therapeutics as Chief Financial Officer
» Press Release | Company News

Editas Medicine
June 13, 2017 - Editas Medicine to Participate in Investor Conferences in June
» Press Release | Company News

Zafgen
June 13, 2017 - Zafgen To Present At The JPM Securities Life Sciences Conference
» Press Release | Company News

Sesen Bio
June 12, 2017 - Eleven Biotherapeutics to Present at 2017 Marcum MicroCap Conference
» Press Release | Company News

SAGE Therapeutics
June 12, 2017 - Sage Therapeutics Announces The Lancet Publishes Positive Phase 2 Brexanolone (SAGE-547) Clinical Data in Severe Postpartum Depression
» Press Release | Company News

Zafgen
June 10, 2017 - Zafgen Presents New Data Highlighting Potential Of ZGN-1061 For The Treatment Of Type 2 Diabetes And Obesity At The American Diabetes Association's 77th Annual Scientific Sessions
» Press Release | Company News

Myokardia
June 9, 2017 - MyoKardia Reports First Quarter 2017 Financial Results and Operational Progress
» Press Release | Company News

bluebird bio
June 8, 2017 - bluebird bio Appoints John O. Agwunobi, M.D. and Douglas A. Melton, Ph.D. to Board of Directors
» Press Release | Company News

Foundation Medicine
June 8, 2017 - ASCO and Foundation Medicine Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization (TAPUR) Study
» Press Release | Company News

SAGE Therapeutics
June 8, 2017 - Sage Therapeutics to Present at Goldman Sachs Healthcare Conference
» Press Release | Company News

Foundation Medicine
June 7, 2017 - Foundation Medicine to Identify Patients Eligible for National Cancer Institute's NCI-MATCH (Molecular Analysis for Therapy Choice) Study
» Press Release | Company News

Agios Pharmaceuticals
June 6, 2017 - Updated Data from Phase 1 Trial of Oral IDHIFA® (enasidenib) Demonstrate Complete Responses and Duration of Response in Patients with Relapsed or Refractory AML and an IDH2 Mutation
» Press Release | Company News

Sesen Bio
June 6, 2017 - Eleven Biotherapeutics to Collaborate with AstraZeneca and the National Cancer Institute on Development of ViciniumTM in Combination with Durvalumab for the Treatment of Non-Muscle Invasive Bladder Cancer
» Press Release | Company News

GBT
June 6, 2017 - Global Blood Therapeutics Announces Participation at the Goldman Sachs 38th Annual Global Healthcare Conference
» Press Release | Company News

Zafgen
June 6, 2017 - Zafgen To Present Two Late-Breaking Abstracts for ZGN-1061 At The American Diabetes Association 77th Scientific Sessions
» Press Release | Company News

bluebird bio
June 5, 2017 - bluebird bio and Celgene Corporation Announce Updated Clinical Results from Ongoing First-in-Human Multicenter Study of bb2121 Anti-BCMA CAR T Cell Therapy in Relapsed/Refractory Multiple Myeloma at ASCO Annual Meeting
» Press Release | Company News

Blueprint Medicines
June 5, 2017 - Blueprint Medicines Announces New Phase 1 Clinical Data for BLU-285 in Advanced Gastrointestinal Stromal Tumors and Plans to Pursue Expedited Development in Patients with a PDGFRα D842V Mutation
» Press Release | Company News

Foundation Medicine
June 5, 2017 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Jounce Therapeutics
June 5, 2017 - Jounce Therapeutics Presents Phase 1 Data from ICONIC Study of JTX-2011 in Patients with Advanced Solid Tumors at 2017 ASCO Annual Meeting
» Press Release | Company News

SAGE Therapeutics
June 5, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Agios Pharmaceuticals
June 3, 2017 - Agios Presents Phase 1 Data from Dose-Escalation and Expansion Cohorts of AG-120 (Ivosidenib) in Patients with Previously Treated IDH1 Mutant Positive Cholangiocarcinoma
» Press Release | Company News

Voyager Therapeutics
June 2, 2017 - Voyager Therapeutics to Attend Upcoming Investor Conferences
» Press Release | Company News

bluebird bio
June 1, 2017 - bluebird bio to Present at Two Investor Conferences in June
» Press Release | Company News

Blueprint Medicines
June 1, 2017 - Blueprint Medicines to Present at Upcoming Investor Conferences in June
» Press Release | Company News

Sesen Bio
June 1, 2017 - Eleven Biotherapeutics Announces Data and Safety Monitoring Board (DSMB) Recommendation to Continue Phase 3 Registration Trial with Vicinium™ in Non-Muscle Invasive Bladder Cancer Based on Review of Safety and Efficacy Data
» Press Release | Company News

Voyager Therapeutics
June 1, 2017 - Voyager Therapeutics Selects Lead Clinical Candidate for Huntington’s Disease
» Press Release | Company News

Agios Pharmaceuticals
May 31, 2017 - Agios Appoints David Scadden, M.D., to the Board of Directors
» Press Release | Company News

Editas Medicine
May 31, 2017 - Editas Medicine Names Andrew Hirsch to Board of Directors
» Press Release | Company News

Constellation Pharmaceuticals
May 25, 2017 - Jigar Raythatha Rejoins Constellation Pharmaceuticals as President and CEO
» Press Release | Company News

CytomX Therapeutics
May 25, 2017 - CytomX to Present at the Jefferies 2017 Global Healthcare Conference
» Press Release | Company News

bluebird bio
May 23, 2017 - bluebird bio Announces Collaboration with Duke University’s Robert J. Margolis, MD, Center for Health Policy on Value-Based Payment Framework for Gene Therapy
» Press Release | Company News

Agios Pharmaceuticals
May 18, 2017 - Agios to Present Updated Clinical Data from PKR Activator AG-348 at EHA
» Press Release | Company News

bluebird bio
May 18, 2017 - bluebird bio to Present New Data from LentiGlobinTM Clinical Studies at European Hematology Association (EHA) Annual Meeting
» Press Release | Company News

Foundation Medicine
May 18, 2017 - Foundation Medicine and Its Collaborators to Present New Data at ASCO 2017 Supporting the Integration of Comprehensive Genomic Profiling (CGP) in Personalized Clinical Care in Oncology
» Press Release | Company News

GBT
May 18, 2017 - Global Blood Therapeutics Announces Upcoming Presentation of GBT440 Data in Adolescents with Sickle Cell Disease at European Hematology Association’s 22nd Congress
» Press Release | Company News

Magenta Therapeutics
May 18, 2017 - Magenta Therapeutics Selected as “Hottest Early Stage Startup” in Healthcare in New England Venture Capital Association’s 2017 NEVY Awards
» Press Release | Company News

SAGE Therapeutics
May 18, 2017 - Sage Therapeutics Receives Fast Track Designation for SAGE-217 for the Treatment of Major Depressive Disorder
» Press Release | Company News

Agios Pharmaceuticals
May 17, 2017 - Agios to Present New Clinical Data from its IDH Programs at ASCO
» Press Release | Company News

bluebird bio
May 17, 2017 - bluebird bio to Present Updated Clinical Results from Novel Anti-BCMA CAR T Cell Therapy bb2121 at American Society of Clinical Oncology (ASCO) Annual Meeting
» Press Release | Company News

Blueprint Medicines
May 17, 2017 - Blueprint Medicines to Present New Data from Ongoing Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors at 2017 ASCO Annual Meeting
» Press Release | Company News

CytomX Therapeutics
May 17, 2017 - CytomX Announces Upcoming Poster Presentation at American Society for Clinical Oncology Annual Meeting
» Press Release | Company News

Decibel Therapeutics
May 17, 2017 - Decibel Therapeutics Opens New Headquarters and The Fenway’s First Lab
» Press Release | Company News

Sesen Bio
May 17, 2017 - Eleven Biotherapeutics Continues Expansion of Clinical Development Team with Appointment of David Brooks, M.D., Ph.D., to Senior Vice President, Clinical Development
» Press Release | Company News

Jounce Therapeutics
May 17, 2017 - Jounce Therapeutics to Present Phase 1 Data from JTX-2011 ICONIC Trial at 2017 American Society of Clinical Oncology Annual Meeting
» Press Release | Company News

Rhythm Pharmaceuticals
May 17, 2017 - Rhythm Expands Phase 2 Clinical Trials of Setmelanotide to the Treatment of Bardet-Biedl Syndrome Obesity
» Press Release | Company News

CytomX Therapeutics
May 15, 2017 - CytomX Announces Management Team Changes
» Press Release | Company News

Editas Medicine
May 15, 2017 - Editas Medicine Announces First Quarter 2017 Results and Update
» Press Release | Company News

Editas Medicine
May 13, 2017 - Editas Medicine Demonstrates First Achievement of In Vivo Editing in Non-human Primate Retinas
» Press Release | Company News

Editas Medicine
May 11, 2017 - Editas Medicine Announces Pre-Clinical Data for Program to Treat Sickle Cell Disease and Beta-Thalassemia
» Press Release | Company News

Rhythm Pharmaceuticals
May 11, 2017 - Rhythm Receives Expanded FDA Breakthrough Therapy Designation for Setmelanotide for Rare Genetic Disorders of Obesity
» Press Release | Company News

Fulcrum Therapeutics
May 10, 2017 - Fulcrum Therapeutics Announces Additional Series A Financing from GV
» Press Release | Company News

Magenta Therapeutics
May 10, 2017 - Magenta Therapeutics Announces New Clinical Data on its Lead Expansion Clinical Program, MGTA-456, Presented at American Society of Gene and Cell Therapy Annual Meeting
» Press Release | Company News

Foundation Medicine
May 9, 2017 - Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights
» Press Release | Company News

Jounce Therapeutics
May 9, 2017 - Jounce Therapeutics Reports First Quarter 2017 Financial Results
» Press Release | Company News

Myokardia
May 9, 2017 - MyoKardia Reports First Quarter 2017 Financial Results and Operational Progress
» Press Release | Company News

SAGE Therapeutics
May 9, 2017 - Sage Therapeutics Announces First Quarter 2017 Financial Results and Provides Pipeline Update
» Press Release | Company News

Voyager Therapeutics
May 9, 2017 - Voyager Therapeutics Reports First Quarter 2017 Financial Results and Corporate Highlights
» Press Release | Company News

Zafgen
May 9, 2017 - Zafgen Reports First Quarter 2017 Financial Results
» Press Release | Company News

Editas Medicine
May 8, 2017 - Editas Medicine to Present at Investor Conferences in May
» Press Release | Company News

Editas Medicine
May 8, 2017 - Editas Medicine to Host Conference Call Discussing First Quarter 2017 Corporate Update and Results
» Press Release | Company News

CytomX Therapeutics
May 5, 2017 - CytomX Announces First Quarter 2017 Financial Results
» Press Release | Company News

Ninepoint Medical
May 5, 2017 - NinePoint Medical to Feature the NvisionVLE® Imaging System with Real-time TargetingTM at DDW 2017; Twenty-four Scientific Abstracts to be Presented
» Press Release | Company News

Agios Pharmaceuticals
May 4, 2017 - Agios Reports First Quarter 2017 Financial Results
» Press Release | Company News

Sesen Bio
May 4, 2017 - Eleven Biotherapeutics Reports First Quarter 2017 Financial Results
» Press Release | Company News

Rhythm Pharmaceuticals
May 4, 2017 - Rhythm Starts Phase 3 Clinical Trial of Setmelanotide for Rare Genetic Disorder of Obesity
» Press Release | Company News

SAGE Therapeutics
May 4, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Voyager Therapeutics
May 4, 2017 - Voyager Therapeutics to Host First Quarter 2017 Financial Results and Corporate Highlights Conference Call
» Press Release | Company News

Zafgen
May 4, 2017 - Zafgen Announces Positive Topline Phase 1 Data for ZGN-1061, a Second Generation MetAP2 Inhibitor
» Press Release | Company News

bluebird bio
May 3, 2017 - bluebird bio Reports First Quarter 2017 Financial Results and Recent Operational Progress
» Press Release | Company News

Blueprint Medicines
May 3, 2017 - Blueprint Medicines Reports First Quarter 2017 Financial Results
» Press Release | Company News

Fulcrum Therapeutics
May 3, 2017 - Fulcrum Therapeutics Expands Leadership Team with Appointment of Owen Wallace, Ph.D., as Chief Scientific Officer and Amit Hasija as Chief Business Officer
» Press Release | Company News

bluebird bio
May 2, 2017 - bluebird bio Licenses Lentiviral Vector Patent Rights for Development and Commercialization of Cell Therapies
» Press Release | Company News

bluebird bio
May 2, 2017 - bluebird bio Enters Lentiviral Vector Patent License Agreement with GlaxoSmithKline for Commercialization of Gene Therapies
» Press Release | Company News

Magenta Therapeutics
May 2, 2017 - Magenta Therapeutics Advances Stem Cell Transplantation Strategy with $50 Million Series B Financing, Licensing of Clinical-Stage Stem Cell Expansion Program and Strategic Partnership with Be The Match BioTherapies
» Press Release | Company News

Myokardia
May 2, 2017 - MyoKardia to Announce First Quarter 2017 Financial Results and Host Conference Call on Tuesday, May 9, 2017
» Press Release | Company News

GBT
May 1, 2017 - Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2017 Financial Results
» Press Release | Company News

Kala Pharmaceuticals
May 1, 2017 - Kala Pharmaceuticals Announces Positive Results from Confirmatory Phase 3 Trial of KPI-121 1% Following Cataract Surgery
» Press Release | Company News

Sesen Bio
April 28, 2017 - Eleven Biotherapeutics to Report First Quarter 2017 Financial Results on Thursday, May 4, 2017
» Press Release | Company News

Agios Pharmaceuticals
April 28, 2017 - Agios Announces Closing of Over-Allotment Option in Public Offering
» Press Release | Company News

Agios Pharmaceuticals
April 27, 2017 - Agios to Webcast Conference Call of First Quarter 2017 Financial Results on May 4, 2017
» Press Release | Company News

Agios Pharmaceuticals
April 27, 2017 - Agios and Aurigene Enter into Exclusive License Agreement for Novel Small Molecules for Cancer Metabolism Target
» Press Release | Company News

CytomX Therapeutics
April 27, 2017 - CytomX Therapeutics to Announce First Quarter 2017 Financial Results
» Press Release | Company News

SAGE Therapeutics
April 27, 2017 - Sage Therapeutics Announces Initiation of Phase 1 Development and First Dosing of SAGE-718
» Press Release | Company News

Agios Pharmaceuticals
April 26, 2017 - Agios Announces Exercise of Over-Allotment Option in Public Offering
» Press Release | Company News

bluebird bio
April 26, 2017 - bluebird bio to Present at Upcoming Investor Conferences
» Press Release | Company News

Blueprint Medicines
April 26, 2017 - Blueprint Medicines to Report First Quarter 2017 Financial Results on Wednesday, May 3, 2017
» Press Release | Company News

SAGE Therapeutics
April 25, 2017 - Sage Therapeutics to Report First Quarter 2017 Financial Results on Tuesday, May 9, 2017
» Press Release | Company News

Voyager Therapeutics
April 25, 2017 - Voyager Therapeutics Announces Additional Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
» Press Release | Company News

Agios Pharmaceuticals
April 24, 2017 - Agios Announces Closing of Public Offering
» Press Release | Company News

Editas Medicine
April 24, 2017 - Editas Medicine to Present New Data Demonstrating Advancements for Translating CRISPR Technologies into Medicines at the American Society of Gene & Cell Therapy Annual Meeting
» Press Release | Company News

SAGE Therapeutics
April 24, 2017 - Sage Therapeutics Appoints Michael Cloonan as Chief Business Officer and Expands Executive Team
» Press Release | Company News

Foundation Medicine
April 20, 2017 - Foundation Medicine Announces Timing for First Quarter 2017 Financial Results and Conference Call
» Press Release | Company News

Jounce Therapeutics
April 20, 2017 - Jounce Therapeutics Initiates Phase 2 Portion of ICONIC Study of JTX-2011 in Patients with Advanced Solid Tumors
» Press Release | Company News

SAGE Therapeutics
April 19, 2017 - Sage Therapeutics to Present at American Academy of Neurology 2017 Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
April 18, 2017 - Agios Announces Pricing of $250 Million Public Offering of Common Stock
» Press Release | Company News

Myokardia
April 18, 2017 - MyoKardia Appoints David Meeker, M.D., to Board of Directors
» Press Release | Company News

Agios Pharmaceuticals
April 17, 2017 - Agios Announces Proposed Offering of Common Stock
» Press Release | Company News

Rhythm Pharmaceuticals
April 11, 2017 - Rhythm Appoints Head of Sanofi Genzyme, Dr. David Meeker, as Chairman of Board of Directors
» Press Release | Company News

SAGE Therapeutics
April 5, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Blueprint Medicines
April 4, 2017 - Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock
» Press Release | Company News

Relay Therapeutics
April 4, 2017 - Relay Therapeutics Appoints Pharmaceutical Leader Sanjiv K. Patel, M.D. to President and Chief Executive Officer
» Press Release | Company News

Sesen Bio
April 2, 2017 - Eleven Biotherapeutics Presents New Preclinical Data at AACR Supporting the Potential of the Company's Locally- and Systematically-Administered Drug Candidates
» Press Release | Company News

Jounce Therapeutics
March 31, 2017 - Jounce Therapeutics Added to Russell 2000®, 3000® and Microcap® Indexes
» Press Release | Company News

Tango Therapeutics
March 30, 2017 - Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
» Press Release | Company News

Agios Pharmaceuticals
March 30, 2017 - Agios to Present at the 16th Annual Needham Healthcare Conference on Tuesday April 4, 2017
» Press Release | Company News

CytomX Therapeutics
March 30, 2017 - CytomX Therapeutics Appoints Marion McCourt to Board of Directors
» Press Release | Company News

Foundation Medicine
March 30, 2017 - Bristol-Myers Squibb Enters Collaboration to Leverage Foundation Medicine's Molecular Information Platform to Identify Predictive Biomarkers Across Multiple Tumor Types and Immunotherapy Agents
» Press Release | Company News

Blueprint Medicines
March 29, 2017 - Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
» Press Release | Company News

Blueprint Medicines
March 29, 2017 - Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
» Press Release | Company News

GBT
March 29, 2017 - Global Blood Therapeutics to Present at the 16th Annual Needham Healthcare Conference
» Press Release | Company News

Warp Drive Bio
March 29, 2017 - Warp Drive Bio Forms Technology Alliance with GSK to Discover Potential Therapeutics in Oncology and Other Diseases
» Press Release | Company News

Blueprint Medicines
March 27, 2017 - Blueprint Medicines to Present on BLU-285 and BLU-554 at Upcoming Scientific Conferences
» Press Release | Company News

Sesen Bio
March 27, 2017 - Eleven Biotherapeutics to Present New Preclinical Data at the American Association for Cancer Research Annual Meeting 2017
» Press Release | Company News

Sesen Bio
March 24, 2017 - Eleven Biotherapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Sesen Bio
March 22, 2017 - Eleven Biotherapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on Friday, March 24, 2017
» Press Release | Company News

Jounce Therapeutics
March 22, 2017 - Jounce Therapeutics to Present at AACR Annual Meeting on JTX-2011 Cancer Immunotherapy Program
» Press Release | Company News

bluebird bio
March 20, 2017 - bluebird bio Appoints New Senior Manufacturing and Corporate Development Executives
» Press Release | Company News

Blueprint Medicines
March 20, 2017 - Blueprint Medicines Announces Enrollment of First Patient in Phase 1 Clinical Trial for BLU-667
» Press Release | Company News

CytomX Therapeutics
March 20, 2017 - Bristol-Myers Squibb and CytomX Therapeutics Extend Worldwide Collaboration to Discover Probody™ Therapeutics for the Treatment of Cancer and Other Diseases
» Press Release | Company News

Sesen Bio
March 20, 2017 - Eleven Biotherapeutics to Present at Oppenheimer's 27th Annual Healthcare Conference
» Press Release | Company News

REVOLUTION Medicines
March 20, 2017 - REVOLUTION Medicines Appoints Cancer Leader Dr. Stephen Kelsey as President of Research and Development
» Press Release | Company News

CytomX Therapeutics
March 19, 2017 - CytomX Therapeutics Announces Teleconference and Webcast to Provide Corporate Update
» Press Release | Company News

Myokardia
March 17, 2017 - MyoKardia Appoints Kim Popovits and Wendy Yarno to Board of Directors
» Press Release | Company News

Editas Medicine
March 16, 2017 - Editas Medicine, Inc. Announces Pricing of $90 Million Offering of Common Stock
» Press Release | Company News

Editas Medicine
March 15, 2017 - Editas Medicine, Inc., Announces Proposed Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
March 15, 2017 - Voyager Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results and Corporate Highlights
» Press Release | Company News

Editas Medicine
March 14, 2017 - Allergan and Editas Medicine Enter into Strategic R&D Alliance to Discover and Develop CRISPR Genome Editing Medicines for Eye Diseases
» Press Release | Company News

Agios Pharmaceuticals
March 13, 2017 - Agios Announces MTAP Pathway Research Program as Development Program and Development Candidate Under Master Research and Collaboration Agreement with Celgene
» Press Release | Company News

GBT
March 13, 2017 - Global Blood Therapeutics Reports Recent Business Progress and Fourth Quarter and Year-End 2016 Financial Results
» Press Release | Company News

Myokardia
March 13, 2017 - MyoKardia Reports Fourth Quarter and Full Year 2016 Financial Results and Operational Progress
» Press Release | Company News

Jounce Therapeutics
March 10, 2017 - Jounce Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Blueprint Medicines
March 9, 2017 - Blueprint Medicines Reports Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Zafgen
March 9, 2017 - Zafgen Reports Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Voyager Therapeutics
March 8, 2017 - Voyager Therapeutics to Host Fourth Quarter and Full Year 2016 Financial Results Conference call
» Press Release | Company News

Editas Medicine
March 7, 2017 - Editas Medicine Announces Fourth Quarter and Full Year 2016 Results and Update
» Press Release | Company News

Editas Medicine
March 3, 2017 - Editas Medicine Announces Departure of Chief Operating Officer
» Press Release | Company News

Allena Pharmaceuticals
March 3, 2017 - Allena Pharmaceuticals to Present at The Cowen And Company 37th Annual Health Care Conference
» Press Release | Company News

Blueprint Medicines
March 2, 2017 - Blueprint Medicines to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, March 9, 2017
» Press Release | Company News

CytomX Therapeutics
March 2, 2017 - CytomX Announces Full-Year 2016 Financial Results
» Press Release | Company News

Foundation Medicine
March 2, 2017 - Foundation Medicine Receives Medicare Payment in Non-Small Cell Lung Cancer under a Local Coverage Determination for FoundationOne®, the Company's Comprehensive Genomic Profiling Assay
» Press Release | Company News

SAGE Therapeutics
March 2, 2017 - Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Zafgen
March 2, 2017 - Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2016 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
March 1, 2017 - FDA Accepts New Drug Application and Grants Priority Review for Enasidenib in Relapsed or Refractory AML with an IDH2 Mutation
» Press Release | Company News

bluebird bio
March 1, 2017 - bluebird bio Announces Publication of Case Study on First Patient with Severe Sickle Cell Disease Treated with Gene Therapy in The New England Journal of Medicine
» Press Release | Company News

CytomX Therapeutics
March 1, 2017 - CytomX Therapeutics to Announce Full-Year 2016 Financial Results
» Press Release | Company News

Sesen Bio
March 1, 2017 - Eleven Biotherapeutics to Present at Upcoming Investor Conferences in March
» Press Release | Company News

GBT
March 1, 2017 - Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in March
» Press Release | Company News

Agios Pharmaceuticals
February 28, 2017 - Agios to Present at the Cowen and Company 37th Annual Health Care Conference on Monday, March 6, 2017
» Press Release | Company News

bluebird bio
February 28, 2017 - bluebird bio to Present at Two Investor Conferences in March
» Press Release | Company News

Blueprint Medicines
February 28, 2017 - Blueprint Medicines to Present at Upcoming Investor Conferences in March
» Press Release | Company News

Editas Medicine
February 28, 2017 - Editas Medicine Joins Global Movement to Raise Awareness on Rare Disease Day 2017
» Press Release | Company News

Editas Medicine
February 28, 2017 - Editas Medicine to Host Conference Call Discussing Fourth Quarter and Full Year 2016 Corporate Update and Results
» Press Release | Company News

Foundation Medicine
February 28, 2017 - Foundation Medicine to Present at Cowen and Company's 37th Annual Healthcare Conference
» Press Release | Company News

Jounce Therapeutics
February 28, 2017 - Jounce Therapeutics to Present at Cowen and Company 37th Annual Health Care Conference
» Press Release | Company News

Myokardia
February 28, 2017 - MyoKardia to Present at Cowen and Company 37th Annual Health Care Conference
» Press Release | Company News

Voyager Therapeutics
February 28, 2017 - Voyager Therapeutics Supports Rare Disease Day® and Global Movement to Raise Awareness for Rare Diseases
» Press Release | Company News

Zafgen
February 28, 2017 - Zafgen to Present at Upcoming Investor Conferences
» Press Release | Company News

Editas Medicine
February 27, 2017 - Editas Medicine to Present at Investor Conferences in March
» Press Release | Company News

GBT
February 27, 2017 - Global Blood Therapeutics Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

SAGE Therapeutics
February 23, 2017 - Sage Therapeutics Announces Fourth Quarter and Full Year 2016 Financial Results and Provides Corporate Update
» Press Release | Company News

Seventh Sense BioSystems
February 23, 2017 - First-Ever Device for Fast and Virtually Painless Blood Draw Receives FDA Clearance
» Press Release | Company News

bluebird bio
February 22, 2017 - bluebird bio Reports Fourth Quarter and Full Year 2016 Financial Results and Recent Operational Progress
» Press Release | Company News

Foundation Medicine
February 22, 2017 - Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook
» Press Release | Company News

GBT
February 22, 2017 - Global Blood Therapeutics Prices a $125.0 Million Upsized Common Stock Public Offering
» Press Release | Company News

CytomX Therapeutics
February 21, 2017 - CytomX Therapeutics to Present at Upcoming Investor Conferences
» Press Release | Company News

GBT
February 21, 2017 - Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Neon Therapeutics
February 21, 2017 - Using Mono-allelic Mass Spectrometry Data to Improve Epitope Prediction Algorithms Published in Immunity
» Press Release | Company News

SAGE Therapeutics
February 17, 2017 - Sage Therapeutics to Report Fourth Quarter and Full Year 2016 Financial Results on Thursday, February 23, 2017
» Press Release | Company News

Agios Pharmaceuticals
February 16, 2017 - Agios Reports Fourth Quarter and Full Year 2016 Financial Results and Highlights Key 2017 Milestones
» Press Release | Company News

GBT
February 16, 2017 - Global Blood Therapeutics Announces Initiation of Phase 1 Trial to Evaluate the Physiologic Effects of GBT440 in Healthy Volunteers Under Hypoxemic Conditions
» Press Release | Company News

Rhythm Pharmaceuticals
February 16, 2017 - Rhythm Announces Completion of $41 Million Mezzanine Financing
» Press Release | Company News

SAGE Therapeutics
February 16, 2017 - Sage Therapeutics Not in M&A Discussions: STATEMENT
» Press Release | Company News

Blueprint Medicines
February 15, 2017 - Blueprint Medicines to Present at 2017 RBC Capital Markets Global Healthcare Conference
» Press Release | Company News

Editas Medicine
February 15, 2017 - Editas Medicine Announces U.S. Patent and Trademark Office Decision Favorable to Broad Institute in CRISPR Interference
» Press Release | Company News

Ablexis
February 14, 2017 - Ablexis Announces Perpetual License Agreement for AlivaMab Mouse with Janssen
» Press Release | Company News

GBT
February 14, 2017 - Global Blood Therapeutics Announces Publication of Paper Describing Discovery of GBT440 in ACS Medicinal Chemistry Letters
» Press Release | Company News

Decibel Therapeutics
February 13, 2017 - Decibel Therapeutics Presents at 2017 Annual Association for Research in Otolaryngology (ARO) Meeting
» Press Release | Company News

SAGE Therapeutics
February 13, 2017 - Sage Therapeutics Advances SAGE-217 into Placebo-Controlled Phase 2 Clinical Trial in Major Depressive Disorder
» Press Release | Company News

Voyager Therapeutics
February 13, 2017 - Voyager Therapeutics Announces Lead Clinical Candidate Selection for Monogenic Form of Amyotrophic Lateral Sclerosis (ALS)
» Press Release | Company News

Editas Medicine
February 10, 2017 - Editas Medicine to Present at Upcoming February Investor Conferences
» Press Release | Company News

Agios Pharmaceuticals
February 9, 2017 - Agios to Webcast Conference Call of Fourth Quarter and Full Year 2016 Financial Results on February 16, 2017
» Press Release | Company News

Goldfinch Bio
February 9, 2017 - Goldfinch Bio Appoints Nephrologist Louis Brenner, M.D., M.B.A. to Board of Directors
» Press Release | Company News

Zafgen
February 9, 2017 - Zafgen to Present at the Leerink Partners 6th Annual Global Healthcare Conference
» Press Release | Company News

Sesen Bio
February 7, 2017 - Eleven Biotherapeutics to Present at the 2017 BIO CEO & Investor Conference
» Press Release | Company News

Fulcrum Therapeutics
February 7, 2017 - Fulcrum Therapeutics Strengthens its Board of Directors with the Addition of Alan Ezekowitz, MBChB, D.Phil., and James J. Collins, Ph.D.
» Press Release | Company News

SAGE Therapeutics
February 7, 2017 - Sage Therapeutics to Participate in Upcoming February Investor Conferences
» Press Release | Company News

Foundation Medicine
February 6, 2017 - Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2016 Financial Results and Conference Call
» Press Release | Company News

bluebird bio
February 3, 2017 - bluebird bio Announces First Patient Treated with LentiGlobin™ Drug Product Under Amended Study Protocol in HGB-206 Phase 1 Study of Patients with Severe Sickle Cell Disease
» Press Release | Company News

CytomX Therapeutics
February 2, 2017 - CytomX Announces the First Patient Treated in Phase 1/2 PROCLAIM-072 Trial
» Press Release | Company News

CytomX Therapeutics
February 2, 2017 - CytomX to Present at Upcoming Investor Conferences
» Press Release | Company News

Myokardia
February 2, 2017 - First Subjects Dosed in MyoKardia Phase 1 Study of Dilated Cardiomyopathy Candidate MYK-491
» Press Release | Company News

Voyager Therapeutics
February 2, 2017 - Voyager Therapeutics to Attend Upcoming Investor Conferences
» Press Release | Company News

Myokardia
February 1, 2017 - MyoKardia Announces Appointment of June Lee, M.D., as Chief Operating Officer and Radhika Tripuraneni, M.D., as Vice President, Medical Affairs
» Press Release | Company News

Jounce Therapeutics
January 26, 2017 - Jounce Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

Voyager Therapeutics
January 25, 2017 - Voyager Therapeutics Announces Publication of Vectored Anti-Tau Monoclonal Antibody Study in The Journal of Neuroscience
» Press Release | Company News

Voyager Therapeutics
January 20, 2017 - Voyager Therapeutics Announces Updates from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
» Press Release | Company News

GBT
January 18, 2017 - Global Blood Therapeutics Announces Enrollment of First Patient in Phase 3 HOPE Study in Sickle Cell Disease
» Press Release | Company News

Decibel Therapeutics
January 18, 2017 - Decibel Therapeutics Expands Leadership Team With World-Class Bioinformatics Scientist; Appoints Three New Members to its Board of Directors
» Press Release | Company News

Agios Pharmaceuticals
January 9, 2017 - Agios Announces Key Upcoming Milestones to Support Evolution to a Commercial Stage Biopharmaceutical Company in 2017
» Press Release | Company News

CytomX Therapeutics
January 9, 2017 - CytomX to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

CytomX Therapeutics
January 9, 2017 - UPDATE: CytomX Announces Time Change for its Presentation at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Editas Medicine
January 9, 2017 - Editas Medicine Reports on Recent Progress and 2017 Goals at J.P. Morgan Healthcare Conference
» Press Release | Company News

Foundation Medicine
January 9, 2017 - Foundation Medicine Reports Preliminary 2016 Results
» Press Release | Company News

Foundation Medicine
January 6, 2017 - Foundation Medicine Announces Executive Leadership Transition
» Press Release | Company News

Kala Pharmaceuticals
January 6, 2017 - Kala Pharmaceuticals to Present Update on Phase 3 Programs at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Taris Biomedical
January 6, 2017 - TARIS Biomedical® Announces Positive Results from Ph1b Trial of TAR-200 (GemRIS™) in Patients with Muscle Invasive Bladder Cancer
» Press Release | Company News

Allena Pharmaceuticals
January 5, 2017 - Allena Pharmaceuticals To Present At The 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Neon Therapeutics
January 5, 2017 - Neon Therapeutics Secures $70 Million in Series B Financing
» Press Release | Company News

Pliant Therapeutics
January 5, 2017 - Pliant Therapeutics Appoints Leading Academic Researcher and Industry Veteran Rik Derynck, Ph.D. As Scientific Founder
» Press Release | Company News

Voyager Therapeutics
January 5, 2017 - Voyager Therapeutics Elects Wendy Dixon, Ph.D. and Glenn Pierce, M.D., Ph.D. to Board of Directors
» Press Release | Company News

bluebird bio
January 4, 2017 - bluebird bio to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Editas Medicine
January 4, 2017 - Editas Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
January 3, 2017 - Agios to Present at the 35th Annual J.P. Morgan Healthcare Conference on Monday, January 9, 2017
» Press Release | Company News

Agios Pharmaceuticals
January 3, 2017 - Agios Appoints Ian Clark to Board of Directors
» Press Release | Company News

Foundation Medicine
January 3, 2017 - Foundation Medicine to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

GBT
January 3, 2017 - Global Blood Therapeutics to Present at the 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Myokardia
January 3, 2017 - MyoKardia Announces Advancement to Next Phase of Global Collaboration with Sanofi
» Press Release | Company News

SAGE Therapeutics
January 3, 2017 - Sage Therapeutics to Present at J.P. Morgan Healthcare Conference on Tuesday, January 10, 2017
» Press Release | Company News

Voyager Therapeutics
January 3, 2017 - Voyager Therapeutics Appoints Jane Pritchett Henderson as Chief Financial Officer
» Press Release | Company News

SAGE Therapeutics
December 29, 2016 - Sage Therapeutics to Participate in Goldman Sachs Healthcare Conference
» Press Release | Company News

Neon Therapeutics
December 28, 2016 - Neon Therapeutics to Present at 35th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

REVOLUTION Medicines
December 20, 2016 - REVOLUTION Medicines Raises Additional $25 Million in Series A Financing
» Press Release | Company News

Editas Medicine
December 19, 2016 - Editas Medicine Extends CRISPR Genome Editing Leadership Through Licensing of New CRISPR Technologies
» Press Release | Company News

Foundation Medicine
December 19, 2016 - Foundation Medicine Receives FDA Approval of FoundationFocus™ CDxBRCA as a Companion Diagnostic for Rubraca™ (rucaparib) for the Treatment of Women with Ovarian Cancer
» Press Release | Company News

SAGE Therapeutics
December 19, 2016 - Sage Therapeutics Announces Initiation of Phase 2 Clinical Development for SAGE-217 in Mood Disorders
» Press Release | Company News

GBT
December 16, 2016 - Global Blood Therapeutics Added to NASDAQ Biotechnology Index
» Press Release | Company News

Agios Pharmaceuticals
December 15, 2016 - Agios Provides Update on PKR Program
» Press Release | Company News

bluebird bio
December 15, 2016 - bluebird bio and apceth Biopharma Establish Commercial Drug Product Manufacturing Agreement
» Press Release | Company News

Goldfinch Bio
December 14, 2016 - Third Rock Ventures launches Goldfinch Bio with $55M in Series A funding to bring precision medicine to patients with kidney disease
» Press Release | Company News

bluebird bio
December 14, 2016 - bluebird bio Announces First Patient Treated with LentiGlobin Drug Product in Northstar-2 (HGB-207) Phase 3 Trial of Patients with Transfusion-Dependent β-Thalassemia
» Press Release | Company News

CytomX Therapeutics
December 14, 2016 - CytomX Announces U.S. FDA Clearance of Investigational New Drug Application for Phase 1/2 Clinical Study of Anti-PD-L1 Probody Therapeutic, CX-072
» Press Release | Company News

CytomX Therapeutics
December 13, 2016 - CytomX Announces Selection by Bristol-Myers Squibb of First Clinical Candidate Probody From Collaboration
» Press Release | Company News

REVOLUTION Medicines
December 13, 2016 - REVOLUTION Medicines Names Distinguished Cancer Scientists and Drug Hunters to Senior Advisory Roles
» Press Release | Company News

SAGE Therapeutics
December 13, 2016 - Sage Therapeutics Announces Initiation of Phase 2 Clinical Development for SAGE-217 in Movement Disorders
» Press Release | Company News

Voyager Therapeutics
December 9, 2016 - Voyager Therapeutics to Attend Upcoming Investor Conference
» Press Release | Company News

Myokardia
December 8, 2016 - MyoKardia to Present at 2016 BMO Capital Markets Healthcare Conference
» Press Release | Company News

Blueprint Medicines
December 7, 2016 - Blueprint Medicines Announces Pricing of Public Offering of Shares of Common Stock
» Press Release | Company News

Fulcrum Therapeutics
December 7, 2016 - Fulcrum Therapeutics Appoints Renowned Experts in CNS Disorders and Muscular Dystrophies to Serve on Newly Formed Scientific Advisory Board
» Press Release | Company News

SAGE Therapeutics
December 7, 2016 - Sage Therapeutics to Webcast R&D Day on December 13, 2016
» Press Release | Company News

Voyager Therapeutics
December 7, 2016 - Voyager Therapeutics Announces Positive Interim Results from Phase 1b Trial of VY-AADC01 for Advanced Parkinson’s Disease
» Press Release | Company News

bluebird bio
December 6, 2016 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

bluebird bio
December 6, 2016 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Blueprint Medicines
December 6, 2016 - Blueprint Medicines Announces Proposed Public Offering of Shares of Common Stock
» Press Release | Company News

Nurix, Inc.
December 6, 2016 - Nurix Appoints Robert Tjian, Ph.D. of The Column Group to its Board of Directors
» Press Release | Company News

SAGE Therapeutics
December 6, 2016 - Sage Announces Expedited Development Plan for SAGE-547 in the Treatment of Postpartum Depression based on FDA Breakthrough Therapy Meeting
» Press Release | Company News

Agios Pharmaceuticals
December 5, 2016 - Agios Announces New Clinical Data from Dose-Escalation Portion of Phase 1 Trial of Single Agent AG-120 Showing Durable Molecular Responses in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

bluebird bio
December 5, 2016 - bluebird bio Provides Updates on HSC Gene Therapy Programs
» Press Release | Company News

CytomX Therapeutics
December 5, 2016 - CytomX Announces Fourth Target Selection by Bristol-Myers Squibb Under Strategic Oncology Collaboration
» Press Release | Company News

GBT
December 5, 2016 - Global Blood Therapeutics Announces New Details on its Novel Patient Reported Outcomes (PRO) Tool to be used in Phase 3 HOPE Study
» Press Release | Company News

Agios Pharmaceuticals
December 4, 2016 - Agios Announces New Data from AG-348 and AG-519 Demonstrating Potential for First Disease-modifying Treatment for Patients with PK Deficiency
» Press Release | Company News

Blueprint Medicines
December 4, 2016 - Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Systemic Mastocytosis
» Press Release | Company News

GBT
December 4, 2016 - Global Blood Therapeutics Announces New Long-Term Clinical Data from Ongoing Phase 1/2 Trial of GBT440 in Sickle Cell Disease at ASH
» Press Release | Company News

bluebird bio
December 3, 2016 - bluebird bio Presents New Data from HGB-205 Study of LentiGlobin™ Drug Product in Patients with Transfusion-Dependent β-Thalassemia (TDT) and Severe Sickle Cell Disease at American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

bluebird bio
December 2, 2016 - bluebird bio Announces Management Appointments
» Press Release | Company News

Myokardia
December 2, 2016 - MyoKardia Announces Receipt of Milestone Payment from Sanofi for DCM Candidate MYK-491
» Press Release | Company News

Magenta Therapeutics
December 2, 2016 - Magenta Therapeutics Cofounder David Scadden Honored at the American Society of Hematology Annual Meeting, as Scientific Founders Present New Stem Cell Biology Data
» Press Release | Company News

Myokardia
December 1, 2016 - MyoKardia Announces Appointment of Marc Semigran, M.D., as Chief Medical Officer
» Press Release | Company News

SAGE Therapeutics
December 1, 2016 - Sage Therapeutics to Present at American Epilepsy Society 70th Annual Meeting
» Press Release | Company News

bluebird bio
November 30, 2016 - bluebird bio Announces Interim Phase 1 Dose Escalation Data for its Anti-BCMA CAR T Product Candidate in Patients with Relapsed/Refractory Multiple Myeloma
» Press Release | Company News

Blueprint Medicines
November 30, 2016 - Blueprint Medicines Announces Proof-of-Concept Data from Phase 1 Clinical Trial of BLU-285 in Patients with Advanced Gastrointestinal Stromal Tumors
» Press Release | Company News

GBT
November 30, 2016 - Global Blood Therapeutics Announces GBT440 Granted Orphan Drug Designation in Europe for Treatment of Sickle Cell Disease
» Press Release | Company News

GBT
November 30, 2016 - Global Blood Therapeutics Announces Upcoming Investor Webcast to Review GBT440 Data Being Presented at ASH that Support Sickle Cell Disease Program
» Press Release | Company News

Voyager Therapeutics
November 29, 2016 - Voyager Therapeutics and REGENXBIO Announce Exercise of Options for Rights to NAV Vectors
» Press Release | Company News

Warp Drive Bio
November 29, 2016 - Warp Drive Bio Achieves Key Milestone in Antibiotics Collaboration with Sanofi
» Press Release | Company News

Blueprint Medicines
November 28, 2016 - Blueprint Medicines Announces Proof-of-Concept Data from Global Phase 1 Clinical Trial of BLU-554 in Patients with Advanced Hepatocellular Carcinoma
» Press Release | Company News

GBT
November 28, 2016 - Global Blood Therapeutics Announces Initiation of Phase 2a Trial of GBT440 in Idiopathic Pulmonary Fibrosis (IPF)
» Press Release | Company News

Seventh Sense BioSystems
November 18, 2016 - Seventh Sense Biosystems Raises Series C Round of Funding
» Press Release | Company News

Agios Pharmaceuticals
November 18, 2016 - Agios Announces Phase 1 Data from Dose Expansion Cohorts of AG-120 in Patients with IDH1 Mutant Positive Glioma and Chondrosarcoma
» Press Release | Company News

Neon Therapeutics
November 17, 2016 - Neon Therapeutics Announces First Patient Enrolled in Inaugural Clinical Trial for Personalized Cancer Vaccine NEO-PV-01
» Press Release | Company News

Corvia Medical
November 16, 2016 - Corvia Medical Announces Strong Positive One-Year Data from Reduce LAP-HF Clinical Study
» Press Release | Company News

Magenta Therapeutics
November 16, 2016 - Magenta Therapeutics Announces $48.5M Series A Financing to Transform Stem Cell Transplant for Immune and Blood Diseases
» Press Release | Company News

SAGE Therapeutics
November 16, 2016 - SAGE-547 Granted PRIME Designation by EMA for the Treatment of Postpartum Depression
» Press Release | Company News

Blueprint Medicines
November 15, 2016 - Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trials for BLU-285 and BLU-554 at 28th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
» Press Release | Company News

Ninepoint Medical
November 15, 2016 - NinePoint Medical Announces Substantial Hospital Reimbursement Increase for Procedures Using the NvisionVLE® Imaging System with Real-time Targeting™
» Press Release | Company News

bluebird bio
November 14, 2016 - bluebird bio to Present New Data from Novel Anti-BCMA CAR T Cell Therapy bb2121 at EORTC-NCI-AACR Molecular Targets and Cancer Therapies Symposium
» Press Release | Company News

Blueprint Medicines
November 14, 2016 - Blueprint Medicines Announces Appointment of Marion Dorsch, Ph.D. as Chief Scientific Officer and the Transition of Christoph Lengauer, Ph.D., MBA, to a Newly Created Executive Vice President Role
» Press Release | Company News

Sesen Bio
November 14, 2016 - Eleven Biotherapeutics Reports Third Quarter 2016 Financial Results
» Press Release | Company News

Myokardia
November 11, 2016 - MyoKardia Announces Exploratory Digital Health Substudy as Part of PIONEER-HCM Trial of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients
» Press Release | Company News

Blueprint Medicines
November 10, 2016 - Blueprint Medicines Reports Third Quarter 2016 Financial Results
» Press Release | Company News

SAGE Therapeutics
November 10, 2016 - Sage Therapeutics to Present at Society for Neuroscience 2016 Annual Meeting
» Press Release | Company News

Voyager Therapeutics
November 10, 2016 - Voyager Therapeutics Provides Third Quarter 2016 Investor Update
» Press Release | Company News

CytomX Therapeutics
November 9, 2016 - CytomX to Present at the Jefferies 2016 London Healthcare Conference
» Press Release | Company News

Editas Medicine
November 9, 2016 - Editas Medicine to Present at the Stifel Healthcare Conference 2016
» Press Release | Company News

GBT
November 9, 2016 - Global Blood Therapeutics Reports Recent Business Progress and Provides Third Quarter 2016 Financial Results
» Press Release | Company News

SAGE Therapeutics
November 9, 2016 - Sage Therapeutics to Present at the Stifel 2016 Healthcare Conference
» Press Release | Company News

Zafgen
November 9, 2016 - Zafgen Reports Third Quarter 2016 Financial Results
» Press Release | Company News

Editas Medicine
November 7, 2016 - Editas Medicine Announces Third Quarter 2016 Results and Update
» Press Release | Company News

Myokardia
November 7, 2016 - MyoKardia Reports Progress on Clinical Programs and Third Quarter 2016 Financial Results
» Press Release | Company News

Neon Therapeutics
November 7, 2016 - Neon Therapeutics Appoints Dr. Richard Gaynor to President of Research and Development
» Press Release | Company News

Myokardia
November 4, 2016 - MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2016
» Press Release | Company News

Rhythm Pharmaceuticals
November 4, 2016 - Rhythm Presents Positive Initial Data for Setmelanotide in LepR Deficiency Obesity
» Press Release | Company News

Agios Pharmaceuticals
November 3, 2016 - Agios Reports Third Quarter 2016 Financial Results and Reviews Recent Progress in IDH and PKR Development Programs
» Press Release | Company News

Agios Pharmaceuticals
November 3, 2016 - Agios to Present New Data from PKR and IDH Programs at the 2016 ASH Annual Meeting
» Press Release | Company News

bluebird bio
November 3, 2016 - bluebird bio to Present New Data from Three LentiGlobinTM Clinical Studies at American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

Blueprint Medicines
November 3, 2016 - Blueprint Medicines to Present Preliminary Data from Ongoing Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocytosis at 2016 ASH Annual Meeting
» Press Release | Company News

Blueprint Medicines
November 3, 2016 - Blueprint Medicines to Report Third Quarter 2016 Financial Results on Thursday, November 10, 2016
» Press Release | Company News

CytomX Therapeutics
November 3, 2016 - CytomX Therapeutics Announces Third Quarter 2016 Financial Results and Provides Pipeline Update
» Press Release | Company News

Foundation Medicine
November 3, 2016 - Flatiron Health and Foundation Medicine Unveil Powerful Oncology Information Resource to Advance Precision Medicine
» Press Release | Company News

GBT
November 3, 2016 - Global Blood Therapeutics Announces Upcoming Presentation of Data Supporting Sickle Cell Disease Program at the 58th American Society of Hematology (ASH) Annual Meeting & Exposition Conference
» Press Release | Company News

SAGE Therapeutics
November 3, 2016 - Sage Therapeutics Announces Third Quarter 2016 Financial Results and Provides SRSE European Update
» Press Release | Company News

bluebird bio
November 2, 2016 - bluebird bio Reports Third Quarter 2016 Financial Results and Recent Operational Progress
» Press Release | Company News

Foundation Medicine
November 2, 2016 - Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights
» Press Release | Company News

Myokardia
November 2, 2016 - MyoKardia Announces Dosing of First Patient in Phase 2 PIONEER-HCM Study of MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy
» Press Release | Company News

Agios Pharmaceuticals
November 1, 2016 - Agios to Present at the 25th Annual Credit Suisse Healthcare Conference Tuesday, November 8, 2016
» Press Release | Company News

bluebird bio
November 1, 2016 - bluebird bio to Present at Two Investor Conferences in November
» Press Release | Company News

Decibel Therapeutics
November 1, 2016 - Decibel Therapeutics Assembles World-Class Scientific Advisory Board
» Press Release | Company News

Voyager Therapeutics
November 1, 2016 - Voyager Therapeutics to Host Third Quarter 2016 Investor Update Call
» Press Release | Company News

Editas Medicine
October 31, 2016 - Editas Medicine to Host Conference Call Discussing Third Quarter 2016 Corporate Update and Results
» Press Release | Company News

Foundation Medicine
October 31, 2016 - Foundation Medicine and Sarah Cannon Collaborate to Advance Personalized Medicine for Patients with Cancer
» Press Release | Company News

Myokardia
October 31, 2016 - MyoKardia to Present at Two Upcoming Investor Conferences in November
» Press Release | Company News

Alcresta Therapeutics
October 28, 2016 - Alcresta Therapeutics’ RELiZORB™ Increases Fat Absorption in Adult and Pediatric Patients with Cystic Fibrosis Receiving Enteral Nutrition
» Press Release | Company News

Blueprint Medicines
October 28, 2016 - Blueprint Medicines to Present Preclinical Data and Provide Enrollment Updates for Phase 1 Clinical Trial for BLU-285 in Advanced Systemic Mastocytosis at ECNM Annual Meeting 2016
» Press Release | Company News

Agios Pharmaceuticals
October 27, 2016 - Agios to Webcast Conference Call of Third Quarter 2016 Financial Results on November 3, 2016
» Press Release | Company News

CytomX Therapeutics
October 27, 2016 - CytomX Therapeutics to Announce Third Quarter 2016 Financial Results
» Press Release | Company News

Foundation Medicine
October 27, 2016 - Foundation Medicine Adds Life Sciences Leader Michael R. Dougherty to its Board of Directors
» Press Release | Company News

Motus
October 27, 2016 - Allergan to Acquire GI Disease Subsidiary of Rhythm Holding Company, LLC, Expanding Innovative Gastroenterology Pipeline
» Press Release | Company News

SAGE Therapeutics
October 27, 2016 - Sage Therapeutics to Report Third Quarter 2016 Financial Results on Thursday, November 3, 2016
» Press Release | Company News

GBT
October 24, 2016 - Global Blood Therapeutics Announces Pivotal Study for GBT440 in Sickle Cell Disease with Primary Hemoglobin Endpoint
» Press Release | Company News

SAGE Therapeutics
October 20, 2016 - Sage Therapeutics and Collaborators Publish New Pre-clinical Data in Neuropharmacology Demonstrating a Novel Metabotropic Mechanism of Sage Compounds Resulting in Enhanced Effects
» Press Release | Company News

Voyager Therapeutics
October 18, 2016 - Voyager Therapeutics Announces Planned Transition Process for Chief Financial Officer
» Press Release | Company News

Editas Medicine
October 17, 2016 - Editas Medicine to Present Data on CRISPR/Cas9-mediated Gene Editing in Hematopoietic Stem/Progenitor Cells at ESGCT-ISSCR 2016
» Press Release | Company News

Warp Drive Bio
October 17, 2016 - Warp Drive Bio Appoints Steven H. Holtzman to its Board of Directors
» Press Release | Company News

Ninepoint Medical
October 15, 2016 - New Clinical Data using the NvisionVLE® Imaging System to be presented at ACG 2016 and UEGW 2016
» Press Release | Company News

PanOptica
October 14, 2016 - PanOptica Reports Positive Results from Phase 1/2 Clinical Trial of PAN-90806, a Novel Topical Anti-VEGF Eye Drop
» Press Release | Company News

bluebird bio
October 13, 2016 - bluebird bio Provides Update on LentiGlobin™ Programs and Research and Development Strategy at Gene Therapy Day
» Press Release | Company News

Foundation Medicine
October 12, 2016 - Foundation Medicine Announces Timing for Third Quarter 2016 Financial Results and Conference Call
» Press Release | Company News

Agios Pharmaceuticals
October 12, 2016 - Celgene and Agios Announce Collaborations with Abbott for Diagnostic Identification of IDH Mutations in AML
» Press Release | Company News

GBT
October 12, 2016 - Global Blood Therapeutics Announces Appointment of Tricia Suvari as Chief Legal Officer
» Press Release | Company News

GBT
October 7, 2016 - Global Blood Therapeutics Presents GBT440 Data that Continue to Support Durability, Safety and Mechanism of Action in Sickle Cell Disease
» Press Release | Company News

bluebird bio
October 6, 2016 - bluebird bio Announces Topics for Gene Therapy Day, October Investor Presentation
» Press Release | Company News

Editas Medicine
October 6, 2016 - Editas Medicine Reports Inducement Grant to New Chief Medical Officer
» Press Release | Company News

Allena Pharmaceuticals
October 4, 2016 - Allena Pharmaceuticals and Health Advances Present Analysis of Recurrent Kidney Stone Disease at the Academy of Managed Care Pharmacy Nexus Conference
» Press Release | Company News

Editas Medicine
October 3, 2016 - Editas Medicine Expands Senior Management Team
» Press Release | Company News

Editas Medicine
October 3, 2016 - Editas Medicine to Present at the Jefferies Gene Editing/Therapy Summit
» Press Release | Company News

Myokardia
October 3, 2016 - MyoKardia Announces Closing of Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

bluebird bio
September 29, 2016 - bluebird bio and Medigene Establish Strategic T Cell Receptor (TCR) Alliance in Cancer Immunotherapy
» Press Release | Company News

Myokardia
September 27, 2016 - MyoKardia Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Neon Therapeutics
September 27, 2016 - Neon Therapeutics Appoints Oncology Veteran Hugh O’Dowd to Chief Executive Officer
» Press Release | Company News

SAGE Therapeutics
September 27, 2016 - Sage Reports Additional Positive Data on Secondary Endpoints from Phase 2 Clinical Trial of SAGE-547 in Severe Postpartum Depression at the Marcé Society for Perinatal Mental Health Biennial Scientific Meeting
» Press Release | Company News

Jounce Therapeutics
September 26, 2016 - Jounce Therapeutics Appoints Stephen Farrand, Ph.D., to Chief Technical Officer
» Press Release | Company News

Myokardia
September 26, 2016 - MyoKardia Announces Proposed Public Offering of Common Stock
» Press Release | Company News

bluebird bio
September 21, 2016 - LentiGlobin™ Investigational Gene Therapy for Transfusion-Dependent Beta-Thalassemia Accepted into European Medicines Agency’s PRIME Program
» Press Release | Company News

Sesen Bio
September 21, 2016 - Eleven Biotherapeutics Acquires Viventia Bio to Create Targeted Protein Therapeutics Oncology Company
» Press Release | Company News

Sesen Bio
September 21, 2016 - Eleven Biotherapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
» Press Release | Company News

Myokardia
September 21, 2016 - MyoKardia Outlines Path to Registration for MYK-461 in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients and Provides Pipeline and Research Updates at Inaugural R&D Day
» Press Release | Company News

SAGE Therapeutics
September 21, 2016 - Sage Therapeutics to Present at the Leerink Partners Rare Disease Roundtable
» Press Release | Company News

Agios Pharmaceuticals
September 20, 2016 - Agios Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Zafgen
September 20, 2016 - Zafgen Initiates Multiple Ascending Dose Cohorts in Phase 1 Clinical Trial of ZGN-1061
» Press Release | Company News

Fulcrum Therapeutics
September 19, 2016 - FierceBiotech names Fulcrum Therapeutics as one of its “Fierce 15” Biotech Companies of 2016
» Press Release | Company News

Neon Therapeutics
September 19, 2016 - FierceBiotech names Neon Therapeutics as one of its “Fierce 15” Biotech Companies of 2016
» Press Release | Company News

Rhythm Pharmaceuticals
September 19, 2016 - FierceBiotech Names Rhythm as a “Fierce 15” Biotechnology Company of 2016
» Press Release | Company News

SAGE Therapeutics
September 16, 2016 - Sage Therapeutics to Present at the Neurocritical Care Society 14th Annual Meeting
» Press Release | Company News

Sesen Bio
September 16, 2016 - Eleven Biotherapeutics Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology, Including EBI-031
» Press Release | Company News

Voyager Therapeutics
September 15, 2016 - Voyager Therapeutics Licenses Novel Gene Therapy Capsids from the California Institute of Technology
» Press Release | Company News

Agios Pharmaceuticals
September 14, 2016 - Agios Announces Pricing of $150 Million Public Offering of Common Stock
» Press Release | Company News

Relay Therapeutics
September 14, 2016 - Third Rock Ventures Launches Relay Therapeutics with $57 Million Series A Financing to Create Breakthrough Medicines Based on Protein Motion
» Press Release | Company News

GBT
September 14, 2016 - Global Blood Therapeutics Announces Publication of Preclinical Results Supporting GBT440 Program for Hypoxemic Pulmonary Disorders
» Press Release | Company News

Myokardia
September 14, 2016 - MyoKardia to Host R&D Day on September 21
» Press Release | Company News

Agios Pharmaceuticals
September 13, 2016 - Agios Announces Proposed Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
September 12, 2016 - Voyager Therapeutics and CHDI Foundation Collaborate to Develop Novel Gene Therapy for Huntington’s Disease
» Press Release | Company News

bluebird bio
September 9, 2016 - bluebird bio Announces Webcast of Gene Therapy Day
» Press Release | Company News

Blueprint Medicines
September 9, 2016 - Blueprint Medicines Announces New Drug Discovery Program Targeting PRKACA Kinase Fusions for the Treatment of Fibrolamellar Carcinoma at 10th International Liver Cancer Association (ILCA) Annual Conference
» Press Release | Company News

bluebird bio
September 8, 2016 - bluebird bio Opens Phase 3 Study of LentiGlobin™ Drug Product in Patients with Transfusion-Dependent Beta-Thalassemia
» Press Release | Company News

SAGE Therapeutics
September 8, 2016 - Sage Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Allena Pharmaceuticals
September 7, 2016 - Allena Pharmaceuticals Strengthens Leadership Team, Names Edward Wholihan As Chief Financial Officer And Robert Alexander, Phd, To Board Of Directors
» Press Release | Company News

Blueprint Medicines
September 7, 2016 - Blueprint Medicines to Present at Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Decibel Therapeutics
September 7, 2016 - Decibel Therapeutics Expands Leadership Team
» Press Release | Company News

Jounce Therapeutics
September 7, 2016 - Jounce Therapeutics Initiates Phase 1/2 ICONIC Study of JTX­2011 in Patients with Advanced Solid Tumors
» Press Release | Company News

SAGE Therapeutics
September 7, 2016 - Sage Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
September 6, 2016 - Agios to Present at Morgan Stanley Global Healthcare Conference Tuesday, September 13, 2016
» Press Release | Company News

Blueprint Medicines
September 6, 2016 - Blueprint Medicines Announces Appointment of Tracey McCain as Chief Legal Officer and Executive Vice President
» Press Release | Company News

Editas Medicine
September 6, 2016 - Editas Medicine to Present at the Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Foundation Medicine
September 6, 2016 - Foundation Medicine to Present at the Morgan Stanley Global Healthcare Conference
» Press Release | Company News

GBT
September 6, 2016 - Global Blood Therapeutics Joins Sickle Cell Disease (SCD) Coalition in Support of SCD Community with Goal to Improve Treatment and Care
» Press Release | Company News

SAGE Therapeutics
September 6, 2016 - Sage Receives FDA Breakthrough Therapy Designation for SAGE-547 for the Treatment of Postpartum Depression
» Press Release | Company News

Myokardia
September 1, 2016 - MyoKardia to Present at 2016 Wells Fargo Healthcare Conference
» Press Release | Company News

GBT
August 31, 2016 - Global Blood Therapeutics Announces Participation at Two Upcoming Investor Conferences in September
» Press Release | Company News

bluebird bio
August 30, 2016 - bluebird bio to Present at Four Upcoming Conferences
» Press Release | Company News

Pliant Therapeutics
August 30, 2016 - Pliant Therapeutics Appoints Suzanne Bruhn, Ph.D., to Board of Directors
» Press Release | Company News

SAGE Therapeutics
August 30, 2016 - Sage Therapeutics and Collaborators Announce Publication Highlighting Epidemiology and Burden of Illness for Super-Refractory Status Epilepticus in Journal of Medical Economics
» Press Release | Company News

Warp Drive Bio
August 30, 2016 - Warp Drive Bio Awarded Patent Covering Proprietary Method for Discovering New Medicines
» Press Release | Company News

Editas Medicine
August 22, 2016 - Editas Medicine Names Charles Albright as Chief Scientific Officer
» Press Release | Company News

Foundation Medicine
August 22, 2016 - Foundation Medicine Adds New Immunotherapy Features to Its Market-Leading Products
» Press Release | Company News

Agios Pharmaceuticals
August 16, 2016 - Agios Appoints Andrew Hirsch as Chief Financial Officer
» Press Release | Company News

Sesen Bio
August 16, 2016 - Eleven Biotherapeutics Completes Exclusive Licensing Deal for IL-6 Antagonist Antibody Technology, Including EBI-031
» Press Release | Company News

Sesen Bio
August 12, 2016 - Eleven Biotherapeutics Reports Second Quarter 2016 Financial Results and Provides Strategic Update
» Press Release | Company News

Voyager Therapeutics
August 12, 2016 - Voyager Therapeutics to Attend Upcoming Investor Conferences
» Press Release | Company News

Voyager Therapeutics
August 11, 2016 - Voyager Therapeutics Provides Second Quarter 2016 Investor Update
» Press Release | Company News

GBT
August 10, 2016 - Global Blood Therapeutics Reports Recent Business Progress and Provides Second Quarter 2016 Financial Results
» Press Release | Company News

Myokardia
August 10, 2016 - MyoKardia to Present at the 2016 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Taris Biomedical
August 10, 2016 - TARIS Biomedical® Launches Second Phase 1b Clinical Trial of TAR-200 (GemRISTM) in Patients with Bladder Cancer
» Press Release | Company News

Blueprint Medicines
August 9, 2016 - Blueprint Medicines Reports Second Quarter 2016 Financial Results
» Press Release | Company News

Editas Medicine
August 9, 2016 - Adverum Biotechnologies and Editas Medicine Announce Collaboration to Explore Delivery of Genome Editing Medicines to the Eye
» Press Release | Company News

Editas Medicine
August 9, 2016 - Editas Medicine Announces Second Quarter 2016 Results and Update
» Press Release | Company News

GBT
August 9, 2016 - Global Blood Therapeutics to Present at the Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Myokardia
August 9, 2016 - MyoKardia Reports Second Quarter 2016 Financial Results and Continued Progress on Clinical Programs
» Press Release | Company News

SAGE Therapeutics
August 9, 2016 - Sage Therapeutics Announces Second Quarter 2016 Financial Results and Provides Corporate Update
» Press Release | Company News

Voyager Therapeutics
August 9, 2016 - Voyager Therapeutics Initiates Third Cohort in Ongoing Phase 1b Clinical Trial of VY-AADC01 in Advanced Parkinson’s Disease
» Press Release | Company News

Agios Pharmaceuticals
August 5, 2016 - Agios to Present at Canaccord Genuity 36th Annual Growth Conference Wednesday, August 10, 2016
» Press Release | Company News

Agios Pharmaceuticals
August 4, 2016 - Agios Reports Second Quarter 2016 Financial Results
» Press Release | Company News

bluebird bio
August 4, 2016 - bluebird bio to Present at Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Decibel Therapeutics
August 4, 2016 - Decibel Therapeutics to Open New Headquarters and Laboratories in The Fenway
» Press Release | Company News

Voyager Therapeutics
August 4, 2016 - Voyager Therapeutics to Host Second Quarter 2016 Investor Update Call
» Press Release | Company News

Zafgen
August 4, 2016 - Zafgen Reports Second Quarter 2016 Financial Results
» Press Release | Company News

bluebird bio
August 3, 2016 - bluebird bio Reports Second Quarter 2016 Financial Results and Recent Operational Progress
» Press Release | Company News

Blueprint Medicines
August 3, 2016 - Blueprint Medicines to Present at Upcoming Investor Conferences in August
» Press Release | Company News

CytomX Therapeutics
August 3, 2016 - CytomX Announces Second Quarter 2016 Financial Results
» Press Release | Company News

Editas Medicine
August 3, 2016 - Editas Medicine Announces Exclusive License to Advanced CRISPR Genome Editing Technology from Massachusetts General Hospital
» Press Release | Company News

SAGE Therapeutics
August 3, 2016 - Sage Therapeutics to Present at the Canaccord Genuity 36th Annual Growth Conference
» Press Release | Company News

Zafgen
August 3, 2016 - Zafgen to Present at Canaccord Genuity's 36th Annual Growth Conference
» Press Release | Company News

Blueprint Medicines
August 2, 2016 - Blueprint Medicines to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016
» Press Release | Company News

Editas Medicine
August 2, 2016 - Editas Medicine to Host Conference Call Discussing Second Quarter 2016 Corporate Update and Results
» Press Release | Company News

Foundation Medicine
August 2, 2016 - FoundationOne® Accepted by FDA and CMS for Parallel Review and FDA Expedited Access Pathway
» Press Release | Company News

Foundation Medicine
August 2, 2016 - Foundation Medicine Announces 2016 Second Quarter Results and Recent Highlights
» Press Release | Company News

SAGE Therapeutics
August 2, 2016 - Sage Therapeutics to Report Second Quarter 2016 Financial Results on Tuesday, August 9, 2016
» Press Release | Company News

Editas Medicine
July 29, 2016 - Editas Medicine Appoints Akshay Vaishnaw, M.D., Ph.D., to its Board of Directors
» Press Release | Company News

Neon Therapeutics
July 29, 2016 - Neon Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Cancer Vaccine NEO­PV­01
» Press Release | Company News

Agios Pharmaceuticals
July 28, 2016 - Agios to Webcast Conference Call of Second Quarter 2016 Financial Results on August 4, 2016
» Press Release | Company News

Editas Medicine
July 28, 2016 - Editas Medicine Announces Scientific Multi-Year Collaboration with Fondazione Telethon and Ospedale San Raffaele
» Press Release | Company News

CytomX Therapeutics
July 27, 2016 - CytomX Therapeutics to Announce Second Quarter 2016 Financial Results and Provide Mid-Year Update
» Press Release | Company News

Rhythm Pharmaceuticals
July 27, 2016 - Rhythm Announces “The Genetic Obesity Project” to Expand Understanding of Rare Genetic Disorders of Obesity
» Press Release | Company News

Alcresta Therapeutics
July 26, 2016 - RELiZORB™ Recognized for Medical Design Excellence
» Press Release | Company News

Ablexis
July 20, 2016 - Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma
» Press Release | Company News

Rhythm Pharmaceuticals
July 20, 2016 - Rhythm Announces New England Journal of Medicine Publication of Setmelanotide Phase 2 Data for Treatment of POMC Deficiency Obesity
» Press Release | Company News

Fulcrum Therapeutics
July 19, 2016 - Third Rock Ventures Launches Fulcrum Therapeutics with $55 Million Series A Investment
» Press Release | Company News

Jounce Therapeutics
July 19, 2016 - Jounce Therapeutics Announces Major Strategic Collaboration with Celgene Corporation to Develop Next-generation Immuno-oncology Therapies for Patients with Cancer
» Press Release | Company News

SAGE Therapeutics
July 19, 2016 - Sage Appoints Geno Germano to Company's Board of Directors
» Press Release | Company News

Zafgen
July 19, 2016 - Zafgen Refocuses Resources on Development of Differentiated Second-Generation MetAP2 Inhibitor ZGN-1061
» Press Release | Company News

bluebird bio
July 18, 2016 - bluebird bio Presents megaTAL Genome Editing Data at American Society of Hematology (ASH) Workshop on Genome Editing
» Press Release | Company News

Myokardia
July 14, 2016 - SHaRe Registry Data Published in PNAS Demonstrate the Power of Combining Clinical, Genetic and Structural Data to Gain Insight into Hypertrophic Cardiomyopathy
» Press Release | Company News

Decibel Therapeutics
July 13, 2016 - Decibel Therapeutics Appoints Steven H. Holtzman as President and Chief Executive Officer
» Press Release | Company News

Taris Biomedical
July 13, 2016 - TARIS Biomedical® Initiates Phase 1b Clinical Trial of TAR-200 (GemRIS™) in Patients with Muscle-Invasive Bladder Cancer
» Press Release | Company News

Foundation Medicine
July 12, 2016 - Foundation Medicine Announces Timing for Second Quarter 2016 Financial Results and Conference Call
» Press Release | Company News

SAGE Therapeutics
July 12, 2016 - Sage Reports Positive Top-line Results Including Demonstration of 30-Day Durability from Phase 2 Clinical Trial of SAGE-547 in Severe Postpartum Depression
» Press Release | Company News

Jounce Therapeutics
July 11, 2016 - Jounce Therapeutics to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
» Press Release | Company News

Myokardia
July 11, 2016 - MyoKardia Announces Topline Clinical Data Supporting Advancement of MYK-461 to Phase 2 PIONEER-HCM Study in Symptomatic, Obstructive Hypertrophic Cardiomyopathy Patients
» Press Release | Company News

GBT
July 8, 2016 - Global Blood Therapeutics Announces Publication of Preclinical GBT440 Results in British Journal of Haematology that Support Sickle Cell Disease (SCD) Program
» Press Release | Company News

Sesen Bio
July 7, 2016 - Eleven Biotherapeutics Announces Effectiveness of Investigational New Drug Application for EBI-031
» Press Release | Company News

Warp Drive Bio
July 5, 2016 - Warp Drive Bio Appoints Rachel K. King to its Board of Directors
» Press Release | Company News

Foundation Medicine
June 29, 2016 - Foundation Medicine Announces Release of Molecular Information from FoundationCORE™ to the National Cancer Institute in Support of the National Cancer Moonshot and Precision Medicine Initiatives
» Press Release | Company News

GBT
June 29, 2016 - Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Adolescents with Sickle Cell Disease
» Press Release | Company News

Voyager Therapeutics
June 22, 2016 - Voyager Therapeutics Announces Interim Phase 1b Surgical Results for VY-AADC01 in Advanced Parkinson’s Disease
» Press Release | Company News

GBT
June 20, 2016 - Global Blood Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

GBT
June 20, 2016 - Global Blood Therapeutics Announces Initiation of Phase 2a Study of GBT440 in Idiopathic Pulmonary Fibrosis
» Press Release | Company News

GBT
June 20, 2016 - Global Blood Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

REVOLUTION Medicines
June 14, 2016 - REVOLUTION Medicines Names Academic Co-Founder, Michael Fischbach, Ph.D., and Senior Advisor, Eric Gordon, Ph.D.
» Press Release | Company News

CytomX Therapeutics
June 13, 2016 - CytomX Therapeutics Appoints John A. Scarlett, M.D., to Board of Directors
» Press Release | Company News

Sesen Bio
June 13, 2016 - Eleven Biotherapeutics Announces Investigational New Drug Application Submission to Initiate Clinical Trials of EBI-031 for Ocular Diseases
» Press Release | Company News

Sesen Bio
June 13, 2016 - Eleven Biotherapeutics Announces Signing of Exclusive License Agreement
» Press Release | Company News

Agios Pharmaceuticals
June 11, 2016 - AG-348 Achieves Proof-of-Concept in Ongoing Phase 2 DRIVE-PK Study and Demonstrates Rapid and Sustained Hemoglobin Increases in Adults with Pyruvate Kinase Deficiency
» Press Release | Company News

Zafgen
June 11, 2016 - Zafgen Presents New Data From The Phase 2b Clinical Trial Evaluating Beloranib In Severe Obesity Complicated By Type 2 Diabetes At The American Diabetes Association's 76th Scientific Sessions
» Press Release | Company News

GBT
June 10, 2016 - Global Blood Therapeutics Announces New Clinical Data that Continue to Support Safety and Efficacy Profile of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease
» Press Release | Company News

Afferent Pharmaceuticals
June 9, 2016 - Merck to Acquire Afferent Pharmaceuticals
» Press Release | Company News

Agios Pharmaceuticals
June 9, 2016 - Agios Reports Initial Data from Phase 1 Study of AG-519 in Healthy Volunteers
» Press Release | Company News

bluebird bio
June 9, 2016 - Lonza and bluebird bio, Inc., Establish a Long-term Commercial Manufacturing Agreement for Lenti-D™ and LentiGlobin™ Drug Products
» Press Release | Company News

Alcresta Therapeutics
June 7, 2016 - Alcresta Therapeutics Launches RELiZORB™ in the U.S.
» Press Release | Company News

SAGE Therapeutics
June 7, 2016 - Sage Reports Positive Top-line Results from Phase 1 Clinical Program of SAGE-217
» Press Release | Company News

Foundation Medicine
June 6, 2016 - Data From a Study Utilizing FoundationOne® Heme Indicates Age-Associated Genomic Profiles in Acute Myeloid Leukemia
» Press Release | Company News

Foundation Medicine
June 6, 2016 - New Data from Foundation Medicine and Collaborators Supports Use of Comprehensive Genomic Profiling to Inform Therapeutic Choices in Advanced Breast Cancer
» Press Release | Company News

Foundation Medicine
June 5, 2016 - Foundation Medicine Presents New Data at ASCO 2016 Demonstrating that FoundationOne® May Help Predict Response to Cancer Immunotherapy Across a Variety of Advanced Cancers
» Press Release | Company News

Foundation Medicine
June 4, 2016 - Foundation Medicine and AstraZeneca Enter Strategic Collaboration for Lynparza Companion Diagnostic Assay
» Press Release | Company News

Foundation Medicine
June 4, 2016 - FoundationOne® Identifies Patients with Advanced Lung Cancer Likely to Respond or Develop Resistance to Certain RET Inhibitor Therapies
» Press Release | Company News

Allena Pharmaceuticals
June 2, 2016 - Allena Pharmaceuticals to Present at the 2016 Jefferies Healthcare Conference
» Press Release | Company News

GBT
June 2, 2016 - Global Blood Therapeutics to Host Investor Event on Friday, June 10 to Review GBT440 Data in Sickle Cell Disease Being Presented at the European Hematology Association's 21st Congress
» Press Release | Company News

Agios Pharmaceuticals
June 1, 2016 - Agios to Host Conference Call from the 21st Congress of the European Hematology Association
» Press Release | Company News

Blueprint Medicines
June 1, 2016 - Blueprint Medicines to Present at Upcoming Investor Conferences in June
» Press Release | Company News

Foundation Medicine
June 1, 2016 - Foundation Medicine to Present at the Goldman Sachs Annual Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
June 1, 2016 - Sage Therapeutics to Present at the Goldman Sachs 37th Annual Global Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
May 26, 2016 - Sage Therapeutics Announces Completion of Enrollment for Phase 2 Proof-of-Concept Trial of SAGE-547 in Severe Postpartum Depression
» Press Release | Company News

Jounce Therapeutics
May 25, 2016 - Jounce Therapeutics Appoints Barbara G. Duncan to its Board of Directors
» Press Release | Company News

CytomX Therapeutics
May 24, 2016 - CytomX to Present at the Jefferies 2016 Healthcare Conference
» Press Release | Company News

Editas Medicine
May 24, 2016 - Editas Medicine to Present at Upcoming June Investor Conferences
» Press Release | Company News

bluebird bio
May 23, 2016 - bluebird bio to Present at Goldman Sachs 37th Annual Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
May 19, 2016 - Agios to Present Clinical and Preclinical Data from PKR Activators AG-348 and AG-519 at the 21st Congress of the European Hematology Association
» Press Release | Company News

GBT
May 19, 2016 - Global Blood Therapeutics Announces Presentation of New GBT440 Data in Sickle Cell Disease at the European Hematology Association's 21st Congress
» Press Release | Company News

Ninepoint Medical
May 19, 2016 - NinePoint Medical Announces Completion of Clinical Registry and Publication of Results at DDW 2016
» Press Release | Company News

Afferent Pharmaceuticals
May 18, 2016 - Afferent Pharmaceuticals Reports Cardiovascular Research Showing P2X3 Antagonism Successfully Reduces Hypertension By Restoring Autonomic Nervous Balance at the 2016 American Thoracic Society Conference
» Press Release | Company News

Foundation Medicine
May 18, 2016 - Foundation Medicine Announces Presentations at ASCO
» Press Release | Company News

GBT
May 18, 2016 - Global Blood Therapeutics to Present at the UBS 2016 Global Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
May 17, 2016 - Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement
» Press Release | Company News

Agios Pharmaceuticals
May 17, 2016 - Agios Updates 2016 Financial Guidance
» Press Release | Company News

Agios Pharmaceuticals
May 17, 2016 - Agios and Celgene Establish New Collaboration in Metabolic Immuno-Oncology and Amend Certain Rights from 2010 Agreement
» Press Release | Company News

Foundation Medicine
May 17, 2016 - Foundation Medicine Receives Patent Covering Fundamental Methods in Comprehensive Genomic Analysis in Cancer
» Press Release | Company News

Afferent Pharmaceuticals
May 16, 2016 - Afferent Pharmaceuticals Presents Updated Positive Results with AF-219 from Phase 2B Chronic Cough Study at the 2016 American Thoracic Society (ATS) International Conference
» Press Release | Company News

Editas Medicine
May 16, 2016 - Editas Medicine Announces First Quarter 2016 Results and Update
» Press Release | Company News

Editas Medicine
May 16, 2016 - Editas Medicine Announces Agreement with Cystic Fibrosis Foundation Therapeutics to Advance New CRISPR/Cas9 Medicines
» Press Release | Company News

Myokardia
May 16, 2016 - MyoKardia to Present at 2016 UBS Global Healthcare Conference
» Press Release | Company News

GBT
May 12, 2016 - Global Blood Therapeutics Reports Recent Business Progress and Provides First Quarter 2016 Financial Results
» Press Release | Company News

Myokardia
May 12, 2016 - MyoKardia Reports First Quarter 2016 Financial Results and Operational Progress
» Press Release | Company News

Voyager Therapeutics
May 12, 2016 - Voyager Therapeutics Provides First Quarter 2016 Investor Update
» Press Release | Company News

Voyager Therapeutics
May 11, 2016 - Voyager Therapeutics to Present at Upcoming Investor Conferences
» Press Release | Company News

Blueprint Medicines
May 10, 2016 - Blueprint Medicines Reports First Quarter 2016 Financial Results
» Press Release | Company News

Ninepoint Medical
May 10, 2016 - NinePoint Medical Announces FDA 510(k) Clearance of a Real-Time Targeting Feature for the NvisionVLE® Imaging System and the First Clinical Cases in the U.S.
» Press Release | Company News

Zafgen
May 10, 2016 - Zafgen Reports First Quarter 2016 Financial Results
» Press Release | Company News

bluebird bio
May 9, 2016 - bluebird bio Presents Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting
» Press Release | Company News

Editas Medicine
May 9, 2016 - Editas Medicine to Host Conference Call Discussing First Quarter 2016 Corporate Update and Results
» Press Release | Company News

CytomX Therapeutics
May 6, 2016 - CytomX Announces First Quarter 2016 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
May 5, 2016 - FDA Grants Orphan Drug Designation to Allena’s Investigational Therapy for the Treatment of Pediatric Hyperoxaluria
» Press Release | Company News

Agios Pharmaceuticals
May 5, 2016 - Agios Reports First Quarter 2016 Financial Results
» Press Release | Company News

Sesen Bio
May 5, 2016 - Eleven Biotherapeutics Reports First Quarter 2016 Financial Results
» Press Release | Company News

SAGE Therapeutics
May 5, 2016 - Sage Therapeutics Announces First Quarter 2016 Financial Results
» Press Release | Company News

Voyager Therapeutics
May 5, 2016 - Voyager Therapeutics to Host First Quarter 2016 Investor Update Call
» Press Release | Company News

bluebird bio
May 4, 2016 - bluebird bio Reports First Quarter 2016 Financial Results and Recent Operational Progress
» Press Release | Company News

Editas Medicine
May 4, 2016 - Editas Medicine Achieves Milestone under its Collaboration with Juno Therapeutics
» Press Release | Company News

Blueprint Medicines
May 3, 2016 - Blueprint Medicines to Report First Quarter 2016 Financial Results on Tuesday, May 10, 2016
» Press Release | Company News

Foundation Medicine
May 3, 2016 - Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights
» Press Release | Company News

Foundation Medicine
May 3, 2016 - Foundation Medicine Announces Commercial Launch of Liquid Biopsy Assay, FoundationACT™
» Press Release | Company News

Foundation Medicine
May 3, 2016 - Foundation Medicine and AstraZeneca Collaborate to Develop Companion Diagnostic Assays in Oncology
» Press Release | Company News

Ninepoint Medical
May 3, 2016 - NinePoint Medical Strengthens Sales Leadership by appointing John Temple as Vice President of Sales
» Press Release | Company News

Nurix, Inc.
May 3, 2016 - Nurix Announces New Appointments to its Board of Directors
» Press Release | Company News

Nurix, Inc.
May 3, 2016 - Nurix Strengthens Executive Leadership Team
» Press Release | Company News

Zafgen
May 3, 2016 - Zafgen to Host Conference Call to Discuss First Quarter 2016 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
May 2, 2016 - Agios to Webcast Conference Call of First Quarter 2016 Financial Results on May 5, 2016
» Press Release | Company News

Myokardia
May 2, 2016 - MyoKardia Receives Orphan Drug Designation for MYK-461 for Treatment of Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM)
» Press Release | Company News

Sesen Bio
April 29, 2016 - Eleven Biotherapeutics to Present Data at the ARVO 2016 Annual Meeting
» Press Release | Company News

Voyager Therapeutics
April 29, 2016 - Voyager Therapeutics Highlights Programs in Parkinson’s Disease and ALS; Announces Expansion of CNS Pipeline at R&D Day
» Press Release | Company News

Foundation Medicine
April 28, 2016 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Pliant Therapeutics
April 28, 2016 - Pliant Therapeutics Expands Leadership Team
» Press Release | Company News

SAGE Therapeutics
April 28, 2016 - Sage Therapeutics to Report First Quarter 2016 Financial Results on Thursday, May 5, 2016
» Press Release | Company News

bluebird bio
April 27, 2016 - bluebird bio to Present at Two Upcoming Investor Conferences
» Press Release | Company News

Editas Medicine
April 27, 2016 - Editas Medicine to Present at Deutsche Bank 41st Annual Health Care Conference
» Press Release | Company News

Editas Medicine
April 27, 2016 - Editas Medicine Announces Presentations at Upcoming Scientific Conferences
» Press Release | Company News

CytomX Therapeutics
April 26, 2016 - CytomX to Present at the 2016 Bank of America Merrill Lynch Healthcare Conference
» Press Release | Company News

Afferent Pharmaceuticals
April 25, 2016 - Afferent Pharmaceuticals Announces Presentations of Chronic Cough Clinical Data and Hypertension Research for the Upcoming American Thoracic Society (ATS) 2016 International Conference
» Press Release | Company News

CytomX Therapeutics
April 21, 2016 - CytomX and AbbVie Announce Strategic Collaboration for Probody Drug Conjugates
» Press Release | Company News

bluebird bio
April 20, 2016 - bluebird bio Reports Interim Clinical Data from Starbeam Study of Lenti-D™ at AAN 2016 Annual Meeting
» Press Release | Company News

Constellation Pharmaceuticals
April 19, 2016 - Constellation Pharmaceuticals, Inc. To Present At The Epigenetics: Cancer and Beyond Symposium
» Press Release | Company News

Jounce Therapeutics
April 19, 2016 - Jounce Therapeutics to Deliver Keynote Address and Overview of Lead Program at PEGS Boston 2016
» Press Release | Company News

bluebird bio
April 18, 2016 - bluebird bio to Present Immuno-Oncology and Gene Therapy Data at the ASGCT 19th Annual Meeting
» Press Release | Company News

Foundation Medicine
April 18, 2016 - Foundation Medicine's Molecular Information Supports Discovery of Precision Therapeutics for Pediatric Cancers
» Press Release | Company News

Jounce Therapeutics
April 17, 2016 - Jounce Therapeutics Presents Data Highlighting Advances From Two Programs in its Immuno-Oncology Pipeline at the 2016 AACR Annual Meeting
» Press Release | Company News

SAGE Therapeutics
April 17, 2016 - Sage Therapeutics Expands Scientific, Clinical and Burden of Illness Data for SAGE-547 in SRSE and Essential Tremor at the 2016 American Academy of Neurology Annual Meeting
» Press Release | Company News

Blueprint Medicines
April 15, 2016 - Blueprint Medicines Appoints Lynn Seely, M.D. to Board of Directors
» Press Release | Company News

Voyager Therapeutics
April 14, 2016 - Voyager Therapeutics to Host R&D Day and Webcast on April 29, 2016
» Press Release | Company News

Kala Pharmaceuticals
April 13, 2016 - Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing
» Press Release | Company News

Myokardia
April 13, 2016 - MyoKardia Names Mary Cranston to Board of Directors
» Press Release | Company News

Seventh Sense BioSystems
April 13, 2016 - Seventh Sense Biosystems Launches Pivotal Trial For Groundbreaking TAP Diagnostic Blood Collection Device
» Press Release | Company News

Foundation Medicine
April 7, 2016 - Foundation Medicine Announces Timing for First Quarter 2016 Financial Results and Conference Call
» Press Release | Company News

Editas Medicine
April 6, 2016 - Editas Medicine to Present at 15th Annual Needham Healthcare Conference
» Press Release | Company News

Warp Drive Bio
April 6, 2016 - Warp Drive Bio Appoints Alan C. Rigby, Ph.D., as Chief Scientific Officer
» Press Release | Company News

Blueprint Medicines
April 5, 2016 - Blueprint Medicines to Present at 15th Annual Needham Healthcare Conference
» Press Release | Company News

Constellation Pharmaceuticals
April 4, 2016 - Constellation Pharmaceuticals, Inc. To Present At The 15th Annual Needham Healthcare Conference
» Press Release | Company News

GBT
April 4, 2016 - Global Blood Therapeutics Announces Appointment of Jeffrey Farrow as CFO
» Press Release | Company News

Motus
April 4, 2016 - Motus Completes Enrollment of Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
» Press Release | Company News

Motus
April 4, 2016 - Motus Presents Clinical Proof-of-Concept Results for Relamorelin in the Treatment of Anorexia
» Press Release | Company News

Zafgen
April 3, 2016 - Zafgen Presents New Data from the Phase 3 bestPWS Study Evaluating Beloranib in Prader-Willi Syndrome at ENDO 2016
» Press Release | Company News

Agios Pharmaceuticals
March 30, 2016 - Agios Announces Initiation of Phase 1/2 Frontline Combination Study of AG-221 or AG-120 with VIDAZA® (azacitidine for injection) in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients Not Eligible for Intensive Chemotherapy
» Press Release | Company News

Editas Medicine
March 30, 2016 - Editas Medicine Reports Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

GBT
March 29, 2016 - Global Blood Therapeutics Reports Recent Business Progress and Provides Fourth Quarter and Year-End 2015 Financial Results
» Press Release | Company News

SAGE Therapeutics
March 28, 2016 - Sage Therapeutics to Present Data at the Society of Biological Psychiatry 71st Annual Scientific Meeting
» Press Release | Company News

Zafgen
March 28, 2016 - Zafgen to Present Data from bestPWS Study of Beloranib in Prader-Willi Syndrome at ENDO 2016
» Press Release | Company News

Sesen Bio
March 24, 2016 - Eleven Biotherapeutics Reports Fourth Quarter and Full Year 2015 Financial Results and Provides Strategic Update
» Press Release | Company News

Foundation Medicine
March 24, 2016 - New Data with FoundationOne® Supports Clinical Utility and Improved Outcomes from Molecularly Matching Non-Small Cell Lung Cancer Patients to Targeted Therapy
» Press Release | Company News

Foundation Medicine
March 23, 2016 - Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for FoundationOne® Heme in the Journal Blood
» Press Release | Company News

Ablexis
March 22, 2016 - Ablexis Announces Perpetual License of the AlivaMab Mouse to a Top 15 Pharma
» Press Release | Company News

Myokardia
March 18, 2016 - MyoKardia Reports Fourth Quarter and 2015 Financial Results and Key Milestones
» Press Release | Company News

Blueprint Medicines
March 17, 2016 - Blueprint Medicines to Present Preclinical Data on RET Inhibitors in an Oral Presentation at American Association for Cancer Research Annual Meeting
» Press Release | Company News

Foundation Medicine
March 17, 2016 - Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016
» Press Release | Company News

Voyager Therapeutics
March 17, 2016 - Voyager Therapeutics Provides Fourth Quarter and Full Year 2015 Investor Update
» Press Release | Company News

CytomX Therapeutics
March 16, 2016 - CytomX Announces Data to be Presented at the American Association for Cancer Research Annual Meeting 2016
» Press Release | Company News

Foundation Medicine
March 16, 2016 - Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care
» Press Release | Company News

Jounce Therapeutics
March 16, 2016 - Jounce Therapeutics to Present Program Updates at AACR Annual Meeting 2016
» Press Release | Company News

Blueprint Medicines
March 15, 2016 - Blueprint Medicines Announces Worldwide Collaboration to Accelerate and Expand its Development of Novel Medicines in the Field of Cancer Immunotherapy
» Press Release | Company News

Voyager Therapeutics
March 14, 2016 - Voyager Therapeutics to Present at Alliance for Regenerative Medicine’s 4th Annual Cell & Gene Therapy Investor Day
» Press Release | Company News

Blueprint Medicines
March 11, 2016 - Blueprint Medicines Reports Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Voyager Therapeutics
March 10, 2016 - Voyager Therapeutics to Host Fourth Quarter and Full Year 2015 Investor Update Call
» Press Release | Company News

Zafgen
March 9, 2016 - Zafgen Reports Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Zafgen
March 8, 2016 - Zafgen Adds Thomas O. Daniel, M.D. to Its Board of Directors
» Press Release | Company News

Corvia Medical
March 7, 2016 - Corvia Medical Receives IDE Approval for REDUCE LAP-HF I Clinical Study & Announces Agreement with Strategic Partner for Exclusive Option to Purchase Company
» Press Release | Company News

CytomX Therapeutics
March 7, 2016 - CytomX Announces Year-End 2015 Financial Results
» Press Release | Company News

Myokardia
March 7, 2016 - MyoKardia Names Sunil Agarwal, M.D., to Board of Directors, New VPs Strengthen Research and Development
» Press Release | Company News

Warp Drive Bio
March 7, 2016 - Warp Drive Bio to Present at the Cowen and Company 36th Annual Healthcare Conference
» Press Release | Company News

bluebird bio
March 3, 2016 - bluebird bio to Present Clinical Data on Lenti-D in CALD in Plenary Session at AAN 2016 Annual Meeting
» Press Release | Company News

CytomX Therapeutics
March 3, 2016 - CytomX to Present at Cowen and Company’s 36th Annual Health Care Conference
» Press Release | Company News

Blueprint Medicines
March 3, 2016 - Blueprint Medicines to Present at Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

SAGE Therapeutics
March 3, 2016 - Sage Therapeutics to Present SAGE-547 Clinical Data and SRSE Health Economic Data in Five Abstracts at the American Academy of Neurology 2016 Annual Meeting
» Press Release | Company News

bluebird bio
March 2, 2016 - bluebird bio to Present at Three Upcoming Investor Conferences
» Press Release | Company News

Zafgen
March 2, 2016 - Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
March 1, 2016 - Allena Pharmaceuticals to Present at the 36th Annual Cowen and Company Health Care Conference
» Press Release | Company News

Editas Medicine
March 1, 2016 - Editas Medicine to Present at Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

Agios Pharmaceuticals
March 1, 2016 - Agios to Present at the Cowen and Company 36th Annual Health Care Conference on Tuesday, March 8
» Press Release | Company News

Myokardia
March 1, 2016 - MyoKardia to Present at Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

Zafgen
March 1, 2016 - Zafgen to Present at the Cowen & Company 36th Annual Health Care Conference
» Press Release | Company News

Foundation Medicine
February 29, 2016 - Foundation Medicine to Present at Cowen and Company's 36th Annual Healthcare Conference
» Press Release | Company News

GBT
February 29, 2016 - Global Blood Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

Voyager Therapeutics
February 29, 2016 - Voyager Therapeutics to Present at Cowen and Company 36th Annual Health Care Conference
» Press Release | Company News

Zafgen
February 29, 2016 - Zafgen Joins NORD in Raising Awareness of Rare Disease Day
» Press Release | Company News

SAGE Therapeutics
February 26, 2016 - Sage Therapeutics to Present at the Cowen & Co. 36th Annual Health Care Conference
» Press Release | Company News

bluebird bio
February 25, 2016 - bluebird bio Announces Transition of Chief Financial Officer
» Press Release | Company News

Foundation Medicine
February 25, 2016 - Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE™ to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers
» Press Release | Company News

bluebird bio
February 24, 2016 - bluebird bio Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Operational Progress
» Press Release | Company News

SAGE Therapeutics
February 24, 2016 - Sage Therapeutics Announces Fourth Quarter and Full Year 2015 Financial Results
» Press Release | Company News

Foundation Medicine
February 23, 2016 - Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook
» Press Release | Company News

Myokardia
February 23, 2016 - MyoKardia Announces Transition of Chief Medical Officer
» Press Release | Company News

Neon Therapeutics
February 23, 2016 - Neon Therapeutics Enters Collaborative Research Agreement with the Netherlands Cancer Institute
» Press Release | Company News

Pliant Therapeutics
February 18, 2016 - Third Rock Ventures Launches Pliant Therapeutics with $45 Million Series A to Treat Fibrotic Diseases
» Press Release | Company News

Agios Pharmaceuticals
February 18, 2016 - Agios Reports Fourth Quarter and Full Year 2015 Financial Results and Highlights Key 2016 Milestones
» Press Release | Company News

Zafgen
February 18, 2016 - Zafgen's Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes Achieves Primary Efficacy Endpoint
» Press Release | Company News

bluebird bio
February 17, 2016 - bluebird bio Announces First Patient Treated with bb2121 in CRB-401 Phase 1 Study in Patients with Relapsed/Refractory Multiple Myeloma
» Press Release | Company News

Neon Therapeutics
February 17, 2016 - Neon Therapeutics Enters License Agreement with Sanquin for Peptide-MHC Assay Technology
» Press Release | Company News

SAGE Therapeutics
February 17, 2016 - Sage Therapeutics to Report Fourth Quarter and Full Year 2015 Financial Results on Wednesday, February 24, 2016
» Press Release | Company News

Blueprint Medicines
February 16, 2016 - Blueprint Medicines to Present at RBC Capital Markets 2016 Global Healthcare Conference
» Press Release | Company News

Zafgen
February 16, 2016 - Zafgen to Participate in Upcoming Investor Conferences
» Press Release | Company News

bluebird bio
February 14, 2016 - bluebird bio Reports Fourth Quarter and Full Year 2015 Financial Results and Recent Operational Progress
» Press Release | Company News

Agios Pharmaceuticals
February 11, 2016 - Agios to Webcast Conference Call of Fourth Quarter and Full Year 2015 Financial Results on February 18, 2016
» Press Release | Company News

Allena Pharmaceuticals
February 10, 2016 - Allena Pharmaceuticals Initiates Patient Treatment in Third Phase 2 Trial of ALLN-177 for Secondary Hyperoxaluria
» Press Release | Company News

Editas Medicine
February 8, 2016 - Editas Medicine Announces Closing of Initial Public Offering and Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

GBT
February 8, 2016 - Global Blood Therapeutics Announces Changes to Board of Directors
» Press Release | Company News

Blueprint Medicines
February 4, 2016 - Blueprint Medicines Appoints Lonnel Coats to Board of Directors
» Press Release | Company News

Foundation Medicine
February 4, 2016 - Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2015 Financial Results and Conference Call
» Press Release | Company News

Myokardia
February 4, 2016 - MyoKardia Publishes Article in Science Demonstrating That MYK-461 Prevents and Reverses Disease in Genetic Mouse Models of Hypertrophic Cardiomyopathy
» Press Release | Company News

Agios Pharmaceuticals
February 3, 2016 - Agios to Present at the Leerink Partners 5th Annual Global Healthcare Conference on Wednesday, February 10
» Press Release | Company News

SAGE Therapeutics
February 3, 2016 - Sage Therapeutics to Present at the 2016 Leerink Global Healthcare Conference
» Press Release | Company News

Editas Medicine
February 2, 2016 - Editas Medicine Announces Pricing of Initial Public Offering
» Press Release | Company News

Foundation Medicine
February 2, 2016 - Foundation Medicine to Present at the Leerink Global Healthcare Conference
» Press Release | Company News

Voyager Therapeutics
February 2, 2016 - Voyager Therapeutics Promotes Jeff Goater to Chief Financial Officer
» Press Release | Company News

Zafgen
February 2, 2016 - Zafgen to Present at Upcoming Investor Conferences
» Press Release | Company News

Editas Medicine
January 28, 2016 - Editas Medicine Appoints John D. Mendlein, Ph.D., to Board of Directors
» Press Release | Company News

Sesen Bio
January 26, 2016 - Albumedix and Eleven Biotherapeutics Announce Albumin Variant Technology Agreement
» Press Release | Company News

Jounce Therapeutics
January 21, 2016 - Jounce Therapeutics Appoints Perry Karsen to its Board of Directors
» Press Release | Company News

CytomX Therapeutics
January 20, 2016 - CytomX Announces Third Target Selection by Bristol-Myers Squibb, Triggering Milestone
» Press Release | Company News

Zafgen
January 20, 2016 - Zafgen's Pivotal Phase 3 Trial of Beloranib in Prader-Willi Syndrome Achieves Co-Primary Efficacy Endpoints
» Press Release | Company News

Sesen Bio
January 15, 2016 - Eleven Biotherapeutics Reports Phase 3 Data on Isunakinra (EBI-005) in Allergic Conjunctivitis
» Press Release | Company News

Foundation Medicine
January 13, 2016 - Foundation Medicine, Horizon Healthcare Services, Inc. and COTA Collaborate to Demonstrate the Benefits of a Precision Medicine Treatment Approach for Patients with Metastatic Non-Small Cell Lung Cancer
» Press Release | Company News

Agios Pharmaceuticals
January 11, 2016 - Agios Outlines Key 2016 Goals and Priorities
» Press Release | Company News

Foundation Medicine
January 11, 2016 - Foundation Medicine Reports Preliminary 2015 Results and Provides 2016 Business Outlook, including Commercial Launch of its ctDNA Assay
» Press Release | Company News

Warp Drive Bio
January 11, 2016 - Sanofi and Warp Drive Bio to Collaborate on the Development of Novel Oncology Therapies and Antibiotics Based on Proprietary Platforms
» Press Release | Company News

Allena Pharmaceuticals
January 8, 2016 - Allena Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Rhythm Pharmaceuticals
January 7, 2016 - Rhythm Receives Orphan Drug Designation for Setmelanotide for the Treatment of Prader-Willi Syndrome
» Press Release | Company News

Rhythm Pharmaceuticals
January 7, 2016 - Rhythm Receives FDA Breakthrough Therapy Designation for Setmelanotide for Treatment of POMC Deficiency Obesity
» Press Release | Company News

Alcresta Therapeutics
January 6, 2016 - Alcresta Pharmaceuticals to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

GBT
January 6, 2016 - Global Blood Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
January 6, 2016 - Sage Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

bluebird bio
January 5, 2016 - bluebird bio to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Blueprint Medicines
January 5, 2016 - Blueprint Medicines Strengthens Executive Leadership Team
» Press Release | Company News

Constellation Pharmaceuticals
January 5, 2016 - Constellation’s CEO Keith Dionne to present at 34th Annual J.P. Morgan Healthcare Conference in San Francisco. 7:30 am on January 11th 2016
» Press Release | Company News

Editas Medicine
January 5, 2016 - Editas Medicine Expands Leadership Team with Key Organizational Appointments
» Press Release | Company News

Foundation Medicine
January 5, 2016 - Foundation Medicine Announces Presentations at the 2016 Genitourinary Cancers Symposium
» Press Release | Company News

Rhythm Pharmaceuticals
January 5, 2016 - Rhythm and Camurus Announce License Agreement for Extended Release FluidCrystal Setmelanotide
» Press Release | Company News

SAGE Therapeutics
January 5, 2016 - Sage Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
January 4, 2016 - Agios to Present at the 34th Annual J.P. Morgan Healthcare Conference on Monday, January 11
» Press Release | Company News

Foundation Medicine
January 4, 2016 - Foundation Medicine to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

GBT
January 4, 2016 - Global Blood Therapeutics Appoints Scott Morrison to Board of Directors
» Press Release | Company News

SAGE Therapeutics
January 4, 2016 - Sage Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

GBT
December 31, 2015 - Global Blood Therapeutics Receives FDA Orphan Drug Designation for GBT440 in Sickle Cell Disease
» Press Release | Company News

Foundation Medicine
December 21, 2015 - Foundation Medicine And Mirati Therapeutics Collaborate To Develop A Companion Diagnostic For Glesatinib (MGCD265) In Non-Small Cell Lung Cancer (NSCLC)
» Press Release | Company News

Foundation Medicine
December 21, 2015 - Foundation Medicine Announces National Agreement with UnitedHealthcare for FoundationOne® in Metastatic Non-Small Cell Lung Cancer
» Press Release | Company News

Agios Pharmaceuticals
December 18, 2015 - Agios Announces Initiation of Phase 1b Frontline Trial of AG-221 or AG-120 in Combination with Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients
» Press Release | Company News

Voyager Therapeutics
December 18, 2015 - Voyager Therapeutics Added to Russell 2000®, 3000® and Global Indexes
» Press Release | Company News

CytomX Therapeutics
December 18, 2015 - CytomX Added to Russell 2000® Index
» Press Release | Company News

Blueprint Medicines
December 17, 2015 - Blueprint Medicines Added to NASDAQ Biotechnology Index
» Press Release | Company News

Voyager Therapeutics
December 17, 2015 - Voyager Therapeutics Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Rhythm Pharmaceuticals
December 16, 2015 - Rhythm Appoints David Meeker, MD, and David McGirr to Board of Directors
» Press Release | Company News

Decibel Therapeutics
December 16, 2015 - Decibel Therapeutics Appoints Jeff Jonas, M.D., CEO of SAGE Therapeutics, to its Board of Directors
» Press Release | Company News

Neon Therapeutics
December 15, 2015 - Neon Therapeutics and Bristol-Myers Squibb Enter Clinical Trial Collaboration
» Press Release | Company News

SAGE Therapeutics
December 15, 2015 - SAGE Updates Guidance for Top-Line Results of Phase 3 STATUS Trial of SAGE-547
» Press Release | Company News

Blueprint Medicines
December 13, 2015 - Blueprint Medicines Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares of Common Stock
» Press Release | Company News

CytomX Therapeutics
December 11, 2015 - CytomX Selects Probody Drug Conjugate Clinical Candidate, CX-2009, Targeting Highly Expressed Tumor Antigen, CD166
» Press Release | Company News

Allena Pharmaceuticals
December 9, 2015 - Allena Pharmaceuticals Raises $53 Million in Series C Financing
» Press Release | Company News

Neon Therapeutics
December 9, 2015 - Neon Therapeutics Enters License Agreement with the Broad Institute, Dana-Farber Cancer Institute and Massachusetts General Hospital
» Press Release | Company News

Constellation Pharmaceuticals
December 9, 2015 - CONSTELLATION PHARMACEUTICALS, INC. RAISES $55 MILLION IN MEZZANINE FINANCING
» Press Release | Company News

Afferent Pharmaceuticals
December 8, 2015 - Afferent Pharmaceuticals Advances Novel Molecule, AF-130, to Phase 1 Clinical Trial
» Press Release | Company News

Foundation Medicine
December 7, 2015 - Foundation Medicine Announces Presentations at the 2015 San Antonio Breast Cancer Symposium
» Press Release | Company News

Agios Pharmaceuticals
December 6, 2015 - Agios Announces Data from Ongoing Phase 1/2 Trial of AG-221 Showing Durable Responses in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

bluebird bio
December 6, 2015 - bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 and HGB-206 Studies of LentiGlobin® at ASH Annual Meeting
» Press Release | Company News

bluebird bio
December 6, 2015 - bluebird bio Presents Pre-Clinical and Manufacturing Data from CAR T Oncology Programs at ASH Annual Meeting
» Press Release | Company News

GBT
December 6, 2015 - Global Blood Therapeutics Announces Positive Phase 1/2 Data Supporting Development of GBT440 as a Potentially Disease-Modifying Therapy for Sickle Cell Disease
» Press Release | Company News

Agios Pharmaceuticals
December 5, 2015 - Agios Announces Data from Ongoing Phase 1 Trial of AG-120 Showing Durable Responses in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

bluebird bio
December 5, 2015 - bluebird bio Reports New Beta-thalassemia Major Data from Northstar Study of LentiGlobin® at ASH Annual Meeting
» Press Release | Company News

bluebird bio
December 3, 2015 - bluebird bio and ViroMed Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
» Press Release | Company News

Alcresta Therapeutics
December 2, 2015 - Alcresta Pharmaceuticals Receives FDA Clearance for RELiZORB™
» Press Release | Company News

SAGE Therapeutics
December 2, 2015 - SAGE to Present Three Poster Presentations at the American Epilepsy Society 69th Annual Meeting
» Press Release | Company News

Zafgen
December 2, 2015 - Zafgen Provides Clinical Update on Beloranib
» Press Release | Company News

Zafgen
December 2, 2015 - Zafgen Announces Beloranib IND Placed on Complete Clinical Hold
» Press Release | Company News

Blueprint Medicines
December 1, 2015 - Blueprint Medicines and PatientCrossroads Launch Registry for Mastocytosis Patients to Increase Understanding of Disease and Speed Therapeutic Development
» Press Release | Company News

CytomX Therapeutics
December 1, 2015 - CytomX to Present at Oppenheimer's 26th Annual Healthcare Conference
» Press Release | Company News

Editas Medicine
December 1, 2015 - Editas Medicine Comments in Connection with International Summit on Human Gene Editing
» Press Release | Company News

GBT
November 30, 2015 - Global Blood Therapeutics Announces Upcoming Investor Webcasts Including Event to Highlight GBT440 Data in Sickle Cell Disease at ASH
» Press Release | Company News

bluebird bio
November 25, 2015 - bluebird bio Announces Participation in 27th Annual Piper Jaffray Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
November 24, 2015 - SAGE to Present at the Piper Jaffray 27th Annual Healthcare Conference
» Press Release | Company News

CytomX Therapeutics
November 23, 2015 - CytomX Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Afferent Pharmaceuticals
November 19, 2015 - Afferent Pharmaceuticals Expands Executive Leadership Team With Appointments of Prabha N. Ibrahim, PhD, as Chief Technology Officer and Michelle Carpenter, JD, RAC, as Vice President, Regulatory Affairs and Project Management
» Press Release | Company News

Jounce Therapeutics
November 17, 2015 - Jounce Therapeutics Appoints Duncan Higgons to Its Board of Directors
» Press Release | Company News

Voyager Therapeutics
November 16, 2015 - Voyager Therapeutics Announces Closing of Initial Public Offering, Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

PanOptica
November 13, 2015 - PanOptica Reports Progress with PAN-90806, a Topical AntiVEGF Eyedrop for the Treatment of Neovascular (Wet) AMD
» Press Release | Company News

Allena Pharmaceuticals
November 12, 2015 - Allena Pharmaceuticals Announces Presentation of Successful Phase 2 Data from ALLN-177 Program at American Society of Nephrology Kidney Week
» Press Release | Company News

Blueprint Medicines
November 12, 2015 - Blueprint Medicines to Present Preclinical Data at 2015 ASH Annual Meeting Demonstrating Anti-tumor Activity of BLU-285 in a Model of Acute Myeloid Leukemia
» Press Release | Company News

Foundation Medicine
November 12, 2015 - Foundation Medicine to Present at the Goldman Sachs SMID Cap Growth Conference
» Press Release | Company News

GBT
November 12, 2015 - Global Blood Therapeutics Reports Recent Business Progress and Third Quarter 2015 Financial Results
» Press Release | Company News

Afferent Pharmaceuticals
November 11, 2015 - Afferent Pharmaceuticals Announces Phase 2 Clinical Trial with AF-219 in Cough in Idiopathic Pulmonary Fibrosis (IPF) Patients
» Press Release | Company News

GBT
November 10, 2015 - Global Blood Therapeutics Announces Multiple Data Presentations Supporting GBT440 Program for Hypoxemic Pulmonary Disorders, Including Idiopathic Pulmonary Fibrosis
» Press Release | Company News

Voyager Therapeutics
November 10, 2015 - Voyager Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

Zafgen
November 10, 2015 - Zafgen Announces Third Quarter 2015 Financial Results
» Press Release | Company News

Blueprint Medicines
November 9, 2015 - Blueprint Medicines Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Blueprint Medicines
November 9, 2015 - Blueprint Medicines Highlights Advances in Preclinical Discovery Efforts
» Press Release | Company News

Foundation Medicine
November 9, 2015 - Foundation Medicine and Collaborators to Present New Clinical Data Supporting Comprehensive Genomic Profiling in Advanced Sarcomas and Hematologic Malignancies with FoundationOne® Heme
» Press Release | Company News

Warp Drive Bio
November 9, 2015 - Warp Drive Bio Announces Breakthrough in the Ability to Target the Previously Undruggable Oncogene RAS
» Press Release | Company News

Warp Drive Bio
November 9, 2015 - Warp Drive Bio Announces Formation of Board of World-Leading Oncology Experts to Focus on Company’s RAS Program
» Press Release | Company News

Agios Pharmaceuticals
November 8, 2015 - Agios Announces Data from Dose-Escalation Phase 1 Study of AG-120 in Patients with IDH1 Mutant Positive Advanced Solid Tumors
» Press Release | Company News

CytomX Therapeutics
November 8, 2015 - CytomX Highlights Data from Multiple Probody Pipeline Programs at Investor Event During AACR-NCI-EORTC Conference
» Press Release | Company News

Rhythm Pharmaceuticals
November 6, 2015 - Rhythm Presents Cardiovascular Safety Data from Phase 1b/2a Clinical Trials of Setmelanotide in Obesity
» Press Release | Company News

Rhythm Pharmaceuticals
November 6, 2015 - Rhythm Presents Positive Data from Phase 1b Study of Setmelanotide for the Treatment of Genetic Obesity
» Press Release | Company News

Agios Pharmaceuticals
November 5, 2015 - Agios Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
November 5, 2015 - Agios to Present New Data From Lead Programs at the 2015 ASH Annual Meeting
» Press Release | Company News

bluebird bio
November 5, 2015 - bluebird bio to present LentiGlobin® BB305 Clinical Data and bb2121 Preclinical Data at Annual Meeting of the American Society of Hematology
» Press Release | Company News

CytomX Therapeutics
November 5, 2015 - CytomX and MD Anderson Cancer Center Enter Into Strategic Collaboration for Probody-Enabled CAR-NK Cell Therapies
» Press Release | Company News

GBT
November 5, 2015 - Global Blood Therapeutics Announces New GBT440 Data in Sickle Cell Disease to be Presented at the American Society of Hematology (ASH) Annual Meeting
» Press Release | Company News

SAGE Therapeutics
November 5, 2015 - SAGE Announces Third Quarter 2015 Financial Results and Recent Pipeline Progress
» Press Release | Company News

Allena Pharmaceuticals
November 4, 2015 - Allena Pharmaceuticals To Present Phase 2 Data on ALLN-177 Program at ASN Kidney Week 2015
» Press Release | Company News

bluebird bio
November 4, 2015 - bluebird bio Announces Participation in 24th Annual Credit Suisse Healthcare Conference
» Press Release | Company News

bluebird bio
November 4, 2015 - bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress
» Press Release | Company News

Sesen Bio
November 4, 2015 - Eleven Biotherapeutics Reports Third Quarter 2015 Financial Results
» Press Release | Company News

Myokardia
November 4, 2015 - MyoKardia Announces Presentations at American Heart Association Scientific Sessions 2015
» Press Release | Company News

Agios Pharmaceuticals
November 3, 2015 - Agios to Present at Credit Suisse 24th Annual Healthcare Conference on Tuesday, November 10
» Press Release | Company News

CytomX Therapeutics
November 3, 2015 - CytomX Appoints Matthew Young to Board of Directors
» Press Release | Company News

Foundation Medicine
November 3, 2015 - Foundation Medicine Announces 2015 Third Quarter Results and Recent Highlights
» Press Release | Company News

Jounce Therapeutics
November 3, 2015 - Jounce Therapeutics Appoints Elizabeth Trehu, M.D., to Chief Medical Officer
» Press Release | Company News

Myokardia
November 3, 2015 - MyoKardia Announces Closing of Initial Public Offering
» Press Release | Company News

SAGE Therapeutics
November 3, 2015 - SAGE Announces Presentations at Upcoming November Investor Conferences
» Press Release | Company News

Zafgen
November 3, 2015 - Zafgen to Host Conference Call to Discuss Third Quarter 2015 Financial Results
» Press Release | Company News

Foundation Medicine
November 2, 2015 - Foundation Medicine Announces Roche Pharmaceuticals (Israel) Ltd. to Commence Commercial Activities in Support of its Molecular Information Products in Oncology
» Press Release | Company News

Warp Drive Bio
November 2, 2015 - Warp Drive Bio to Present First Program Using Small Molecule Assisted Receptor Targeting (SMART) Platform Against the RAS Oncogene at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
» Press Release | Company News

Agios Pharmaceuticals
October 29, 2015 - Agios to Webcast Conference Call of Third Quarter 2015 Financial Results on November 5, 2015
» Press Release | Company News

SAGE Therapeutics
October 29, 2015 - SAGE to Report Third Quarter 2015 Financial Results on Thursday, November 5, 2015
» Press Release | Company News

Myokardia
October 28, 2015 - MyoKardia Announces Pricing of Initial Public Offering
» Press Release | Company News

Sesen Bio
October 27, 2015 - Eleven Biotherapeutics to Report Third Quarter 2015 Financial Results on November 4, 2015
» Press Release | Company News

Taris Biomedical
October 27, 2015 - TARIS Biomedical® Raises $32 Million and Expands Leadership Team and Board of Directors
» Press Release | Company News

Agios Pharmaceuticals
October 26, 2015 - Agios to Present Clinical Data from Ongoing AG-120 Phase 1 Trial in Advanced Solid Tumors at AACR-NCI-EORTC
» Press Release | Company News

CytomX Therapeutics
October 26, 2015 - Data from CytomX's Probody™ Pipeline to be Presented at the 2015 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
» Press Release | Company News

Zafgen
October 22, 2015 - Zafgen Announces Beloranib Program Update
» Press Release | Company News

bluebird bio
October 19, 2015 - bluebird bio Announces Presentation at Cooley’s Anemia Foundation Symposium
» Press Release | Company News

Agios Pharmaceuticals
October 16, 2015 - Agios Outlines Key Clinical Development & Research Strategies
» Press Release | Company News

Zafgen
October 16, 2015 - Zafgen Announces Partial Clinical Hold Affecting Beloranib Trials
» Press Release | Company News

Decibel Therapeutics
October 15, 2015 - Third Rock Ventures Launches Decibel Therapeutics with $52 Million Series A Financing to Discover New Medicines to Protect, Repair and Restore Hearing
» Press Release | Company News

Sesen Bio
October 15, 2015 - Eleven Biotherapeutics Completes Enrollment in Pivotal Phase 3 Study of Isunakinra (EBI-005) in Patients with Allergic Conjunctivitis
» Press Release | Company News

CytomX Therapeutics
October 14, 2015 - CytomX Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
» Press Release | Company News

GBT
October 14, 2015 - Global Blood Therapeutics to Present at BIO Investor Forum
» Press Release | Company News

Myokardia
October 14, 2015 - MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
» Press Release | Company News

Zafgen
October 14, 2015 - Zafgen Issues Statement
» Press Release | Company News

Foundation Medicine
October 13, 2015 - Foundation Medicine Announces Timing for Third Quarter 2015 Financial Results and Conference Call
» Press Release | Company News

GBT
October 12, 2015 - Global Blood Therapeutics Announces GBT440 Receives FDA Fast Track Designation for Sickle Cell Disease
» Press Release | Company News

Agios Pharmaceuticals
October 8, 2015 - Agios to Webcast R&D Day on October 16, 2015
» Press Release | Company News

Alcresta Therapeutics
October 8, 2015 - Alcresta to Present at 29th Annual North American Cystic Fibrosis Conference
» Press Release | Company News

SAGE Therapeutics
October 8, 2015 - SAGE to Present Data at Upcoming Scientific Conferences
» Press Release | Company News

CytomX Therapeutics
October 7, 2015 - CytomX Announces Pricing of Initial Public Offering
» Press Release | Company News

Myokardia
October 6, 2015 - MyoKardia Provides Update on Two Phase 1 Trials of MYK-461 for the Treatment of Hypertrophic Cardiomyopathy
» Press Release | Company News

SAGE Therapeutics
October 6, 2015 - SAGE Announces Initiation of Phase 1 and First Dosing of SAGE-217
» Press Release | Company News

Jounce Therapeutics
October 1, 2015 - Jounce Therapeutics Announces Presentation at the Leerink Partners Immuno-Oncology Roundtable
» Press Release | Company News

Neon Therapeutics
October 1, 2015 - Neon Therapeutics Launches with $55 Million Series A to Develop Neoantigen-based Cancer Immunotherapies
» Press Release | Company News

Blueprint Medicines
September 30, 2015 - Blueprint Medicines Receives FDA Orphan Drug Designation for Novel Drug Candidate for Treatment of Hepatocellular Carcinoma
» Press Release | Company News

Myokardia
September 30, 2015 - FierceBiotech names MyoKardia as one of its “Fierce 15” Biotech Companies of 2015
» Press Release | Company News

REVOLUTION Medicines
September 30, 2015 - FierceBiotech Names REVOLUTION Medicines as a “Fierce 15” Biotech Company of 2015
» Press Release | Company News

Zafgen
September 30, 2015 - Zafgen Granted Orphan Drug Designation in the European Union for Beloranib, a First-in-Class MetAP2 Inhibitor for the Treatment of Craniopharyngioma
» Press Release | Company News

Afferent Pharmaceuticals
September 28, 2015 - Afferent Pharmaceuticals Announces Positive Results in Phase 2b Chronic Cough Trial
» Press Release | Company News

Zafgen
September 28, 2015 - Zafgen Announces Transition of Board of Directors
» Press Release | Company News

bluebird bio
September 24, 2015 - bluebird bio Announces Participation in Leerink Partners Immuno-Oncology Roundtable
» Press Release | Company News

GBT
September 24, 2015 - Global Blood Therapeutics Appoints Philip A. Pizzo, M.D. to Board of Directors
» Press Release | Company News

Rhythm Pharmaceuticals
September 24, 2015 - FDA Office of Orphan Products Development Awards Rhythm $1 Million Grant to Support Phase 2 Study of Setmelanotide in Prader-Willi Syndrome
» Press Release | Company News

Seventh Sense BioSystems
September 24, 2015 - Seventh Sense Biosystems Announces Expansion of Manufacturing Operations and Facilities in Medford, Massachusetts
» Press Release | Company News

Zafgen
September 24, 2015 - Zafgen to Present at the Leerink Rare Disease Roundtable
» Press Release | Company News

Agios Pharmaceuticals
September 23, 2015 - Agios to Present at Leerink Partners Rare Disease Roundtable
» Press Release | Company News

SAGE Therapeutics
September 23, 2015 - SAGE Therapeutics to Participate in the 4th Annual Leerink Partners Rare Disease Roundtable
» Press Release | Company News

SAGE Therapeutics
September 21, 2015 - SAGE Therapeutics Expands Leadership Team With Key Appointments
» Press Release | Company News

Voyager Therapeutics
September 17, 2015 - Voyager Therapeutics Appoints Neuroscience Expert Steven Hyman, M.D., to Board of Directors
» Press Release | Company News

Nurix, Inc.
September 16, 2015 - Celgene and Nurix Announce Collaboration Targeting Protein Homeostasis for Next-Generation Therapies in Oncology, Inflammation and Immunology
» Press Release | Company News

Foundation Medicine
September 15, 2015 - Foundation Medicine Expands Molecular Information Decision Support Offerings with GeneKit™, a Genomic Solutions Portal for Pathologists
» Press Release | Company News

Foundation Medicine
September 15, 2015 - Foundation Medicine Launches Precision Medicine Exchange Consortium™ (PMEC) to Advance the Integration of Molecular Information in Clinical Oncology and Accelerate Adoption of Precision Care
» Press Release | Company News

Jounce Therapeutics
September 15, 2015 - Jounce Therapeutics Appoints Kim Drapkin, CPA as Chief Financial Officer
» Press Release | Company News

bluebird bio
September 11, 2015 - bluebird bio Announces Participation at Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Blueprint Medicines
September 10, 2015 - Blueprint Medicines Receives FDA Authorization to Advance Novel Drug Candidate into Clinical Trial for Systemic Mastocytosis
» Press Release | Company News

Zafgen
September 10, 2015 - Zafgen to Present at Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Foundation Medicine
September 9, 2015 - Foundation Medicine to Present at Morgan Stanley Global Healthcare Conference
» Press Release | Company News

Zafgen
September 9, 2015 - Zafgen Completes Enrollment of Phase 2b Trial of Beloranib in Severe Obesity Complicated by Type 2 Diabetes
» Press Release | Company News

Blueprint Medicines
September 3, 2015 - Blueprint Medicines to Present at the 22nd Annual NewsMakers in the Biotech Industry Conference
» Press Release | Company News

GBT
September 3, 2015 - Global Blood Therapeutics Announces Participation at Three September Conferences
» Press Release | Company News

SAGE Therapeutics
September 3, 2015 - SAGE Therapeutics Announces Results From Successful Exploratory Trial in Essential Tremor
» Press Release | Company News

Blueprint Medicines
September 1, 2015 - Blueprint Medicines to Present Preclinical Data on BLU-554 and on Novel Drug Target at International Liver Cancer Association 9th Annual Conference
» Press Release | Company News

Sesen Bio
September 1, 2015 - Eleven Biotherapeutics Announces Promotions of Gary Sternberg, MD, MBA to Chief Business Officer and John McCabe, CPA to Senior Vice President, Finance
» Press Release | Company News

Sesen Bio
August 31, 2015 - Eleven Biotherapeutics to Present at NewsMakers in the Biotech Industry Conference
» Press Release | Company News

Foundation Medicine
August 31, 2015 - Foundation Medicine to Webcast Investor & Analyst Day
» Press Release | Company News

CytomX Therapeutics
August 28, 2015 - CytomX Files Registration Statement for Proposed Initial Public Offering
» Press Release | Company News

CytomX Therapeutics
August 27, 2015 - Immuno-Oncology Veteran Rachel Humphrey, M.D., Joins CytomX as Chief Medical Officer
» Press Release | Company News

GBT
August 17, 2015 - Global Blood Therapeutics Announces Closing of Initial Public Offering and Exercise of Over-Allotment Option
» Press Release | Company News

SAGE Therapeutics
August 17, 2015 - SAGE Announces First Patient Treated in Phase 3 STATUS Trial of SAGE-547 in Super-Refractory Status Epilepticus
» Press Release | Company News

Seventh Sense BioSystems
August 17, 2015 - Seventh Sense Biosystems Receives Four Patent Allowances for TAP Blood Collection System in the U.S. and Europe
» Press Release | Company News

Sesen Bio
August 13, 2015 - Eleven Biotherapeutics Reports Second Quarter 2015 Financial Results
» Press Release | Company News

Rhythm Pharmaceuticals
August 13, 2015 - Rhythm Subsidiary Raises $40 Million in Oversubscribed Financing
» Press Release | Company News

Sesen Bio
August 12, 2015 - Eleven Biotherapeutics Announces First Patients Dosed with EBI-005 in Phase 3 Study in Patients with Moderate to Severe Allergic Conjunctivitis
» Press Release | Company News

SAGE Therapeutics
August 12, 2015 - SAGE Therapeutics Announces Second Quarter 2015 Financial Results and Highlights Recent Progress
» Press Release | Company News

GBT
August 11, 2015 - Global Blood Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

Blueprint Medicines
August 10, 2015 - Blueprint Medicines Reports Second Quarter 2015 Financial Results and Provides Business Update Blueprint Medicines
» Press Release | Company News

Editas Medicine
August 10, 2015 - Editas Medicine Raises $120 Million to Advance Genome Editing
» Press Release | Company News

Agios Pharmaceuticals
August 6, 2015 - Agios Reports Second Quarter 2015 Financial Results and Provides Updates on Clinical Development Progress
» Press Release | Company News

bluebird bio
August 6, 2015 - bluebird bio Reports Second Quarter 2015 Financial Results and Recent Operational Progress
» Press Release | Company News

SAGE Therapeutics
August 6, 2015 - SAGE Receives Special Protocol Assessment for Phase 3 STATUS Trial of SAGE-547 in Super-Refractory Status Epilepticus
» Press Release | Company News

Agios Pharmaceuticals
August 5, 2015 - Agios to Present at Canaccord Genuity 35th Annual Growth Conference Wednesday, August 12, 2015
» Press Release | Company News

bluebird bio
August 5, 2015 - bluebird bio Announces Participation at the 2015 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Editas Medicine
August 5, 2015 - Editas Medicine Named A 2015 Technology Pioneer by World Economic Forum
» Press Release | Company News

SAGE Therapeutics
August 5, 2015 - SAGE Therapeutics to Present at the Canaccord Genuity 35th Annual Growth Conference
» Press Release | Company News

Zafgen
August 5, 2015 - Zafgen to Present at Canaccord Genuity 35th Annual Growth Conference 2015
» Press Release | Company News

Allena Pharmaceuticals
August 4, 2015 - Allena Pharmaceuticals Initiates Phase 2b Trial of ALLN-177 for Secondary Hyperoxaluria
» Press Release | Company News

Blueprint Medicines
August 4, 2015 - Blueprint Medicines to Present at 2015 Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Sesen Bio
August 4, 2015 - Eleven Biotherapeutics to Report Second Quarter 2015 Financial Results on August 13, 2015
» Press Release | Company News

Foundation Medicine
August 4, 2015 - Foundation Medicine to Present at Wedbush PacGrow Healthcare Conference
» Press Release | Company News

Zafgen
August 4, 2015 - Zafgen to Host Conference Call to Discuss Second Quarter 2015 Financial Results
» Press Release | Company News

CytomX Therapeutics
August 3, 2015 - CytomX Announces Management Team Promotions
» Press Release | Company News

Agios Pharmaceuticals
July 30, 2015 - Agios to Webcast Conference Call of Second Quarter 2015 Financial Results on August 6, 2015
» Press Release | Company News

Foundation Medicine
July 29, 2015 - Foundation Medicine Announces 2015 Second Quarter Results and Recent Highlights
» Press Release | Company News

Foundation Medicine
July 28, 2015 - Foundation Medicine Initiates Multi-Center Clinical Study Evaluating Its Circulating Tumor DNA (ctDNA) Assay in Multiple Tumor Types
» Press Release | Company News

Alcresta Therapeutics
July 22, 2015 - Alcresta Appoints Russell Clayton, D.O., Chief Medical Officer
» Press Release | Company News

Voyager Therapeutics
July 22, 2015 - Voyager Therapeutics Appoints Michael Higgins to Board of Directors
» Press Release | Company News

Blueprint Medicines
July 13, 2015 - Blueprint Medicines Receives FDA Authorization to Proceed with Clinical Trials for Two Drug Candidates
» Press Release | Company News

Afferent Pharmaceuticals
July 8, 2015 - Afferent Pharmaceuticals Raises $55 Million in Oversubscribed Crossover Financing
» Press Release | Company News

Foundation Medicine
July 6, 2015 - Foundation Medicine Announces Timing for Second Quarter 2015 Financial Results and Conference Call
» Press Release | Company News

Editas Medicine
July 1, 2015 - Editas Medicine Appoints Andrew Hack, M.D., Ph.D., as Chief Financial Officer
» Press Release | Company News

Voyager Therapeutics
July 1, 2015 - Voyager Therapeutics Appoints Perry A. Karsen to Board of Directors
» Press Release | Company News

Blueprint Medicines
June 29, 2015 - Blueprint Medicines Added to Russell 2000®, 3000® and Global Indexes
» Press Release | Company News

Agios Pharmaceuticals
June 24, 2015 - Agios Announces First Patient Dosed with AG-881 in Phase 1 Study in Patients with Advanced Solid Tumors with an IDH Mutation
» Press Release | Company News

Sesen Bio
June 24, 2015 - Eleven Biotherapeutics Announces Executive Change
» Press Release | Company News

Agios Pharmaceuticals
June 23, 2015 - Agios Appoints Maykin Ho, Ph.D., to its Board of Directors
» Press Release | Company News

bluebird bio
June 23, 2015 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

bluebird bio
June 23, 2015 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

bluebird bio
June 23, 2015 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

bluebird bio
June 22, 2015 - Kite Pharma and bluebird bio Announce Strategic Collaboration to Advance Second Generation TCR Cell Therapy Products to Treat HPV-Associated Cancers
» Press Release | Company News

Blueprint Medicines
June 22, 2015 - Blueprint Medicines Debuts Preclinical Data for First-in-Class RET Drug Candidate
» Press Release | Company News

Corvia Medical
June 22, 2015 - DC Devices Completes Enrollment In Clinical Trial of the First Transcatheter Device to Treat Diastolic Heart Failure; Announces Name Change to Corvia Medical
» Press Release | Company News

Foundation Medicine
June 22, 2015 - IMS Health and Foundation Medicine Announce Collaboration to Optimize Targeting of Precision Therapies in Oncology
» Press Release | Company News

Zafgen
June 17, 2015 - Zafgen to Present at JMP Securities Life Sciences Conference 2015
» Press Release | Company News

CytomX Therapeutics
June 16, 2015 - CytomX Raises $70 Million in Series D Financing
» Press Release | Company News

bluebird bio
June 15, 2015 - Philip Gregory, D. Phil., Joins bluebird bio as Chief Scientific Officer
» Press Release | Company News

bluebird bio
June 13, 2015 - bluebird bio Reports New Beta-thalassemia Major and Severe Sickle Cell Disease Data from HGB-205 Study at EHA
» Press Release | Company News

Agios Pharmaceuticals
June 12, 2015 - Agios Reports New, Final Data from Phase 1 Multiple Ascending Dose (MAD) Study in Healthy Volunteers for AG-348, an Investigational Medicine for Pyruvate Kinase (PK) Deficiency
» Press Release | Company News

Agios Pharmaceuticals
June 12, 2015 - Agios Announces New Data from Ongoing Phase 1 Trial of AG-120 Showing Durable Clinical Activity in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

Agios Pharmaceuticals
June 12, 2015 - Agios Announces New Data from Ongoing Phase 1 Dose Escalation and Expansion Trial of AG-221 Showing Durable Clinical Activity in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

Blueprint Medicines
June 11, 2015 - Blueprint Medicines Reports First Quarter 2015 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
June 10, 2015 - Agios Pharmaceuticals Announces FDA Orphan Drug Designation Granted to AG-120 for Treatment of IDH1-Mutant Positive Acute Myelogenous Leukemia
» Press Release | Company News

Zafgen
June 10, 2015 - Zafgen to Present at 2015 BIO International Convention
» Press Release | Company News

bluebird bio
June 9, 2015 - bluebird bio Completes NIH RAC Review of HGB-208 Pediatric Study Protocol
» Press Release | Company News

SAGE Therapeutics
June 9, 2015 - SAGE Therapeutics Announces Positive Top-Line Data in Exploratory Trial of SAGE-547 in Postpartum Depression
» Press Release | Company News

Blueprint Medicines
June 5, 2015 - Blueprint Medicines to Present at Upcoming Investor Conferences in June
» Press Release | Company News

Rhythm Pharmaceuticals
June 4, 2015 - Rhythm Initiates Two Phase 2 Clinical Trials of Setmelanotide (RM-493) in Rare Genetic Disorders of Obesity Caused by MC4 Pathway Deficiencies
» Press Release | Company News

bluebird bio
June 3, 2015 - Celgene and bluebird bio to Develop Anti-BCMA Product Candidates; bluebird bio Regains Rights to CAR T Programs Outside of BCMA
» Press Release | Company News

SAGE Therapeutics
June 3, 2015 - SAGE Therapeutics to Participate in the Goldman Sachs 36th Annual Global Healthcare Conference
» Press Release | Company News

Foundation Medicine
June 2, 2015 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Foundation Medicine
June 1, 2015 - Foundation Medicine Identifies Patients Likely to Respond to Certain MET Inhibitor Targeted Therapies; Durable Responses in Non-Small Cell Lung Cancer (NSCLC) Presented at ASCO Annual Meeting
» Press Release | Company News

REVOLUTION Medicines
June 1, 2015 - Rationally Designed Antifungal Compounds that Evade Resistance Reported in Nature Chemical Biology by Scientific Founder of REVOLUTION Medicines
» Press Release | Company News

CytomX Therapeutics
May 28, 2015 - CytomX to Present at the Jefferies 2015 Global Healthcare Conference
» Press Release | Company News

Zafgen
May 28, 2015 - Zafgen Completes Enrollment of U.S. Phase 3 Trial of Beloranib in Prader-Willi Syndrome
» Press Release | Company News

CytomX Therapeutics
May 27, 2015 - CytomX Expands Executive Leadership Team
» Press Release | Company News

Editas Medicine
May 27, 2015 - Juno Therapeutics and Editas Medicine Announce Exclusive Collaboration to Create Next-Generation CAR T and TCR Cell Therapies
» Press Release | Company News

Zafgen
May 27, 2015 - Zafgen Appoints Global Head of Medical Affairs and Global Head of Regulatory
» Press Release | Company News

bluebird bio
May 26, 2015 - bluebird bio and Five Prime Therapeutics Enter into License Agreement for Novel Antibodies to Develop Chimeric Antigen Receptor T Cell Therapy
» Press Release | Company News

bluebird bio
May 22, 2015 - bluebird bio Announces Participation at the Jefferies 2015 Global Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
May 21, 2015 - Agios to Present Clinical and Preclinical Data at the 20th Congress of the European Hematology Association
» Press Release | Company News

bluebird bio
May 21, 2015 - bluebird bio to Present LentiGlobin Clinical Data at 20th Congress of European Hematology Association
» Press Release | Company News

bluebird bio
May 19, 2015 - bluebird bio Announces Global Regulatory Strategy for LentiGlobin BB305 in Beta-Thalassemia Major
» Press Release | Company News

Agios Pharmaceuticals
May 18, 2015 - Agios Announces FDA Fast Track Designation Granted to AG-120 for Treatment of Patients with Acute Myelogenous Leukemia with an IDH1 Mutation
» Press Release | Company News

Editas Medicine
May 18, 2015 - Editas Medicine Presents Data from Multiple Therapeutic Discovery Programs Emerging from its Genome Editing Platform at the ASGCT Annual Conference
» Press Release | Company News

Sesen Bio
May 18, 2015 - Eleven Biotherapeutics Announces Top-Line Results from Pivotal Phase 3 Study of EBI-005 in Patients with Moderate to Severe Dry Eye Disease
» Press Release | Company News

Foundation Medicine
May 18, 2015 - Foundation Medicine and Collaborators to Present Data in 22 Oral and Poster Presentations at the 2015 ASCO Annual Meeting
» Press Release | Company News

Kala Pharmaceuticals
May 14, 2015 - Kala Pharmaceuticals Appoints Mark Iwicki as Executive Chairman
» Press Release | Company News

SAGE Therapeutics
May 14, 2015 - SAGE Therapeutics Announces SAGE-547 Progress and First Quarter 2015 Financial Results
» Press Release | Company News

SAGE Therapeutics
May 14, 2015 - SAGE Therapeutics Achieves 77 Percent Response Rate in Completed Phase 1/2 Clinical Trial of SAGE-547 in Super-Refractory Status Epilepticus
» Press Release | Company News

Foundation Medicine
May 13, 2015 - Foundation Medicine's Comprehensive Genomic Profile Informs Therapeutic Choices and Leads to Promising Outcomes in Pediatric Patients With Gliomas
» Press Release | Company News

SAGE Therapeutics
May 12, 2015 - SAGE Therapeutics to Present at UBS Global Healthcare Conference
» Press Release | Company News

Zafgen
May 12, 2015 - Zafgen Reports First Quarter 2015 Financial Results
» Press Release | Company News

Blueprint Medicines
May 11, 2015 - Blueprint Medicines Publishes Strategy for Advancing Kinase Drug Discovery
» Press Release | Company News

Foundation Medicine
May 11, 2015 - Foundation Medicine Announces 2015 First Quarter Results and Recent Highlights
» Press Release | Company News

Zafgen
May 8, 2015 - Zafgen Presents Positive Safety and Efficacy Data From Phase 2 Trial of Beloranib in Severe Obesity and Proof of Concept Trial in Prader-Willi Syndrome at ECO 2015
» Press Release | Company News

Agios Pharmaceuticals
May 7, 2015 - Agios Reports First Quarter 2015 Financial Results and Outlines Late-Stage Clinical Development for AG-221 and AG-120
» Press Release | Company News

Sesen Bio
May 7, 2015 - Eleven Biotherapeutics Presents Clinical Data on EBI-005 for the Treatment of Dry Eye Disease and Allergic Conjunctivitis at ARVO 2015 Annual Meeting
» Press Release | Company News

SAGE Therapeutics
May 7, 2015 - SAGE Therapeutics to Report First Quarter 2015 Financial Results on Thursday, May 14
» Press Release | Company News

Zafgen
May 7, 2015 - Zafgen Announces Oral and Poster Presentations at the 22nd European Congress on Obesity
» Press Release | Company News

bluebird bio
May 6, 2015 - bluebird bio Reports First Quarter 2015 Financial Results and Business Updates
» Press Release | Company News

CytomX Therapeutics
May 6, 2015 - CytomX to Present Probody Overview at the Credit Suisse Antibody Day
» Press Release | Company News

Editas Medicine
May 6, 2015 - Editas Medicine Announces Six Scientific Presentations at the American Society of Gene And Cell Therapy 18th Annual Meeting
» Press Release | Company News

Blueprint Medicines
May 5, 2015 - Blueprint Medicines Announces Closing of Initial Public Offering
» Press Release | Company News

Sesen Bio
May 5, 2015 - Eleven Biotherapeutics Presents Data on EBI-031 for the Treatment of Diabetic Macular Edema at ARVO 2015 Annual Meeting
» Press Release | Company News

Foundation Medicine
May 5, 2015 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Jounce Therapeutics
May 5, 2015 - Jounce Therapeutics to Present at the Bank of America Merrill Lynch 2015 Health Care Conference
» Press Release | Company News

Voyager Therapeutics
May 5, 2015 - Voyager Therapeutics to Present at the American Society of Gene & Cell Therapy 18th Annual Meeting
» Press Release | Company News

Zafgen
May 5, 2015 - Zafgen to Host Conference Call to Discuss First Quarter 2015 Financial Results
» Press Release | Company News

Kala Pharmaceuticals
May 1, 2015 - Kala Pharmaceuticals to Present at the Association for Research in Vision and Ophthalmology 2015 Annual Meeting
» Press Release | Company News

bluebird bio
April 30, 2015 - bluebird bio Announces Participation at Two Upcoming Health Care Conferences
» Press Release | Company News

Sesen Bio
April 30, 2015 - Eleven Biotherapeutics Reports First Quarter 2015 Financial Results
» Press Release | Company News

Myokardia
April 30, 2015 - MyoKardia, Inc. Completes $46 Million Series B Financing
» Press Release | Company News

Agios Pharmaceuticals
April 29, 2015 - Agios Pharmaceuticals Selects Third Novel IDH Mutant Inhibitor, AG-881, for Clinical Development
» Press Release | Company News

Blueprint Medicines
April 29, 2015 - Blueprint Medicines Announces Pricing of Initial Public Offering
» Press Release | Company News

Sesen Bio
April 29, 2015 - Eleven Biotherapeutics Publishes Clinical Data on EBI-005 for the Treatment of Allergic Conjunctivitis
» Press Release | Company News

Agios Pharmaceuticals
April 28, 2015 - Agios Pharmaceuticals to Webcast Conference Call of First Quarter 2015 Financial Results on May 7, 2015
» Press Release | Company News

Constellation Pharmaceuticals
April 28, 2015 - Constellation Pharmaceuticals Initiates Clinical Development of CPI-1205, a Novel Inhibitor of EZH2, in Patients with Lymphoma
» Press Release | Company News

Voyager Therapeutics
April 28, 2015 - Voyager Therapeutics Promotes Jeff Goater to Senior Vice President, Finance and Business Development
» Press Release | Company News

Editas Medicine
April 27, 2015 - Vic Myer, Ph.D. Joins Editas Medicine as Chief Technology Officer
» Press Release | Company News

Blueprint Medicines
April 24, 2015 - Blueprint Medicines Presents New Preclinical Data Demonstrating Its Drug Candidate BLU-554 Induces Significant Tumor Regression in Models of Hepatocellular Carcinoma
» Press Release | Company News

Jounce Therapeutics
April 23, 2015 - Jounce Therapeutics Secures $56 Million in Oversubscribed Series B Financing
» Press Release | Company News

Sesen Bio
April 22, 2015 - Eleven Biotherapeutics to Present Data on Ocular Therapeutics Pipeline at the ARVO 2015 Annual Meeting
» Press Release | Company News

Sesen Bio
April 21, 2015 - Eleven Biotherapeutics to Report First Quarter 2015 Financial Results on April 30, 2015
» Press Release | Company News

SAGE Therapeutics
April 21, 2015 - SAGE Therapeutics Announces Closing of $138 Million Public Offering of Common Stock Including Full Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Foundation Medicine
April 20, 2015 - Foundation Medicine and Collaborators to Present New Data in 12 Oral and Poster Presentations at the AACR Annual Meeting
» Press Release | Company News

Foundation Medicine
April 20, 2015 - Foundation Medicine Announces Its Collaboration with the National Cancer Institute on Exceptional Responders Initiative
» Press Release | Company News

SAGE Therapeutics
April 20, 2015 - SAGE Therapeutics Announces First Patient Treated Under Phase 3 Expanded Access Protocol to Evaluate SAGE-547 in Patients With Super-Refractory Status Epilepticus
» Press Release | Company News

Allena Pharmaceuticals
April 16, 2015 - Allena Pharmaceuticals Appoints Louis Brenner, M.D. as Chief Operating Officer
» Press Release | Company News

Kala Pharmaceuticals
April 16, 2015 - Kala Pharmaceuticals Presents at the Ophthalmology Innovation Summit
» Press Release | Company News

Jounce Therapeutics
April 15, 2015 - Jounce Therapeutics to Present at the Jefferies 2015 Immuno-Oncology Summit
» Press Release | Company News

Foundation Medicine
April 14, 2015 - Foundation Medicine Announces Timing for First Quarter 2015 Financial Results and Conference Call
» Press Release | Company News

GBT
April 14, 2015 - Global Blood Therapeutics Appoints New Chief Business and Strategy Officer
» Press Release | Company News

SAGE Therapeutics
April 14, 2015 - SAGE Therapeutics Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

CytomX Therapeutics
April 13, 2015 - CytomX to Present Overview of Precision Cancer Immunotherapies at the Jefferies Immuno-Oncology Summit
» Press Release | Company News

SAGE Therapeutics
April 13, 2015 - SAGE Therapeutics Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Voyager Therapeutics
April 13, 2015 - Voyager Therapeutics Raises $60 Million in Oversubscribed Series B Financing
» Press Release | Company News

REVOLUTION Medicines
April 9, 2015 - REVOLUTION Medicines Appoints Pharmaceutical Commercial Executive Elizabeth McKee Anderson to Board of Directors
» Press Release | Company News

SAGE Therapeutics
April 9, 2015 - SAGE Therapeutics Announces Presentations at Upcoming Scientific Conferences
» Press Release | Company News

Blueprint Medicines
April 8, 2015 - Blueprint Medicines to Present New Preclinical Data on BLU-285 in Treatment-Resistant GIST and on Novel Cancer Drug Targets at Upcoming AACR Annual Meeting
» Press Release | Company News

Rhythm Pharmaceuticals
April 8, 2015 - Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
» Press Release | Company News

Motus
April 8, 2015 - Rhythm Initiates Phase 2b Clinical Trial of Relamorelin for Diabetic Gastroparesis
» Press Release | Company News

Foundation Medicine
April 7, 2015 - Foundation Medicine and Roche Complete Strategic Transaction to Advance Molecular Information and Precision Medicine in Oncology
» Press Release | Company News

Foundation Medicine
April 2, 2015 - Foundation Medicine Stockholders Approve Pending Roche Transaction at Special Meeting of Stockholders
» Press Release | Company News

GBT
April 2, 2015 - Global Blood Therapeutics Appoints Two New Board Members
» Press Release | Company News

SAGE Therapeutics
April 2, 2015 - SAGE Therapeutics Announces Positive End-of-Phase 2 Meeting With FDA and Planned Initiation of SAGE-547 Global Phase 3 Trial in Mid-2015
» Press Release | Company News

Kala Pharmaceuticals
April 1, 2015 - Kala Pharmaceuticals Announces Positive Results from Phase 3 Trial of KPI-121 in Cataract Surgery
» Press Release | Company News

Kala Pharmaceuticals
April 1, 2015 - Kala Pharmaceuticals Announces Positive Results from Phase 2 Trial of KPI-121 in Dry Eye Disease
» Press Release | Company News

Agios Pharmaceuticals
March 24, 2015 - Agios Pharmaceuticals Announces Orphan Drug Designation of AG-348 for Treatment of Pyruvate Kinase Deficiency
» Press Release | Company News

Blueprint Medicines
March 23, 2015 - Blueprint Medicines Appoints Charles A. Rowland, Jr. to its Board of Directors
» Press Release | Company News

Foundation Medicine
March 23, 2015 - Foundation Medicine and Collaborators to Present New Data in 20 Oral and Poster Presentations at the 2015 USCAP Annual Meeting
» Press Release | Company News

Foundation Medicine
March 23, 2015 - Foundation Medicine Announces Executive Promotions and Expanded Leadership Team to Complement Global Growth Initiatives
» Press Release | Company News

Foundation Medicine
March 23, 2015 - Foundation Medicine Announces Proposed Changes to its Board of Directors in Connection with the Pending Roche Transaction
» Press Release | Company News

Zafgen
March 19, 2015 - Zafgen Reports Fourth Quarter and Full Year 2014 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
March 18, 2015 - Allena Pharmaceuticals Announces Positive Phase 2a Data of ALLN-177 for the Treatment of Hyperoxaluria
» Press Release | Company News

bluebird bio
March 18, 2015 - bluebird bio to Present at Alliance for Regenerative Medicine’s 3rd Annual Regen Med Investor Day
» Press Release | Company News

CytomX Therapeutics
March 18, 2015 - CytomX Appoints Immuno-Oncology Leader Rachel Humphrey, M.D., to Board of Directors
» Press Release | Company News

Blueprint Medicines
March 16, 2015 - Blueprint Medicines Publishes Preclinical Proof-of-Concept Data on Promising New Therapy for Patients with Genomically Defined Hepatocellular Carcinoma
» Press Release | Company News

REVOLUTION Medicines
March 12, 2015 - Major Advances in Synthetic Chemistry Reported in Science by Founding Scientist of REVOLUTION Medicines
» Press Release | Company News

Zafgen
March 12, 2015 - Zafgen to Host Conference Call to Discuss Fourth Quarter and Full Year 2014 Financial Results
» Press Release | Company News

Zafgen
March 7, 2015 - Zafgen Announces New Weight Loss and Safety Data from Phase 2 Trial of Beloranib in Hypothalamic Injury Associated Obesity at ENDO 2015
» Press Release | Company News

REVOLUTION Medicines
March 5, 2015 - REVOLUTION Medicines Expands Executive Leadership Team
» Press Release | Company News

Sesen Bio
March 4, 2015 - Eleven Biotherapeutics Reports Fourth Quarter and Year-End 2014 Financial Results
» Press Release | Company News

Warp Drive Bio
March 4, 2015 - Warp Drive Bio Appoints Industry Veteran Laurence Reid, Ph.D., to Chief Executive Officer
» Press Release | Company News

Blueprint Medicines
March 3, 2015 - Blueprint Medicines Announces Strategic Collaboration with Alexion to Advance Kinase Drug Candidates in Rare Genetic Disease
» Press Release | Company News

Myokardia
March 3, 2015 - MyoKardia Announces Initiation of Phase 1 Clinical Study of MYK-461 for Hypertrophic Cardiomyopathy
» Press Release | Company News

Editas Medicine
March 2, 2015 - Editas Medicine Reports New Data Demonstrating Potential of CRISPR/Cas9 Construct as Novel Gene Repair Mechanism
» Press Release | Company News

CytomX Therapeutics
March 2, 2015 - CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates
» Press Release | Company News

SAGE Therapeutics
February 27, 2015 - SAGE Therapeutics Reports Fourth Quarter and Full Year 2014 Financial Results
» Press Release | Company News

Zafgen
February 27, 2015 - Zafgen Joins NORD to Support Rare Disease Day(R)
» Press Release | Company News

CytomX Therapeutics
February 26, 2015 - CytomX to Present at Cowen and Company 35th Annual Health Care Conference
» Press Release | Company News

Zafgen
February 26, 2015 - Zafgen to Present at Cowen and Company 35th Annual Health Care Conference
» Press Release | Company News

Afferent Pharmaceuticals
February 26, 2015 - Afferent Clinical Data for Lead Candidate, AF-219, Demonstrate Improvements in Pain and Urinary Urgency in Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
» Press Release | Company News

bluebird bio
February 25, 2015 - bluebird bio Reports Fourth Quarter and Full Year 2014 Financial Results and Recent Operational Progress
» Press Release | Company News

Foundation Medicine
February 25, 2015 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

Jounce Therapeutics
February 25, 2015 - Jounce Therapeutics to Present at the Cowen and Company 35th Annual Health Care Conference
» Press Release | Company News

bluebird bio
February 24, 2015 - bluebird bio Announces Participation in Upcoming Investor Conferences
» Press Release | Company News

Sesen Bio
February 24, 2015 - Eleven Biotherapeutics to Present at Cowen & Company 35th Annual Health Care Conference
» Press Release | Company News

Foundation Medicine
February 24, 2015 - Foundation Medicine Announces 2014 Fourth Quarter and Year-End Results, Recent Highlights and 2015 Outlook
» Press Release | Company News

Sesen Bio
February 23, 2015 - Eleven Biotherapeutics to Report Fourth Quarter and Full Year 2014 Financial Results on March 4, 2015
» Press Release | Company News

Foundation Medicine
February 23, 2015 - Foundation Medicine and H3 Biomedicine Announce Collaboration to Develop Precision Therapies for Cancer
» Press Release | Company News

Agios Pharmaceuticals
February 20, 2015 - Agios Pharmaceuticals to Present at Cowen and Company 35th Annual Health Care Conference on Monday, March 2
» Press Release | Company News

Voyager Therapeutics
February 20, 2015 - Voyager Therapeutics to Present at Cowen and Company 35th Annual Health Care Conference
» Press Release | Company News

Foundation Medicine
February 19, 2015 - Foundation Medicine to Present New Clinical Data on Clinical Applications of FoundationOne® at the 16th Annual Advances in Genome Biology and Technology Meeting
» Press Release | Company News

Zafgen
February 18, 2015 - Zafgen to Present at the 2015 RBC Capital Markets Conference
» Press Release | Company News

Agios Pharmaceuticals
February 17, 2015 - Agios Pharmaceuticals Reports Fourth Quarter and Full Year 2014 Financial Results
» Press Release | Company News

SAGE Therapeutics
February 13, 2015 - SAGE Therapeutics Appoints New Vice Presidents to Lead Key Organizational Functions
» Press Release | Company News

Foundation Medicine
February 12, 2015 - New Data from FoundationOne® Demonstrates Genomic Basis for Potential New Routes to Therapy and Improved Outcomes for Individuals with Cancers of Unknown Primary
» Press Release | Company News

Voyager Therapeutics
February 11, 2015 - Voyager Therapeutics & Genzyme Announce Major Strategic Collaboration to Develop and Commercialize Novel AAV Gene Therapies for Patients with CNS Disorders
» Press Release | Company News

Blueprint Medicines
February 11, 2015 - Blueprint Medicines Appoints Anthony Boral, M.D., Ph.D., as Senior Vice President, Clinical Development
» Press Release | Company News

Agios Pharmaceuticals
February 10, 2015 - Agios Pharmaceuticals to Webcast Conference Call of Fourth Quarter and Full Year 2014 Financial Results on February 17, 2015
» Press Release | Company News

GBT
February 10, 2015 - Global Blood Therapeutics Strengthens Management Team with Addition of Vice President of Program Leadership and Business Strategy
» Press Release | Company News

bluebird bio
February 5, 2015 - bluebird bio to Present at the Leerink Global Healthcare Conference
» Press Release | Company News

GBT
February 5, 2015 - Global Blood Therapeutics to Present at 17th Annual BIO CEO & Investor Conference
» Press Release | Company News

REVOLUTION Medicines
February 4, 2015 - Third Rock Ventures Launches REVOLUTION Medicines with $45 Million Series A to Redesign Evolution’s Products to Treat Serious Diseases
» Press Release | Company News

Foundation Medicine
February 4, 2015 - Foundation Medicine to Present at the Leerink Global Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
February 3, 2015 - Agios Pharmaceuticals to Present at the 2015 Leerink Global Healthcare Conference on Wednesday, February 11
» Press Release | Company News

Foundation Medicine
February 3, 2015 - Foundation Medicine Announces Timing for Fourth Quarter and Year-End 2014 Financial Results and Conference Call
» Press Release | Company News

bluebird bio
February 2, 2015 - FDA Grants Breakthrough Therapy Designation to LentiGlobin for Treatment of Beta-Thalassemia Major
» Press Release | Company News

bluebird bio
January 29, 2015 - bluebird bio Announces Transition of Chief Scientific Officer
» Press Release | Company News

Sesen Bio
January 29, 2015 - Eleven Biotherapeutics to Present at Upcoming Investor Conferences in February
» Press Release | Company News

SAGE Therapeutics
January 28, 2015 - SAGE Therapeutics Announces Participation in February Conferences
» Press Release | Company News

Zafgen
January 28, 2015 - Zafgen Announces Closing of Public Offering of Common Stock and Full-Exercise of Option to Purchase Additional Shares
» Press Release | Company News

Sesen Bio
January 22, 2015 - Eleven Biotherapeutics Appoints Barry Gertz, MD, PhD, and Jay S. Duker, MD, to Board of Directors
» Press Release | Company News

Zafgen
January 22, 2015 - Zafgen Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Foundation Medicine
January 12, 2015 - Foundation Medicine Enters a Broad, Strategic Collaboration with Roche in the Field of Molecular Information in Oncology
» Press Release | Company News

Agios Pharmaceuticals
January 12, 2015 - Agios Announces that Celgene Has Agreed to Exercise its Option to License AG-120 under Global Strategic
» Press Release | Company News

Editas Medicine
January 12, 2015 - Editas Medicine Reports New Data Characterizing Novel Properties of Staphylococcus aureus Cas9 as a Tool for CRISPR-Based Genome Engineering
» Press Release | Company News

Foundation Medicine
January 12, 2015 - Foundation Medicine Reports Preliminary 2014 Results
» Press Release | Company News

GBT
January 12, 2015 - Global Blood Therapeutics Announces First Cohort Dosed in Phase I/II Trial of GBT440 in Sickle Cell Disease
» Press Release | Company News

SAGE Therapeutics
January 12, 2015 - SAGE Therapeutics Initiates Phase 2a Trial of SAGE-547 in Postpartum Depression
» Press Release | Company News

Foundation Medicine
January 9, 2015 - FoundationOne® Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer
» Press Release | Company News

SAGE Therapeutics
January 9, 2015 - SAGE Therapeutics Reports Updated Data From Ongoing Clinical Trial and Emergency Use Program of SAGE-547 in Patients With Super-Refractory Status Epilepticus
» Press Release | Company News

Allena Pharmaceuticals
January 8, 2015 - Allena Pharmaceuticals to Present at 2015 J.P. Morgan Healthcare Conference
» Press Release | Company News

Blueprint Medicines
January 8, 2015 - Blueprint Medicines to Present at the 33rd Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Foundation Medicine
January 8, 2015 - Foundation Medicine and Collaborators to Present New Clinical Data on the Application of FoundationOne® at the 2015 Gastrointestinal Cancers Symposium
» Press Release | Company News

GBT
January 8, 2015 - Willie L. Brown, Jr. Joins the Board of Directors of Global Blood Therapeutics
» Press Release | Company News

Jounce Therapeutics
January 8, 2015 - Jounce Therapeutics Appoints Deborah Law, D. Phil., to Chief Scientific Officer
» Press Release | Company News

Foundation Medicine
January 7, 2015 - Foundation Medicine Launches ICE 2, Its New Version of Interactive Cancer Explorer, Featuring PatientMatch
» Press Release | Company News

Zafgen
January 7, 2015 - Zafgen Announces Positive Results From Phase 2 Clinical Trial of Beloranib in Hypothalamic Injury Associated Obesity
» Press Release | Company News

bluebird bio
January 6, 2015 - bluebird bio to Present at the 33rd Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

CytomX Therapeutics
January 6, 2015 - CytomX Raises $20 Million in Series C Round Led by Pfizer Venture Investments
» Press Release | Company News

Foundation Medicine
January 6, 2015 - Foundation Medicine to Present at the J.P. Morgan Healthcare Conference
» Press Release | Company News

GBT
January 6, 2015 - Global Blood Therapeutics Completes $48 Million Series B Financing
» Press Release | Company News

Jounce Therapeutics
January 6, 2015 - Jounce Therapeutics to Present at the J.P. Morgan Healthcare Conference
» Press Release | Company News

Myokardia
January 6, 2015 - MyoKardia to Present at the 33rd Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

Agios Pharmaceuticals
January 5, 2015 - Agios Pharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference on Monday, January 12
» Press Release | Company News

CytomX Therapeutics
January 5, 2015 - CytomX Expands Leadership Team with Addition of Michael Kavanaugh, M.D., as Chief Scientific Officer and Head of Research and Early Development
» Press Release | Company News

GBT
January 5, 2015 - Global Blood Therapeutics to Present at Upcoming Investor Conferences
» Press Release | Company News

SAGE Therapeutics
January 5, 2015 - SAGE Therapeutics to Present at 33rd Annual J.P. Morgan Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
December 17, 2014 - SAGE Therapeutics Added to NASDAQ Biotechnology Index
» Press Release | Company News

Agios Pharmaceuticals
December 16, 2014 - Agios Pharmaceuticals Announces Closing of Public Offering and Full Exercise of Over-Allotment Option
» Press Release | Company News

Foundation Medicine
December 16, 2014 - Foundation Medicine to Be Added to NASDAQ Biotechnology Index
» Press Release | Company News

Zafgen
December 16, 2014 - Zafgen Added to NASDAQ Biotechnology Index
» Press Release | Company News

bluebird bio
December 15, 2014 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

Zafgen
December 15, 2014 - Zafgen Announces Initiation of Phase 2b Trial of Beloranib in Severe Obesity
» Press Release | Company News

Rhythm Pharmaceuticals
December 11, 2014 - Rhythm Appoints Fred T. Fiedorek, M.D., Chief Medical Officer
» Press Release | Company News

Voyager Therapeutics
December 11, 2014 - Voyager Therapeutics and MassBiologics Announce Strategic Collaboration for Viral Vector Manufacturing
» Press Release | Company News

Agios Pharmaceuticals
December 10, 2014 - Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
December 9, 2014 - Agios Pharmaceuticals Announces Proposed Offering of Common Stock
» Press Release | Company News

Agios Pharmaceuticals
December 9, 2014 - Agios Pharmaceuticals Appoints Kaye Foster-Cheek to its Board of Directors
» Press Release | Company News

Foundation Medicine
December 9, 2014 - New Clinical Data Supports the Use of FoundationOne® Heme to Enable Informed Treatment Decisions in a Wide Range of Hematologic Malignancies
» Press Release | Company News

Foundation Medicine
December 9, 2014 - FoundationOne® Identifies Clinically Relevant Genomic Alterations in Patients with Advanced Breast Cancers
» Press Release | Company News

Foundation Medicine
December 8, 2014 - Treatment for Relapsed Multiple Myeloma Patients Guided by FoundationOne® Heme Results in Promising Clinical Activity
» Press Release | Company News

Agios Pharmaceuticals
December 8, 2014 - Agios Announces Celgene Decision to Extend Discovery Phase of Global Strategic Collaboration to April 2016
» Press Release | Company News

Agios Pharmaceuticals
December 8, 2014 - Agios Reports Positive Phase 1 Data in Healthy Volunteers for AG-348, a First-in-Class Investigational Medicine That Targets the Underlying Cause of Pyruvate Kinase (PK) Deficiency
» Press Release | Company News

GBT
December 8, 2014 - Global Blood Therapeutics’ GBT440 Demonstrates Ability to Positively Impact Fundamental Sickle Cell Disease (SCD) Processes in Studies Presented at 2014 American Society of Hematology (ASH) Conference
» Press Release | Company News

bluebird bio
December 8, 2014 - bluebird bio Announces Data Demonstrating First Four Patients with β-Thalassemia Major Treated with LentiGlobin™ are Transfusion-Free
» Press Release | Company News

Blueprint Medicines
December 8, 2014 - Blueprint Medicines Debuts Comprehensive Preclinical Data Set on First Selective Drug for Patients with Systemic Mastocytosis at 2014 American Society of Hematology Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
December 7, 2014 - Agios Announces New Data from Ongoing Phase 1 Trial of AG-221 Showing Robust Clinical Activity in Patients with Advanced Hematologic Malignancies
» Press Release | Company News

Ablexis
December 4, 2014 - Ablexis Announces Availability of the AlivaMab Mouse Technology and Settlement of the Litigation with Regeneron Pharmaceuticals, Inc.
» Press Release | Company News

Allena Pharmaceuticals
December 4, 2014 - Allena Pharmaceuticals Secures $25 Million Series B Financing
» Press Release | Company News

Ninepoint Medical
December 4, 2014 - NinePoint Medical Appoints Christopher von Jako, Ph.D., to Chief Executive Officer
» Press Release | Company News

Afferent Pharmaceuticals
December 3, 2014 - Afferent Pharmaceuticals Announces the Election of Dr. Peter Hirth to the Company’s Board of Directors
» Press Release | Company News

Foundation Medicine
December 3, 2014 - Foundation Medicine and Collaborators to Present New Clinical Data on the Application of FoundationOne® in Breast Cancer at the 2014 San Antonio Breast Cancer Symposium
» Press Release | Company News

Foundation Medicine
December 2, 2014 - Foundation Medicine Appoints David J. Daly as Chief Commercial Officer
» Press Release | Company News

Foundation Medicine
December 2, 2014 - Foundation Medicine and Flatiron Health Collaborate to Develop First-in-Class Data Platform to Accelerate Precision Medicine for Cancer
» Press Release | Company News

GBT
December 2, 2014 - Global Blood Therapeutics to Present New Data Highlighting Therapeutic Potential of GBT440 in Sickle Cell Disease (SCD) at 2014 American Society of Hematology (ASH) Conference
» Press Release | Company News

Nurix, Inc.
December 2, 2014 - Nurix Launches Collaboration with Mount Sinai Hospital’s Lunenfeld-Tanenbaum Research Institute to Expand its Drug Discovery Program
» Press Release | Company News

Editas Medicine
December 1, 2014 - Editas Medicine Licenses Genome Editing Technology from Broad Institute and Harvard University
» Press Release | Company News

Editas Medicine
December 1, 2014 - Editas Medicine Licenses Genome Editing Technology from Massachusetts General Hospital
» Press Release | Company News

Sesen Bio
November 26, 2014 - Eleven Biotherapeutics to Present at Oppenheimer 25th Annual Healthcare Conference
» Press Release | Company News

Afferent Pharmaceuticals
November 25, 2014 - Afferent Clinical Data Demonstrating AF-219 Treatment Reduces Cough Frequency by 75% in Chronic Cough Is Published in The Lancet
» Press Release | Company News

Sesen Bio
November 25, 2014 - Eleven Biotherapeutics Announces Additional Financing of $20 Million
» Press Release | Company News

Foundation Medicine
November 25, 2014 - Foundation Medicine to Present at the Piper Jaffray Healthcare Conference
» Press Release | Company News

Blueprint Medicines
November 20, 2014 - Blueprint Medicines Unveils New Drug Discovery Program for Patients with RET Fusions at 26th EORTC-NCI-AACR Symposium
» Press Release | Company News

Foundation Medicine
November 19, 2014 - Foundation Medicine's Novel Companion Diagnostic Test, Developed in Collaboration with Clovis Oncology, Identifies Expanded Subgroup of Cancer Patients with the Potential to Respond to Clovis Oncology's PARP inhibitor, Rucaparib
» Press Release | Company News

Agios Pharmaceuticals
November 18, 2014 - Agios Pharmaceuticals Announces Early Phase 1 Data Showing Clinical Activity of AG-120 as a Single Agent in Advanced Acute Myeloid Leukemia (AML)
» Press Release | Company News

Blueprint Medicines
November 13, 2014 - Blueprint Medicines to Present Discovery of New Cancer Drug Targets at EORTC-NCI-AACR Symposium
» Press Release | Company News

Sesen Bio
November 13, 2014 - Eleven Biotherapeutics Reports Third Quarter 2014 Financial Results
» Press Release | Company News

Foundation Medicine
November 13, 2014 - Foundation Medicine to Present at Upcoming Investor Conferences
» Press Release | Company News

bluebird bio
November 12, 2014 - bluebird bio Reports Fiscal Third Quarter 2014 Financial Results
» Press Release | Company News

Blueprint Medicines
November 12, 2014 - Blueprint Medicines Secures $50 Million in Series C Financing
» Press Release | Company News

Foundation Medicine
November 12, 2014 - The Robert H. Lurie Comprehensive Cancer Center of Northwestern University and the Northwestern Medicine Developmental Therapeutics Institute Partner with Foundation Medicine to Launch Innovative Clinical Translation Program
» Press Release | Company News

SAGE Therapeutics
November 11, 2014 - SAGE Therapeutics Reports Third Quarter 2014 Results
» Press Release | Company News

Zafgen
November 11, 2014 - Zafgen Reports Third Quarter 2014 Financial Results
» Press Release | Company News

Allena Pharmaceuticals
November 10, 2014 - Allena Pharmaceuticals To Present Data on Lead Program ALLN-177 at ASN Kidney Week 2014
» Press Release | Company News

bluebird bio
November 10, 2014 - James M. DeTore joins bluebird bio as Chief Financial Officer
» Press Release | Company News

SAGE Therapeutics
November 10, 2014 - SAGE Therapeutics Reports Positive Top-Line Phase 2 Data of SAGE-547 in Patients With Super-Refractory Status Epilepticus
» Press Release | Company News

Agios Pharmaceuticals
November 7, 2014 - Agios Pharmaceuticals Reports Third Quarter 2014 Financial Results
» Press Release | Company News

bluebird bio
November 7, 2014 - bluebird bio to Present at Three Upcoming Health Care Conferences
» Press Release | Company News

SAGE Therapeutics
November 7, 2014 - SAGE Therapeutics Announces Six Scientific Presentations at Neuroscience 2014, the Society for Neuroscience's 44th Annual Meeting
» Press Release | Company News

Agios Pharmaceuticals
November 6, 2014 - Agios Pharmaceuticals to Present Clinical and Preclinical Data at the 2014 American Society of Hematology Annual Meeting
» Press Release | Company News

bluebird bio
November 6, 2014 - bluebird bio to Present LentiGlobin Clinical Data at the American Society of Hematology Conference
» Press Release | Company News

Foundation Medicine
November 6, 2014 - Foundation Medicine and Collaborators to Present New Clinical Data on FoundationOne® Heme at the American Society of Hematology Annual Meeting
» Press Release | Company News

Foundation Medicine
November 5, 2014 - Foundation Medicine Announces 2014 Third Quarter Results and Recent Highlights
» Press Release | Company News

SAGE Therapeutics
November 5, 2014 - SAGE to Present at Credit Suisse 23rd Annual Healthcare Conference
» Press Release | Company News

Sesen Bio
November 4, 2014 - Eleven Biotherapeutics to Report Third Quarter 2014 Financial Results on November 13, 2014
» Press Release | Company News

Foundation Medicine
November 4, 2014 - Foundation Medicine Signs Data Partnership with Cancer Outcomes Tracking and Analysis (COTA, Inc.) to Inform Value-Based Cancer Treatment
» Press Release | Company News

Sesen Bio
November 3, 2014 - Eleven Biotherapeutics Completes Enrollment in Pivotal Phase 3 Study of EBI-005 in Patients with Dry Eye Disease
» Press Release | Company News

Foundation Medicine
November 3, 2014 - Foundation Medicine Partners with EmergingMed to Offer Clinical Trial Navigation Services for Physicians and Patients
» Press Release | Company News

SAGE Therapeutics
November 3, 2014 - First Evaluation of SAGE-547 to Treat Super-Refractory Status Epilepticus in Children Published in Annals of Neurology
» Press Release | Company News

Agios Pharmaceuticals
October 27, 2014 - Agios Pharmaceuticals to Webcast Conference Call of Third Quarter 2014 Financial Results on November 7, 2014
» Press Release | Company News

Rhythm Pharmaceuticals
October 24, 2014 - Rhythm Presents Positive Phase 2 Study Results for Relamorelin for Chronic Constipation
» Press Release | Company News

Alcresta Therapeutics
October 23, 2014 - Alcresta Presents New Data Demonstrating Potential of Proprietary Enzyme-Based Technology to Improve Nutrition in Patients with Exocrine Pancreatic Insufficiency
» Press Release | Company News

Sesen Bio
October 23, 2014 - Eleven Biotherapeutics Appoints Wendy L. Dixon, PhD to Board of Directors
» Press Release | Company News

SAGE Therapeutics
October 23, 2014 - SAGE Therapeutics Initiates Exploratory Study of SAGE-547 in Essential Tremor
» Press Release | Company News

Foundation Medicine
October 22, 2014 - Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to Offer Best-in-Class Comprehensive Genomic Profiling in China
» Press Release | Company News

Rhythm Pharmaceuticals
October 22, 2014 - Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin
» Press Release | Company News

Agios Pharmaceuticals
October 21, 2014 - Agios Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of AG-221 in Patients with Advanced Solid Tumors with an IDH2 Mutation
» Press Release | Company News

Voyager Therapeutics
October 21, 2014 - Voyager Therapeutics Commemorates Opening of New Headquarters
» Press Release | Company News

Foundation Medicine
October 16, 2014 - Priority Health is First Health Plan to Cover FoundationOne® and FoundationOne® Heme to Enhance Precision Cancer Treatment
» Press Release | Company News

Foundation Medicine
October 16, 2014 - Foundation Medicine Announces Timing for Third Quarter 2014 Financial Results and Conference Call
» Press Release | Company News

Agios Pharmaceuticals
October 15, 2014 - Agios Pharmaceuticals Announces Initiation of Four Expansion Cohorts in Phase 1 Study of AG-221
» Press Release | Company News

bluebird bio
October 14, 2014 - bluebird bio Announces First Patient with Sickle Cell Disease Transplanted with LentiGlobin Gene Therapy
» Press Release | Company News

Blueprint Medicines
October 14, 2014 - Blueprint Medicines to Present at JMP Securities Life Sciences Private Company Conference
» Press Release | Company News

Constellation Pharmaceuticals
October 9, 2014 - Constellation meets contractual milestones and receives balance of $15 million loan
» Press Release | Company News

Sesen Bio
October 7, 2014 - Eleven Biotherapeutics Granted U.S. Composition-of-Matter Patent for EBI-005
» Press Release | Company News

Agios Pharmaceuticals
October 6, 2014 - Agios Pharmaceuticals to Webcast R&D Day on October 15, 2014
» Press Release | Company News

Sesen Bio
October 2, 2014 - Eleven Biotherapeutics Announces Top-Line Results from Phase 2 Study of EBI-005 in Patients with Moderate to Severe Allergic Conjunctivitis
» Press Release | Company News

Zafgen
October 1, 2014 - Zafgen Announces Initiation of Phase 3 Trial of Beloranib in Prader-Willi Syndrome
» Press Release | Company News

Blueprint Medicines
September 30, 2014 - Blueprint Medicines to Present at 13th Annual BIO Investor Forum
» Press Release | Company News

Agios Pharmaceuticals
September 26, 2014 - Agios Pharmaceuticals to Present Clinical Data from AG-120 Ongoing Phase 1 Study in Hematologic Malignancies at EORTC-NCI-AACR 2014
» Press Release | Company News

SAGE Therapeutics
September 25, 2014 - SAGE Therapeutics to Participate in the 2014 Leerink Partners Rare Disease Roundtable
» Press Release | Company News

Zafgen
September 25, 2014 - Zafgen Completes Enrollment of Phase 2a Trial of Beloranib in Hypothalamic Injury-Associated Obesity
» Press Release | Company News

Zafgen
September 24, 2014 - Zafgen to Present at 2014 Leerink Partners Rare Disease Roundtable
» Press Release | Company News

Agios Pharmaceuticals
September 23, 2014 - Agios Pharmaceuticals to Present at the 2014 Leerink Partners Rare Disease Roundtable
» Press Release | Company News

Editas Medicine
September 22, 2014 - FierceBiotech names Editas Medicine as one of its Fierce 15 Biotech Companies of 2014
» Press Release | Company News

Voyager Therapeutics
September 22, 2014 - FierceBiotech Names Voyager Therapeutics as one of its “Fierce 15” Biotech Companies of 2014
» Press Release | Company News

Blueprint Medicines
September 19, 2014 - First Discovery Of Actionable Genetic Alterations In A Deadly Cancer Reported By Personal Genome Diagnostics And Blueprint Medicines
» Press Release | Company News

Nurix, Inc.
September 18, 2014 - Nurix, Inc. Names Arthur T. Sands, M.D., Ph.D., Chief Executive Officer
» Press Release | Company News

Zafgen
September 18, 2014 - Frances K. Heller Rejoins Zafgen Board of Directors
» Press Release | Company News

Myokardia
September 17, 2014 - Sanofi and MyoKardia Announce Groundbreaking Collaboration to Develop Targeted Therapies for Patients with Genetic Heart Disease
» Press Release | Company News

SAGE Therapeutics
September 16, 2014 - SAGE Therapeutics Appoints Michael F. Cola to the Company's Board of Directors
» Press Release | Company News

Afferent Pharmaceuticals
September 10, 2014 - Afferent Pharmaceuticals Names Kathleen Sereda Glaub as Chief Executive Officer
» Press Release | Company News

Blueprint Medicines
September 10, 2014 - Blueprint Medicines Discovers Novel Cancer Drug Targets
» Press Release | Company News

Blueprint Medicines
September 9, 2014 - Blueprint Medicines to Participate in Morgan Stanley Global Healthcare Conference 2014
» Press Release | Company News

Blueprint Medicines
September 8, 2014 - Blueprint Medicines Presents Positive Data on BLU-554 for Hepatocellular Carcinoma
» Press Release | Company News

Voyager Therapeutics
September 3, 2014 - Voyager Therapeutics Appoints Steven Paul, M.D., to Chief Executive Officer
» Press Release | Company News

Foundation Medicine
September 3, 2014 - Foundation Medicine to Present at the Morgan Stanley Global Healthcare Conference
» Press Release | Company News

SAGE Therapeutics
September 2, 2014 - SAGE Therapeutics Presents New Preclinical Data on SAGE-217 at Eilat Conference on New Anti-Epileptic Drugs
» Press Release | Company News

Sesen Bio
August 28, 2014 - Eleven Biotherapeutics to Participate in Upcoming Investor Conferences in September
» Press Release | Company News

Rhythm Pharmaceuticals
August 27, 2014 - Rhythm Files Registration Statement for Proposed Initial Public Offering
» Press Release | Company News

SAGE Therapeutics
August 14, 2014 - SAGE Therapeutics Reports Second Quarter 2014 Financial Results
» Press Release | Company News

Agios Pharmaceuticals
August 13, 2014 - Agios Pharmaceuticals Announces the U.S. FDA Grants Fast Track Designation to AG-221 for Treatment of Patients With Acute Myelogenous Leukemia That Harbor an IDH2 Mutation
» Press Release | Company News

Sesen Bio
August 13, 2014 - Eleven Biotherapeutics Reports Second Quarter 2014 Financial Results
» Press Release | Company News

Seventh Sense BioSystems
August 13, 2014 - Seventh Sense Biosystems Closes $16 Million Series B Financing
» Press Release | Company News

Taris Biomedical
August 13, 2014 - Allergan Acquires LiRIS® Program from TARIS Biomedical®
» Press Release | Company News

Zafgen
August 13, 2014 - Zafgen Reports Second Quarter 2014 Financial Results
» Press Release | Company News

bluebird bio
August 12, 2014 - bluebird bio Reports Fiscal Second Quarter 2014 Financial Results
» Press Release | Company News

Foundation Medicine
August 12, 2014 - Foundation Medicine Announces 2014 Second Quarter Results and Recent Highlights
» Press Release | Company News

Foundation Medicine
August 12, 2014 - Foundation Medicine to Present at the Wedbush 2014 Life Sciences Conference
» Press Release | Company News

Zafgen
August 11, 2014 - Zafgen to Present at 34th Annual Canaccord Genuity Growth Conference
» Press Release | Company News

Agios Pharmaceuticals
August 7, 2014 - Agios Pharmaceuticals Reports Second Quarter 2014 Financial Results
» Press Release | Company News

Foundation Medicine
August 7, 2014 - Foundation Medicine Appoints Lisa Ricciardi Senior Vice President, Corporate and Business Development
» Press Release | Company News

SAGE Therapeutics
August 7, 2014 - SAGE Therapeutics to Present at Canaccord Genuity 34th Annual Growth Conference
» Press Release | Company News

Zafgen
August 7, 2014 - Zafgen to Host Conference Call to Discuss Second Quarter 2014 Financial Results
» Press Release | Company News

Blueprint Medicines
August 6, 2014 - Blueprint Medicines to Present at Wedbush 2014 Life Sciences Management Access Conference
» Press Release | Company News

bluebird bio
August 5, 2014 - bluebird bio to Present at Two Upcoming Health Care Conferences
» Press Release | Company News

Constellation Pharmaceuticals
August 4, 2014 - Constellation Expands Clinical Studies of CPI-0610
» Press Release | Company News

GBT
August 4, 2014 - Global Blood Therapeutics Names Hing Sham Senior Vice President of Chemistry, Promotes Uma Sinha to Chief Scientific Officer
» Press Release | Company News

Sesen Bio
August 1, 2014 - Eleven Biotherapeutics to Report Second Quarter 2014 Financial Results on August 13, 2014
» Press Release | Company News

Voyager Therapeutics
August 1, 2014 - Dinah Sah, Senior Vice President of Neuroscience and Rob Kotin, Vice President of Production Honored Among PharmaVOICE 100 Most Inspiring People
» Press Release | Company News

Kala Pharmaceuticals
July 31, 2014 - Kala Pharmaceuticals Initiates Phase 2 Clinical Trial to Evaluate LE-MPP (KPI-121) in Patients with Retinal Vein Occlusion and Diabetic Macular Edema
» Press Release | Company News

Foundation Medicine
July 29, 2014 - Foundation Medicine Releases Enhanced Version of FoundationOne®
» Press Release | Company News

Sesen Bio
July 29, 2014 - Eleven Biotherapeutics to Present at Wedbush 2014 Life Sciences Management Access Conference
» Press Release | Company News

Agios Pharmaceuticals
July 28, 2014 - Agios Pharmaceuticals to Webcast Conference Call of Second Quarter 2014 Financial Results on August 7, 2014
» Press Release | Company News

Blueprint Medicines
July 24, 2014 - Blueprint Medicines Appoints Jeffrey Albers as Chief Executive Officer
» Press Release | Company News

Foundation Medicine
July 23, 2014 - Foundation Medicine Partners with the Addario Lung Cancer Medical Institute for Innovative Prospective Study Linking the Genomic Drivers of Lung Cancer in Young Adults with Treatment Options
» Press Release | Company News

SAGE Therapeutics
July 23, 2014 - SAGE Therapeutics Announces Closing of Initial Public Offering
» Press Release | Company News

SAGE Therapeutics
July 22, 2014 - SAGE Therapeutics Receives Fast Track Designation for Lead Compound SAGE-547 to Treat Status Epilepticus
» Press Release | Company News

SAGE Therapeutics
July 21, 2014 - SAGE Therapeutics Announces Full Exercise of Over-Allotment Option
» Press Release | Company News

Foundation Medicine
July 17, 2014 - Foundation Medicine Receives Approvals from New York State Department of Health for FoundationOne® and FoundationOne Heme®
» Press Release | Company News

SAGE Therapeutics
July 17, 2014 - SAGE Therapeutics Announces Pricing of Initial Public Offering
» Press Release | Company News

bluebird bio
July 16, 2014 - bluebird bio Appoints Mark Vachon to its Board of Directors
» Press Release | Company News

Foundation Medicine
July 16, 2014 - Foundation Medicine Announces Timing for Second Quarter 2014 Financial Results and Conference Call
» Press Release | Company News

Zafgen
July 10, 2014 - Zafgen Granted Orphan Drug Designation in the European Union for Beloranib, a first-in-class METAP2 Inhibitor for the Treatment of Prader-willi Syndrome
» Press Release | Company News

Jounce Therapeutics
July 10, 2014 - Jounce Therapeutics Appoints Richard Murray, Ph.D., to Chief Executive Officer
» Press Release | Company News

bluebird bio
July 8, 2014 - bluebird bio Announces Pricing of Public Offering of Common Stock
» Press Release | Company News

bluebird bio
July 7, 2014 - bluebird bio Announces Proposed Public Offering of Common Stock
» Press Release | Company News

Corvia Medical
July 1, 2014 - DC Devices Closes $34M Series D Financing to Complete Clinical Evaluation of the First Transcatheter Device to Treat Diastolic Heart Failure